FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Messias, CV
   Loss-Morais, G
   de Carvalho, JB
   Gonzalez, MN
   Cunha, DP
   Vasconcelos, Z
   Arge, LWP
   Farias-de-Oliveira, DA
   Gerber, AL
   Portari, EA
   Ferreira, N
   Raphael, LMS
   Bonaldo, MC
   Riederer, I
   Moreira, MEL
   Cotta-de-Almeida, V
   Vasconcelos, ATR
   Mendes-da-Cruz, DA
   Savino, W
AF Messias, Carolina V.
   Loss-Morais, Guilherme
   de Carvalho, Joseane Biso
   Gonzalez, Mariela N.
   Cunha, Daniela P.
   Vasconcelos, Zilton
   Arge, Luis W. P.
   Farias-de-Oliveira, Desio A.
   Gerber, Alexandra L.
   Portari, Elyzabeth A.
   Ferreira, Nilma
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Riederer, Ingo
   Lopes Moreira, Maria E.
   Cotta-de-Almeida, Vinicius
   Vasconcelos, Ana T. R.
   Mendes-da-Cruz, Daniella A.
   Savino, Wilson
TI Zika virus targets the human thymic epithelium
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; NONCODING RNA; MEDIATED INTERACTIONS; CELLS;
   INFECTION; THYMOCYTES; MIGRATION; DIFFERENTIATION; EXPRESSION; MOLECULES
AB Previous work showed that the thymus can be infected by RNA viruses as HIV and HTLV-1. We thus hypothesized that the thymus might also be infected by the Zika virus (ZIKV). Herein we provide compelling evidence that ZIKV targets human thymic epithelial cells (TEC) in vivo and in vitro. ZIKV-infection enhances keratinization of TEC, with a decrease in proliferation and increase in cell death. Moreover, ZIKV modulates a high amount of coding RNAs with upregulation of genes related to cell adhesion and migration, as well as non-coding genes including miRNAs, circRNAs and lncRNAs. Moreover, we observed enhanced attachment of lymphoblastic T-cells to infected TEC, as well as virus transfer to those cells. Lastly, alterations in thymuses from babies congenitally infected were seen, with the presence of viral envelope protein in TEC. Taken together, our data reveals that the thymus, particularly the thymic epithelium, is a target for the ZIKV with changes in the expression of molecules that are relevant for interactions with developing thymocytes.
C1 [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Loss-Morais, Guilherme; de Carvalho, Joseane Biso; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol Flavivirus, Rio De Janeiro, Brazil.
   [Cunha, Daniela P.; Vasconcelos, Zilton; Portari, Elyzabeth A.; Ferreira, Nilma; Lopes Moreira, Maria E.] Fundacao Oswaldo Cruz, Lab High Complex, Fernandes Figueira Natl Inst Hlth Mother Child &, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Vasconcelos, ATR (corresponding author), Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
EM atrv@lncc.br; daniella@ioc.fiocruz.br; wilson.savino@fiocruz.br
RI ; Riederer, Ingo/O-1444-2017; Mendes-da-Cruz, Daniella/E-7875-2016
OI Cunha, Daniela/0000-0002-5954-6054; Riederer, Ingo/0000-0001-7171-9977;
   Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Arge, Luis Willian
   Pacheco/0000-0002-0109-4809
FU Brazilian Funding Agency for Studies and Projects (FINEP)
   [01.16.0078.00]; Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [303170/2017-4, 306699/2018-4,
   307720/2016-0]; Carlos Chagas Filho Foundation for Funding Research in
   the State of Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.826/2018]; Oswaldo Cruz Foundation (Fiocruz); National
   Laboratory for Scientific Computation; Coordination of Superior Level
   Staff Improvement (CAPES) -Brazil [001]; Mercosur Fund for Structural
   Convergence (FOCEM) [03/11]; Program of Preventing and Combating the
   Zika Virus, MCTIC/FNDCT -CNPq/MEC-CAPES/MS-Decit [426767/2018-7,
   88881.130684/2016-01];  [23038.010041/2013-13];  [465489/2014-1]
FX The human postnatal TEC line was kindly provided by Dr. Maria Luiza
   Toribio (Universidad Autonoma de Madrid, Madrid, Spain). The mouse
   monoclonal 4G2 antibody (anti-flavivirus) was gently provided by the
   Laboratory of Monoclonal Antibody Technology from Bio-Manguinhos
   (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil). The authors thank
   Raquel de Souza Martins for confocal analysis assistance. This work was
   funded by Brazilian Funding Agency for Studies and Projects (FINEP)
   #01.16.0078.00; Brazilian National Council for Scientific and
   Technological Development (CNPq) ATRV supported by #303170/2017-4, WS by
   #306699/2018-4, DAMC by #307720/2016-0; Carlos Chagas Filho Foundation
   for Funding Research in the State of Rio de Janeiro (Faperj) ATRV
   supported by #E-26/202.826/2018; the Oswaldo Cruz Foundation (Fiocruz)
   and National Laboratory for Scientific Computation; Coordination of
   Superior Level Staff Improvement (CAPES) -Brazil -Finance Code 001 and
   GLM, JBC and LWPA supported #23038.010041/2013-13; Mercosur Fund for
   Structural Convergence (FOCEM, Mercosur #03/11) and the Program of
   Preventing and Combating the Zika Virus, MCTIC/FNDCT
   -CNPq/MEC-CAPES/MS-Decit (Grants 426767/2018-7 and 88881.130684/2016-01
   for MCB). This work was developed in the framework of the Brazilian
   National Institute of Science and Technology on Neuroimmunomodulation
   (INCT-NIM) WS supported by #465489/2014-1.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Azouz F, 2019, VIRUSES, V11, P1
   Bertoni A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020485
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Braun J, 1996, VIROLOGY, V225, P413, DOI 10.1006/viro.1996.0617
   Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14
   Cadena C, 2017, MOL CELL, V67, P163, DOI 10.1016/j.molcel.2017.07.005
   Carnero E, 2016, EMBO REP, V17, P1013, DOI 10.15252/embr.201541763
   Barros LRC, 2017, IMMUNOBIOLOGY, V222, P1053, DOI 10.1016/j.imbio.2017.08.001
   Cava C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020274
   Dairaghi DJ, 1998, BLOOD, V91, P2905, DOI 10.1182/blood.V91.8.2905.2905_2905_2913
   Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   FERNANDEZ E, 1994, BLOOD, V83, P3245
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LE PT, 1993, INT J CLIN LAB RES, V23, P56, DOI 10.1007/BF02592284
   Limonta D., 2018, VIRUSES, V10, P1
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Liu L, 2019, CELL DEATH DIFFER, V26, P2607, DOI 10.1038/s41418-019-0324-7
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lyu Q, 2019, P NATL ACAD SCI USA, V116, P546, DOI 10.1073/pnas.1810729116
   MAGUERSATTA V, 1995, BLOOD, V86, P1444, DOI 10.1182/blood.V86.4.1444.bloodjournal8641444
   Manca N, 2002, J ACQ IMMUN DEF SYND, V29, P300, DOI 10.1097/00126334-200203010-00012
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Messias CV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4622-y
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Moreira-Ramos K, 2011, MEM I OSWALDO CRUZ, V106, P759, DOI 10.1590/S0074-02762011000600018
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nishitsuji H, 2016, P NATL ACAD SCI USA, V113, P10388, DOI 10.1073/pnas.1525022113
   Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10.1016/j.molimm.2007.05.016
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1988, ENDOCRINOLOGY, V123, P2557, DOI 10.1210/endo-123-5-2557
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Savino W, 2016, NAT REV ENDOCRINOL, V12, P77, DOI 10.1038/nrendo.2015.168
   Savino W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00579
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SINGER KH, 1990, J IMMUNOL, V144, P2931
   Singh P.K., 2018, SCI REP, V8, P1, DOI [10.1038/s41598-018-29329-2., DOI 10.1038/S41598-018-29329-2.]
   Strange DP, 2018, SCI REP, V8, P1
   Wang M, 2017, INT J BIOL SCI, V13, P1497, DOI 10.7150/ijbs.22531
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x
   Zhang CL, 2018, AM J TRANSL RES, V10, P4193
   Zhao JM, 2018, NEOPLASMA, V65, P779, DOI 10.4149/neo_2018_171130N778
NR 66
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 28
PY 2020
VL 10
IS 1
AR 1378
DI 10.1038/s41598-020-58135-y
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NE8OR
UT WOS:000562865600009
PM 31992777
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Messias, CV
   Lemos, JP
   Cunha, DP
   Vasconcelos, Z
   Raphael, LMS
   Bonaldo, MC
   Cister-Alves, B
   Bou-Habib, DC
   Cotta-de-Almeida, V
   Savino, W
   Mendes-da-Cruz, DA
AF Messias, Carolina, V
   Lemos, Julia P.
   Cunha, Daniela P.
   Vasconcelos, Zilton
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Cister-Alves, Bruno
   Bou-Habib, Dumith Chequer
   Cotta-de-Almeida, Vinicius
   Savino, Wilson
   Mendes-da-Cruz, Daniella A.
TI Zika virus infects human blood mononuclear cells
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Lymphocytes; Monocytes; Flow cytometry; RT-qPCR
ID MONOCYTES; TARGET
AB Background Zika virus (ZIKV) infection gained public health concern after the 2015 outbreak in Brazil, when microcephaly rates increased in babies born from infected mothers. It was demonstrated that ZIKV causes a congenital Zika virus syndrome, including various alterations in the development of the central nervous system. Although the infection of cells from the nervous system has been well documented, less is known in respect of ZIKV ability to infect immune cells. Herein, we investigated if peripheral blood mononuclear cells (PBMCs), freshly-isolated from healthy donors, could be infected by ZIKV. Methods PBMCs from healthy donors were isolated and cultured in medium with ZIKV strain Rio-U1 (MOI = 0.1). Infection was analyzed by RT-qPCR and flow cytometry. Results We detected the ZIKV RNA in PBMCs from all donors by RT-qPCR analysis. The detection of viral antigens by flow cytometry revealed that PBMC from more than 50% the donors were infected by ZIKV, with CD3(+)CD4(+) T cells, CD3(-)CD19(+) B cells and CD3(+)CD8(+) T cells being, respectively, the most frequently infected subpopulations, followed by CD14(+) monocytes. Additionally, we observed high variability in PBMC infection rates among different donors, either by numbers or type infected cells. Conclusions These findings raise the hypothesis that PBMCs can act as a reservoir of the virus, which may facilitate viral dissemination to different organs, including immune-privileged sites.
C1 [Messias, Carolina, V; Lemos, Julia P.; Cister-Alves, Bruno; Bou-Habib, Dumith Chequer; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Messias, Carolina, V; Lemos, Julia P.; Cister-Alves, Bruno; Bou-Habib, Dumith Chequer; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Cunha, Daniela P.; Vasconcelos, Zilton] Fundacao Oswaldo Cruz, High Complex Lab, Fernandes Figueira Natl Inst Hlth Mother Infant &, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Mol Biol Flavivirus, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
EM daniareas@yahoo.com.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506
FU Oswaldo Cruz Foundation (Fiocruz); Carlos Chagas Filho Foundation for
   Funding Research in the State of Rio de Janeiro (Faperj)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Brazilian National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brazilian National Coordination for Advancement of
   University Personnel (Capes); Mercosur Fund for Structural Convergence
   (FOCEM) [Mercosur 03/11]
FX This work was funded by the Oswaldo Cruz Foundation (Fiocruz), Carlos
   Chagas Filho Foundation for Funding Research in the State of Rio de
   Janeiro (Faperj), Brazilian National Council for Scientific and
   Technological Development (CNPq), Brazilian National Coordination for
   Advancement of University Personnel (Capes) and Mercosur Fund for
   Structural Convergence (FOCEM-Mercosur 03/11). Additionally, it was
   developed in the framework of the Brazilian National Institute of
   Science and Technology on Neuroimmunomodulation (INCT-NIM). The funding
   body had no role in the design of the study and collection, analysis,
   interpretation of data, nor writing the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 18
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 21
PY 2019
VL 19
IS 1
AR 986
DI 10.1186/s12879-019-4622-y
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA JV9WR
UT WOS:000502710700005
PM 31752731
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Souza, TL
   da Silva, AVA
   Pereira, LDR
   Figueiredo, FB
   Mendes, AAV
   Menezes, RC
   Mendes-da-Cruz, DA
   Boite, MC
   Cupolillo, E
   Porrozzi, R
   Morgado, FN
AF de Souza, Taina Luis
   Andrade da Silva, Aurea Virginia
   Ramos Pereira, Luiza de Oliveira
   Figueiredo, Fabiano Borges
   Velho Mendes Junior, Artur Augusto
   Menezes, Rodrigo Caldas
   Mendes-da-Cruz, Daniella Areas
   Boite, Mariana Cortes
   Cupolillo, Elisa
   Porrozzi, Renato
   Morgado, Fernanda Nazare
TI Pro-Cellular Exhaustion Markers are Associated with Splenic
   Microarchitecture Disorganization and Parasite Load in Dogs with
   Visceral Leishmaniasis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID T-CELLS; B7 FAMILY; APOPTOSIS; LYMPHOCYTES; EXPRESSION; TISSUE; CTLA-4;
   DEATH; INFECTION; RECEPTOR
AB In canine visceral leishmaniasis (CVL), splenic white pulp (SWP) disorganization has been associated with disease progression, reduced cytokine and chemokine expression and failure to control the parasite load. This profile is compatible with the cellular exhaustion previously shown in human visceral leishmaniasis. The present study aimed to evaluate the in situ expression of cellular exhaustion markers and their relation to clinical signs, SWP disorganization and parasite load. Forty dogs naturally infected by Leishmania infantum were grouped according to levels of SWP organization and parasite load. SWP disorganization was associated with reductions in the periarteriolar lymphatic sheath and lymphoid follicles/mm(2) and worsening of the disease. Apoptotic cells expressing CTLA-4(+) increased in dogs with disorganized SWP and a high parasite load. In the same group, PD-L1 and LAG-3 gene expression were reduced. A higher number of CD21(+)TIM-3(+) B cells was detected in disorganized spleens than in organized spleens. Apoptosis is involved in periarteriolar lymphatic sheath reduction and lymphoid follicle atrophy and is associated with CTLA-4(+) cell reductions in the splenic tissue of dogs with visceral leishmaniasis (VL). Failure to control the parasite load was observed, suggesting that cell exhaustion followed by T and B cell apoptosis plays a role in the immunosuppression observed in CVL.
C1 [de Souza, Taina Luis; Andrade da Silva, Aurea Virginia; Ramos Pereira, Luiza de Oliveira; Boite, Mariana Cortes; Cupolillo, Elisa; Porrozzi, Renato; Morgado, Fernanda Nazare] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil.
   [Figueiredo, Fabiano Borges] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Biol Celular, Curitiba, Parana, Brazil.
   [Velho Mendes Junior, Artur Augusto; Menezes, Rodrigo Caldas] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Dermatozoonoses Anim Domest, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, Brazil.
RP Morgado, FN (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil.
EM morgado@ioc.fiocruz.br
RI Menezes, Rodrigo/O-8722-2019; Porrozzi, Renato/U-2166-2019; de Souza,
   Taina Luis/AAN-1975-2020; Morgado, Fernanda N/K-2527-2013; Pereira,
   Luiza O R/P-7606-2018; Mendes-da-Cruz, Daniella/AAN-6644-2020; da Silva,
   Aurea Virginia Andrade/AAD-3022-2019; Boite, Mariana/K-7427-2012
OI Menezes, Rodrigo/0000-0003-1853-3449; Porrozzi,
   Renato/0000-0003-2167-316X; Morgado, Fernanda N/0000-0002-7188-251X;
   Pereira, Luiza O R/0000-0002-8132-1724; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; de Souza, Taina Luis/0000-0001-7151-3354;
   Silva, Aurea Virginia Andrade/0000-0003-1616-4651; Boite,
   Mariana/0000-0002-2903-6280
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   (P.C. Universal grant)National Council for Scientific and Technological
   Development (CNPq) [448951/2014-2, 421223/2018-9]; Fundacao de Amparo a
   Pesquisa do Estado de Rio de Janeiro - FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/010.001018/2016]; PAEF-Fiocruz; IOC-FIOCRUZ, Programa Cientista do
   Nosso Estado [Faperj - E-26/203.069/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq)
FX We are grateful for the administrative staff at Laboratorio de Pesquisa
   em Leishmaniose (LPL-IOC/FIOCRUZ) and Laboratorio de Pesquisa Clinica em
   Dermatozoonoses em Animais Domesticos (LAPCLIN-DERMZOO-INI/FIOCRUZ).
   This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq (P.C. Universal grant Nos 448951/2014-2
   and 421223/2018-9), Fundacao de Amparo a Pesquisa do Estado de Rio de
   Janeiro - FAPERJ (E-26/010.001018/2016), and PAEF-Fiocruz; IOC-FIOCRUZ,
   Programa Cientista do Nosso Estado (Faperj - E-26/203.069/2016). R.P.,
   E.C., R.C.M. and F.B.F. received productivity fellowships from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR da Silva AVA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006445
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09
   Borja LS, 2016, VET PARASITOL, V229, P110, DOI 10.1016/j.vetpar.2016.10.004
   Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
   Cavalcanti AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123009
   Chiku VM, 2016, IMMUNOBIOLOGY, V221, P879, DOI 10.1016/j.imbio.2016.03.007
   Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155
   Costa DL, 2013, PATHOG GLOB HEALTH, V107, P78, DOI 10.1179/2047773213Y.0000000078
   Coy J, 2017, VET COMP ONCOL, V15, P1487, DOI 10.1111/vco.12294
   Doe HT, 2016, MICROBIOL IMMUNOL, V60, P121, DOI 10.1111/1348-0421.12354
   Dong HD, 1999, NAT MED, V5, P1365
   Eichbaum Q, 2011, CURR MED CHEM, V18, P3971, DOI 10.2174/092986711796957239
   Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810
   de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   Hermida MDR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00394
   Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1
   Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431
   Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742
   Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176
   Maia C, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/541571
   Miranda S, 2007, VET PARASITOL, V144, P251, DOI 10.1016/j.vetpar.2006.10.007
   Murphy ML, 1998, J IMMUNOL, V161, P4153
   Nascimento MSL, 2013, VET IMMUNOL IMMUNOP, V153, P202, DOI 10.1016/j.vetimm.2013.02.015
   O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105
   Paltrinieri S, 2016, VET CLIN PATH, V45, P552, DOI 10.1111/vcp.12413
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005
   Quinnell RJ, 2001, J INFECT DIS, V183, P1421, DOI 10.1086/319869
   Moreira PRR, 2013, VET PARASITOL, V192, P149, DOI 10.1016/j.vetpar.2012.09.029
   Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307
   Rodriguez-Cortes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155224
   Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107
   Roy S, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.12
   Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x
   Schaut RG, 2016, J IMMUNOL, V196, P4100, DOI 10.4049/jimmunol.1502678
   Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083
   Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103
   Silva LC, 2013, INT J EXP PATHOL, V94, P133, DOI 10.1111/iep.12010
   Silva-O'Hare J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156733
   Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1598-y
   Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035
NR 47
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 10
PY 2019
VL 9
AR 12962
DI 10.1038/s41598-019-49344-1
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4YK
UT WOS:000484985500010
PM 31506501
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Losada-Barragan, M
   Umana-Perez, A
   Duraes, J
   Cuervo-Escobar, S
   Rodriguez-Vega, A
   Ribeiro-Gomes, FL
   Berbert, LR
   Morgado, F
   Porrozzi, R
   Mendes-da-Cruz, DA
   Aquino, P
   Carvalho, PC
   Savino, W
   Sanchez-Gomez, M
   Padron, G
   Cuervo, P
AF Losada-Barragan, Monica
   Umana-Perez, Adriana
   Duraes, Jonathan
   Cuervo-Escobar, Sergio
   Rodriguez-Vega, Andres
   Ribeiro-Gomes, Flavia L.
   Berbert, Luiz R.
   Morgado, Fernanda
   Porrozzi, Renato
   Mendes-da-Cruz, Daniella Areas
   Aquino, Priscila
   Carvalho, Paulo C.
   Savino, Wilson
   Sanchez-Gomez, Myriam
   Padron, Gabriel
   Cuervo, Patricia
TI Thymic Microenvironment Is Modified by Malnutrition and Leishmania
   infantum Infection
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE thymus; thymic microenvironment; protein malnutrition; Leishmania
   infantum; visceral leishmaniasis; interstitial fl uid; proteomics; fatty
   acid oxidation
ID DENDRITIC CELLS; COMMON TARGET; FACTOR-I; T-CELLS; PROTEIN; GALECTIN-1;
   EXOSOMES; DIFFERENTIATION; IDENTIFICATION; GLYCOPROTEIN
AB Detrimental effects of malnutrition on immune responses to pathogens have long been recognized and it is considered amain risk factor for various infectious diseases, including visceral leishmaniasis (VL). Thymus is a target of both malnutrition and infection, but its role in the immune response to Leishmania infantum in malnourished individuals is barely studied. Because we previously observed thymic atrophy and significant reduction in cellularity and chemokine levels in malnourished mice infected with L. infantum, we postulated that the thymic microenvironment is severely compromised in those animals. To test this, we analyzed the microarchitecture of the organ and measured the protein abundance in its interstitial space in malnourished BALB/c mice infected or not with L. infantum. Malnourished-infected animals exhibited a significant reduction of the thymic cortex: medulla ratio and altered abundance of proteins secreted in the thymic interstitial fluid. Eighty-one percent of identified proteins are secreted by exosomes and malnourished-infected mice showed significant decrease in exosomal proteins, suggesting that exosomal carrier system, and therefore intrathymic communication, is dysregulated in those animals. Malnourished-infected mice also exhibited a significant increase in the abundance of proteins involved in lipid metabolism and tricarboxylic acid cycle, suggestive of a non-proliferative microenvironment. Accordingly, flow cytometry analysis revealed decreased proliferation of single positive and double positive T cells in those animals. Together, the reduced cortical area, decreased proliferation, and altered protein abundance suggest a dysfunctional thymic microenvironment where T cell migration, proliferation, and maturation are compromised, contributing for the thymic atrophy observed in malnourished animals. All these alterations could affect the control of the local and systemic infection, resulting in an impaired response to L. infantuminfection.
C1 [Losada-Barragan, Monica; Duraes, Jonathan; Rodriguez-Vega, Andres; Morgado, Fernanda; Porrozzi, Renato; Padron, Gabriel; Cuervo, Patricia] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Leishmanioses, Rio De Janeiro, Brazil.
   [Losada-Barragan, Monica] Univ Antonio Narino, Dept Biol, Grp Invest Biol Celular & Func & Ingn Biomol, Bogota, Colombia.
   [Umana-Perez, Adriana; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Dept Quim, Grp Invest Hormonas, Bogota, Colombia.
   [Cuervo-Escobar, Sergio] Univ Ciencias Aplicadas & Ambientales, Fac Ciencias, Bogota, Colombia.
   [Ribeiro-Gomes, Flavia L.] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Malaria, Rio De Janeiro, Brazil.
   [Berbert, Luiz R.; Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fiocruz MS, Inst Nacl Ciencia & Tecnol Neuroimunomodulacao, Rio De Janeiro, Brazil.
   [Aquino, Priscila] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Carvalho, Paulo C.] Fiocruz MS, Computat Mass Spectrometry & Prote Grp, Rio De Janeiro, Brazil.
RP Cuervo, P (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Leishmanioses, Rio De Janeiro, Brazil.
EM patricia.cuervo@fiocruz.br
RI Aquino, Priscila/AAJ-3019-2020; Porrozzi, Renato/U-2166-2019; Cuervo,
   Patricia/Y-6048-2019; Mendes-da-Cruz, Daniella/AAN-6644-2020; Morgado,
   Fernanda N/K-2527-2013; BERBERT, LUIZ/AAT-4678-2020
OI Aquino, Priscila/0000-0002-2344-0493; Porrozzi,
   Renato/0000-0003-2167-316X; Cuervo, Patricia/0000-0002-6245-4185;
   Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Morgado, Fernanda
   N/0000-0002-7188-251X; cuervo escobar, sergio/0000-0002-9283-6985;
   Berbert, Luiz Ricardo/0000-0003-0541-4002; Umana-Perez,
   Adriana/0000-0001-9262-2699; Sanchez-Gomez, Myriam/0000-0002-9481-7534;
   Losada Barragan, Monica/0000-0003-1141-1828
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [448007/2014-2, 490560/2013-0]; CNPq-TWAS (Third
   World Academy of Sciences) [190405/2011-2]; FIOCRUZ-CNPqNational Council
   for Scientific and Technological Development (CNPq) [476727/2010-3];
   Departamento Administrativo de Ciencia, Tecnologia e
   Innovacion-ColcienciasDepartamento Administrativo de Ciencia, Tecnologia
   e Innovacion Colciencias [11263-576-2009, 110165843548, 614-2014];
   DIEB-Universidad Nacional de Colombia [37436]; Fundacao de Amparo a
   Pesquisa do Estado de Rio de Janeiro-FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.545/2014, E-26/203.253/2017]; Mercosur Fund for Structural
   Convergence (FOCEM) [03/11]; CAPESCAPES [0344141]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [306393/2014-0,
   305796/2017-8]
FX This research was funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq (PC Universal grant No. 448007/2014-2 and
   Bilateral grant #490560/2013-0); CNPq-TWAS (Third World Academy of
   Sciences) [ML-B scholarship #190405/2011-2], FIOCRUZ-CNPq (PC, RP, FM,
   and ML-B PROEP grant #476727/2010-3); Departamento Administrativo de
   Ciencia, Tecnologia e Innovacion-Colciencias (MS-G, SC-E, and AU-P
   grants #11263-576-2009; 110165843548; 614-2014); DIEB-Universidad
   Nacional de Colombia (AU-P grant #37436); Fundacao de Amparo a Pesquisa
   do Estado de Rio de Janeiro-FAPERJ (PC JCNE E-26/201.545/2014 and JCNE
   E-26/203.253/2017), and Mercosur Fund for Structural Convergence (FOCEM)
   #03/11. GP is a CAPES fellow of the Visitant Professor Program (Process
   No. 0344141). PC is a CNPq PQ-fellow (PQ Process No. 306393/2014-0 and
   305796/2017-8). This work was partially developed in the framework of
   the Brazilian National Institute of Science and Technology on
   Neuroimmunomodulation.
CR Aaby P, 2002, ACTA PAEDIATR, V91, P698, DOI 10.1080/080352502760069142
   Akingbemi BT, 1996, J COMP PATHOL, V115, P13, DOI 10.1016/S0021-9975(96)80024-7
   Akuffo H, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006375
   Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320
   Andrade CF, 2008, CELL IMMUNOL, V253, P1, DOI 10.1016/j.cellimm.2008.06.001
   AREF GH, 1982, J TROP MED HYG, V85, P109
   Aswad H, 2014, DIABETOLOGIA, V57, P2155, DOI 10.1007/s00125-014-3337-2
   Banfai K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00862
   BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877
   Gonzalez FB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004285
   Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025
   Carazzolle MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100385
   Carvalho PC, 2016, NAT PROTOC, V11, P102, DOI 10.1038/nprot.2015.133
   Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529
   Carvalho PC, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-6
   Cecil DL, 2008, J IMMUNOL, V180, P8378, DOI 10.4049/jimmunol.180.12.8378
   Coakley G, 2015, TRENDS PARASITOL, V31, P477, DOI 10.1016/j.pt.2015.06.009
   Cuervo-Escobar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114584
   de Meis J, 2013, IMMUNOTHERAPY-UK, V5, P573, DOI [10.2217/IMT.13.41, 10.2217/imt.13.41]
   Deng ZB, 2013, J IMMUNOL, V190, P3579, DOI 10.4049/jimmunol.1203170
   Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439
   Gameiro J, 2010, CELL ADHES MIGR, V4, P382, DOI 10.4161/cam.4.3.11789
   Garly ML, 2008, J PEDIATR-US, V153, P683, DOI 10.1016/j.jpeds.2008.04.069
   He HL, 2009, CELL BIOCHEM BIOPHYS, V55, P117, DOI 10.1007/s12013-009-9061-8
   Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16
   Ibrahim MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002329
   Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512
   JAMBON B, 1988, AM J CLIN NUTR, V48, P335
   Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633
   LIOTTA LA, 1981, CANCER RES, V41, P4629
   Liu B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.323
   Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181
   Lochner M, 2015, TRENDS IMMUNOL, V36, P81, DOI 10.1016/j.it.2014.12.005
   Lopez-Victorio CJ, 2013, BIOCHEM BIOPH RES CO, V432, P146, DOI 10.1016/j.bbrc.2013.01.069
   Losada-Barragan M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45991
   Lundberg V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36479
   Mariotti M, 2000, J BIOL CHEM, V275, P24047, DOI 10.1074/jbc.M001928200
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004
   Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412
   Nunes-Alves C, 2013, TRENDS IMMUNOL, V34, P502, DOI 10.1016/j.it.2013.06.004
   Olsen E, 1995, ELECTROPHORESIS, V16, P2241, DOI 10.1002/elps.11501601356
   Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454
   Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107
   Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232
   Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Ridder K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001874
   Perez AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034360
   Sanchez-Gomez M, 1999, BRIT J NUTR, V81, P145, DOI 10.1017/S0007114599000288
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247
   Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Savino W, 2010, P NUTR SOC, V69, P636, DOI 10.1017/S0029665110002545
   SCHONLAND M, 1972, Journal of Tropical Pediatrics and Environmental Child Health, V18, P217
   Shin YK, 2009, ELECTROPHORESIS, V30, P2182, DOI 10.1002/elps.200800806
   Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109
   Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI 10.1586/EPR.09.17
   Skogberg G, 2015, IMMUNOL CELL BIOL, V93, P727, DOI 10.1038/icb.2015.33
   Skogberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067554
   SMYTHE PM, 1971, LANCET, V2, P939
   Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778
   Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386
   Wu CC, 2008, PROTEOMICS, V8, P316, DOI 10.1002/pmic.200700819
   Zacarias DA, 2017, TROP MED INT HEALTH, V22, P679, DOI 10.1111/tmi.12877
   Zhang QY, 2015, J CANCER RES CLIN, V141, P691, DOI 10.1007/s00432-014-1830-0
   Zhao XY, 2011, J BIOL CHEM, V286, P36808, DOI 10.1074/jbc.M111.247262
   Zhu YH, 2015, J PROTEOME RES, V14, P4319, DOI 10.1021/acs.jproteome.5b00770
NR 76
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUL 12
PY 2019
VL 9
AR 252
DI 10.3389/fcimb.2019.00252
PG 19
WC Immunology; Microbiology
SC Immunology; Microbiology
GA II8SE
UT WOS:000475461100001
PM 31355153
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Perez, AR
   Mendes-Da-Cruz, DA
   Geenen, V
   Savino, W
AF Rosa Perez, Ana
   Mendes-da-Cruz, Daniella Areas
   Geenen, Vincent
   Savino, Wilson
TI Hormones, Neurotransmitters, and T-Cell Development in Health and
   Disease
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Editorial Material
DE thymus; hormones; neurottransmitters; T lymhocytes; thymopoiesis
C1 [Rosa Perez, Ana] Natl Sci & Tech Res Council, IDICER, Inst Clin & Expt Immunol Rosario, Rosario, Santa Fe, Argentina.
   [Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Natl Inst Sci & Technol Neuroimmunomodulat, Rio De Janeiro, Brazil.
   [Geenen, Vincent] Univ Liege, GIGA Res Inst, GIGA I3 Ctr Immunoendocrinol, Dept Biomed & Preclin Sci, Liege, Belgium.
RP Perez, AR (corresponding author), Natl Sci & Tech Res Council, IDICER, Inst Clin & Expt Immunol Rosario, Rosario, Santa Fe, Argentina.
EM perez_anarosa@yahoo.com.ar
RI Mendes-da-Cruz, Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Geenen,
   Vincent/0000-0002-8733-7284
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD JUL 11
PY 2019
VL 10
AR 454
DI 10.3389/fendo.2019.00454
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA II8LG
UT WOS:000475442900001
PM 31354626
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Mendes-de-Almeida, DP
   Andrade, FG
   Borges, G
   dos Santos-Bueno, FV
   Vieira, IF
   da Rocha, LKMD
   Mendes-da-Cruz, DA
   Zancope-Oliveira, RM
   Calado, RT
   Pombo-de-Oliveira, MS
AF Mendes-de-Almeida, Daniela Palheiro
   Andrade, Francianne Gomes
   Borges, Gustavo
   dos Santos-Bueno, Filipe V.
   Vieira, Iracema F.
   da Rocha, Luana Kelly M. da S.
   Mendes-da-Cruz, Daniella A.
   Zancope-Oliveira, Rosely M.
   Calado, Rodrigo T.
   Pombo-de-Oliveira, Maria S.
TI GATA2 mutation in long stand Mycobacterium kansasii infection,
   myelodysplasia and MonoMAC syndrome: a case-report
SO BMC MEDICAL GENETICS
LA English
DT Article
DE GATA-2 mutation; MonoMAC syndrome; Myelodysplastic syndrome;
   Myelodysplasia; Mycobacterium kansasii
ID SPORADIC MONOCYTOPENIA; AUTOSOMAL-DOMINANT; SUSCEPTIBILITY; DEFICIENCY;
   ONSET
AB BackgroundGATA2 is a transcription factor that is a critical regulator of gene expression in hematopoietic cells. GATA2 deficiency presents with multi-lineage cytopenia, mycobacterial, fungal and viral infections. Patients with GATA2 mutation have a high risk of developing myelodysplastic syndrome or acute myeloid leukemia.Case presentationWe described a 43years-old white male with 20-year follow-up of autoimmune and thrombotic phenomena, hypothyroidism, disseminated refractory Mycobacterium kansasii infection and MonoMAC syndrome. GATA2 c.1061 C>T; p.T354M mutation was identified after he progressed from myelodysplastic pancytopenia to refractory anemia with excess blasts type II. His relatives were also investigated and he underwent unsuccessful haematopoietic stem cell transplantation. We discuss the clinical features, genetic diagnosis and treatment of this immunodeficiency disorder.ConclusionsThis case illustrates the challenge how a multidisciplinary disease should be handle. Once usual causes of immunodeficiency were excluded, clinicians should considerGATA2 deficiency in patients with myelodysplasia and long-standing Mycobacterium kansasii infection.
C1 [Mendes-de-Almeida, Daniela Palheiro] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infectol, Div Hematol, Rio De Janeiro, Brazil.
   [Mendes-de-Almeida, Daniela Palheiro; Andrade, Francianne Gomes; dos Santos-Bueno, Filipe V.; Pombo-de-Oliveira, Maria S.] Inst Nacl Canc INCa, Res Ctr, Pediat Hematol Oncol Program, 6thfloor,Rua Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
   [Borges, Gustavo; Calado, Rodrigo T.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Internal Med, Ribeirao Preto, Brazil.
   [Vieira, Iracema F.] Hosp Servidores Estado, Infect Dis Dept, Rio De Janeiro, Brazil.
   [da Rocha, Luana Kelly M. da S.] Oncologia DOr, Div Hematol, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Inst Sci & Technol Neuroimmunomodulat INC NIM, Rio De Janeiro, RJ, Brazil.
   [Zancope-Oliveira, Rosely M.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infectol, Lab Mycol, Rio De Janeiro, Brazil.
RP Pombo-de-Oliveira, MS (corresponding author), Inst Nacl Canc INCa, Res Ctr, Pediat Hematol Oncol Program, 6thfloor,Rua Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
EM mpombo@inca.gov.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Calado, Rodrigo T/G-2619-2011;
   Pombo-de-Oliveira, Maria S./I-8884-2014
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Calado, Rodrigo
   T/0000-0002-7966-6029; Borges, Gustavo/0000-0001-9797-9953;
   Pombo-de-Oliveira, Maria S./0000-0002-1507-004X
FU Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro-FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [218785/2015]; Fundacao de Amparo a Pesquisa de Estado
   de Sao Paulo-FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/08135-2, 2014/26379-9]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPqNational Council for
   Scientific and Technological Development (CNPq) [301594/2015-5,
   394976/2013-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brasil (CAPES)CAPES [001]
FX This work was partially supported by Fundacao de Amparo a Pesquisa de
   Estado do Rio de Janeiro-FAPERJ, [grant#218785/2015 to D.A.M.C.];
   Fundacao de Amparo a Pesquisa de Estado de Sao Paulo-FAPESP [grants
   #2013/08135-2 and 2014/26379-9 to R.T.C]; M.S.P.O. and R.M.Z.O. are
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPq [#301594/2015-5 and #394976/2013-0, respectively]. This
   study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544
   Bodor C, 2012, HAEMATOL-HEMATOL J, V97, P890, DOI 10.3324/haematol.2011.054361
   Calvo KR, 2011, HAEMATOL-HEMATOL J, V96, P1221, DOI 10.3324/haematol.2011.041152
   Collin M, 2015, BRIT J HAEMATOL, V169, P173, DOI 10.1111/bjh.13317
   Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139
   Cuellar-Rodriguez J, 2011, BLOOD, V118, P3715, DOI 10.1182/blood-2011-06-365049
   Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151
   Donadieu J, 2018, HAEMATOLOGICA, V103, P1278, DOI 10.3324/haematol.2017.181909
   Drazer MW, 2016, BLOOD, V128, P1800, DOI 10.1182/blood-2016-05-670240
   Hirabayashi S, 2017, INT J HEMATOL, V106, P175, DOI 10.1007/s12185-017-2285-2
   Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352
   Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528
   Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629
   Wu UI, 2015, LANCET INFECT DIS, V15, P968, DOI 10.1016/S1473-3099(15)00089-4
NR 14
TC 3
Z9 3
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD APR 29
PY 2019
VL 20
AR 64
DI 10.1186/s12881-019-0799-6
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA HW8MO
UT WOS:000466944000001
PM 31035956
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Mendes-Da-Cruz, DA
   Lemos, JP
   Passos, GA
   Savino, W
AF Mendes-da-Cruz, Daniella A.
   Lemos, Julia P.
   Passos, Geraldo A.
   Savino, Wilson
TI Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice:
   Possible Relationship With the Pathogenesis of Type 1 Autoimmune
   Diabetes
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE non-obese diabetic mouse; type 1 diabetes; thymus; autoimmune diabetes;
   insulin; insulin-like growth factor; miRNA
ID GROWTH-FACTOR-I; INSULIN-RELATED GENES; NOD MOUSE THYMUS; PROINSULIN
   EXPRESSION; PERIPHERAL TISSUE; EPITHELIAL-CELLS; IDDM2 LOCUS; HORMONE;
   DIFFERENTIATION; TOLERANCE
AB Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing cells in the pancreas, by direct interactions with autoreactive pancreas infiltrating T lymphocytes (PILs). One of the most important animal models for this disease is the non-obese diabetic (NOD) mouse. Alterations in the NOD mouse thymus during the pathogenesis of the disease have been reported. From the initial migratory disturbances to the accumulation of mature thymocytes, including regulatory Foxp3(+) T cells, important mechanisms seem to regulate the repertoire of T cells that leave the thymus to settle in peripheral lymphoid organs. A significant modulation of the expression of extracellular matrix and soluble chemoattractant molecules, in addition to integrins and chemokine receptors, may contribute to the progressive accumulation of mature thymocytes and consequent formation of giant perivascular spaces (PVS) that are observed in the NOD mouse thymus. Comparative large-scale transcriptional expression and network analyses involving mRNAs and miRNAs of thymocytes, peripheral T CD3(+) cells and PILs provided evidence that in PILs chemokine receptors and mRNAs are post-transcriptionally regulated by miR-202-3p resulting in decreased activity of these molecules during the onset of T1D in NOD mice. In this review, we discuss the abnormal T-cell development in NOD mice in the context of intrathymic expression of different migration-related molecules, peptides belonging to the family of insulin and insulin-like growth factors as well as the participation of miRNAs as post-transcriptional regulators and their possible influence on the onset of aggressive autoimmunity during the pathogenesis of T1D.
C1 [Mendes-da-Cruz, Daniella A.; Lemos, Julia P.; Savino, Wilson] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella A.; Lemos, Julia P.; Savino, Wilson] Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Passos, Geraldo A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, Brazil.
   [Passos, Geraldo A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, Brazil.
RP Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
EM daniella@ioc.fiocruz.br; savino.w@gmail.com
RI Passos, Geraldo Aleixo/ABE-3251-2020; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella A/E-7875-2016; Passos,
   Geraldo A/A-2899-2008
OI Passos, Geraldo Aleixo/0000-0002-4408-140X; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Passos, Geraldo A/0000-0002-4408-140X
FU Oswaldo Cruz Foundation; Brazilian National Council for Development of
   Science and Technology (CNPq) [306315/2013-0]; Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES
   [88881.068105/2014-01]; State of Rio de Janeiro Foundation for Funding
   Research (FAPERJ); State of Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [13/17481-1]; Mercosur Program for Structural Convergence (FOCEM)
   [03/11]
FX This work was developed in the context of the National Institute of
   Science and Technology on Neuroimmunomodulation (INCT-NIM) and was
   partially funded with grants from the Oswaldo Cruz Foundation, the
   Brazilian National Council for Development of Science and Technology
   (CNPq) grant # 306315/2013-0 to GP, Coordination for the Improvement of
   Higher Education Personnel (CAPES) grant # 88881.068105/2014-01 to GP,
   State of Rio de Janeiro Foundation for Funding Research (FAPERJ), State
   of Sao Paulo Research Foundation (FAPESP) grant # 13/17481-1 to GP, and
   the Mercosur Program for Structural Convergence (FOCEM #03/11).
CR AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x
   Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958
   Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
   Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343
   BERGEROT I, 1995, CLIN EXP IMMUNOL, V102, P335
   Bernacchioni C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-15
   BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604
   Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049
   Brimmes MK, 2002, J AUTOIMMUN, V19, P203, DOI 10.1006/jaut.2002.0616
   BRISSENDEN JE, 1984, NATURE, V310, P781, DOI 10.1038/310781a0
   Burrack AL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00343
   Carlsen M, 2006, ANN NY ACAD SCI, V1079, P205, DOI 10.1196/annals.1375.032
   CetkovicCvrlje M, 1997, DIABETES, V46, P1975, DOI 10.2337/diabetes.46.12.1975
   Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926
   Cheng Bi-Wen, 2018, Oncotarget, V9, P16275, DOI 10.18632/oncotarget.24527
   Chentoufi AA, 2004, DIABETES, V53, P354, DOI 10.2337/diabetes.53.2.354
   Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383
   Chentoufi AA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349368
   Coelho VDM, 2002, NEUROENDOCRINOLOGY, V75, P139, DOI 10.1159/000048230
   de Souza KSC, 2016, DIABETES-METAB RES, V32, P589, DOI 10.1002/dmrr.2772
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   de Mello-Coelho V, 1998, ENDOCRINOLOGY, V139, P3837, DOI 10.1210/en.139.9.3837
   deMelloCoelho V, 1997, J NEUROIMMUNOL, V76, P39, DOI 10.1016/S0165-5728(97)00031-3
   Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
   Di Pietro C, 2016, J IMMUNOL, V197, P3271, DOI 10.4049/jimmunol.1502238
   Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137
   Faideau B, 2006, J IMMUNOL, V177, P53, DOI 10.4049/jimmunol.177.1.53
   Ferreira C, 2014, J IMMUNOL, V192, P4145, DOI 10.4049/jimmunol.1301600
   Fornari TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142688
   Fornari TA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/158735
   French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34
   Gagnerault MC, 1996, ENDOCRINOLOGY, V137, P1719, DOI 10.1210/en.137.5.1719
   Geenen V, 2003, HORM METAB RES, V35, P656
   Geenen V, 1999, NEUROIMMUNOMODULAT, V6, P115, DOI 10.1159/000026371
   GEENEN V, 1993, THYMUS, V21, P115
   Geenen V, 1998, DIABETES METAB REV, V14, P95, DOI 10.1002/(SICI)1099-0895(199803)14:1<95::AID-DMR200>3.0.CO;2-W
   Geenen V, 2012, DIABETES RES CLIN PR, V98, P26, DOI 10.1016/j.diabres.2012.05.023
   Hansenne I, 2006, J IMMUNOL, V176, P4651, DOI 10.4049/jimmunol.176.8.4651
   HAYFORD JT, 1980, DIABETES, V29, P391, DOI 10.2337/diabetes.29.5.391
   Hirokawa K, 2016, BIOGERONTOLOGY, V17, P55, DOI 10.1007/s10522-015-9590-z
   Hull CM, 2017, DIABETOLOGIA, V60, P1839, DOI 10.1007/s00125-017-4377-1
   JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707
   Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
   Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209
   Kecha-Kamoun O, 2001, DIABETES-METAB RES, V17, P146, DOI 10.1002/dmrr.182
   Kermani H, 2012, NEUROIMMUNOMODULAT, V19, P137, DOI 10.1159/000328844
   Lampasona V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0738-2
   Landau D, 2000, Int J Exp Diabetes Res, V1, P9, DOI 10.1155/EDR.2000.9
   Lemos JP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051446
   Levi D, 2013, MOL IMMUNOL, V56, P804, DOI 10.1016/j.molimm.2013.07.015
   Lins MP, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0097-0
   Lundholm M, 2010, J IMMUNOL, V184, P5537, DOI 10.4049/jimmunol.0904012
   Macedo C, 2015, IMMUNOBIOLOGY, V220, P93, DOI 10.1016/j.imbio.2014.08.015
   Martin AP, 2009, J IMMUNOL, V183, P3073, DOI 10.4049/jimmunol.0900275
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   MERTANI HC, 1995, ENDOCRINE, V3, P135, DOI 10.1007/BF02990065
   MERTANI HC, 1995, MOL CELL ENDOCRINOL, V109, P47, DOI 10.1016/0303-7207(95)03485-P
   Michels AW, 2017, DIABETES, V66, P722, DOI 10.2337/db16-1025
   Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100
   Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393
   NEELY EK, 1991, ACTA PAEDIATR SCAND, P116
   Ohkura N, 2010, SEMIN IMMUNOPATHOL, V32, P95, DOI 10.1007/s00281-010-0200-5
   Passos GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00352
   Pearson JA, 2016, DIABETES, V65, P1679, DOI 10.2337/db15-1498
   Pearson JA, 2016, J AUTOIMMUN, V66, P76, DOI 10.1016/j.jaut.2015.08.019
   PIERPAOLI W, 1968, J IMMUNOL, V101, P1036
   Pugliese A, 2005, IUBMB LIFE, V57, P463, DOI 10.1080/15216540500163301
   Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293
   Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397
   Richards DM, 2015, PROG MOL BIOL TRANSL, V136, P175, DOI 10.1016/bs.pmbts.2015.07.014
   Savino W, 2005, NEUROIMMUNOMODULAT, V12, P100, DOI 10.1159/000083582
   SAVINO W, 1991, LAB INVEST, V64, P405
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   Savino W, 2016, NAT REV ENDOCRINOL, V12, P77, DOI 10.1038/nrendo.2015.168
   Savino W, 2012, ANN NY ACAD SCI, V1261, P49, DOI 10.1111/j.1749-6632.2012.06637.x
   SERREZE DV, 1994, CURR OPIN IMMUNOL, V6, P900, DOI 10.1016/0952-7915(94)90011-6
   Shan ZY, 2014, IMMUNOL RES, V58, P351, DOI 10.1007/s12026-014-8500-9
   Shimatsu Akira, 1996, Endocrine Journal, V43, pS71, DOI 10.1507/endocrj.43.Suppl_S71
   Simoni Y, 2011, EUR J IMMUNOL, V41, P3574, DOI 10.1002/eji.201141751
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Smaniotto S, 2004, NEUROIMMUNOMODULAT, V11, P299, DOI 10.1159/000079410
   Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584
   TIMSIT J, 1992, J CLIN ENDOCR METAB, V75, P183, DOI 10.1210/jc.75.1.183
   Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289
   Visperas A, 2016, J IMMUNOL, V197, P3762, DOI 10.4049/jimmunol.1601118
   WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066
   Welniak LA, 2002, J LEUKOCYTE BIOL, V71, P381
   WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639
   Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x
   ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379
   Zheng Y, 2017, CELL MOL IMMUNOL, V14, P488, DOI 10.1038/cmi.2017.7
   Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460
NR 93
TC 4
Z9 4
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD JUL 12
PY 2018
VL 9
AR 381
DI 10.3389/fendo.2018.00381
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GM7KK
UT WOS:000438364700001
PM 30050502
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lemos, JP
   Smaniotto, S
   Messias, CV
   Moreira, OC
   Cotta-de-Almeida, V
   Dardenne, M
   Savino, W
   Mendes-da-Cruz, DA
AF Lemos, Julia P.
   Smaniotto, Salete
   Messias, Carolina V.
   Moreira, Otacilio C.
   Cotta-de-Almeida, Vinicius
   Dardenne, Mireille
   Savino, Wilson
   Mendes-da-Cruz, Daniella A.
TI Sphingosine-1-Phosphate Receptor 1 Is Involved in Non-Obese Diabetic
   Mouse Thymocyte Migration Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE non-obese diabetic mice; thymus; sphingosine-1-phosphate;
   sphingosine-1-phosphate receptor 1; VLA-5 (very late antigen-5); cell
   migration
ID SPHINGOSINE 1-PHOSPHATE RECEPTORS; NOD MOUSE; LYMPHOCYTE EGRESS; CELL
   MIGRATION; THYMUS; MICE; CHEMOTAXIS; EXPRESSION; INSULITIS; ADHESION
AB NOD (non-obese diabetic) mice spontaneously develop type 1 diabetes following T cell-dependent destruction of pancreatic cells. Several alterations are observed in the NOD thymus, including the presence of giant perivascular spaces (PVS) filled with single-positive (SP) CD4(+) and CD8(+) T cells that accumulate in the organ. These cells have a decreased expression of membrane CD49e (the 5 integrin chain of the fibronectin receptor VLA-5 (very late antigen-5). Herein, we observed lower sphingosine-1-phosphate receptor 1 (S1P1) expression in NOD mouse thymocytes when compared with controls, mainly in the mature SP CD4(+)CD62L(hi) and CD8(+)CD62L(hi) subpopulations bearing the CD49e(-) phenotype. In contrast, differences in S1P1 expression were not observed in mature CD49e(+) thymocytes. Functionally, NOD CD49e(-) thymocytes had reduced S1P-driven migratory response, whereas CD49e(+) cells were more responsive to S1P. We further noticed a decreased expression of the sphingosine-1-phosphate lyase (SGPL1) in NOD SP thymocytes, which can lead to a higher sphingosine-1-phosphate (S1P) expression around PVS and S1P1 internalization. In summary, our results indicate that the modulation of S1P1 expression and S1P/S1P1 interactions in NOD mouse thymocytes are part of the T-cell migratory disorder observed during the pathogenesis of type 1 diabetes.
C1 [Lemos, Julia P.; Messias, Carolina V.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21040900 Rio De Janeiro, Brazil.
   [Lemos, Julia P.; Smaniotto, Salete; Messias, Carolina V.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
   [Smaniotto, Salete] Univ Fed Alagoas, Inst Biol & Hlth Sci, Cell Biol Lab, BR-57000001 Maceio, Alagoas, Brazil.
   [Moreira, Otacilio C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, BR-21040900 Rio De Janeiro, Brazil.
   [Dardenne, Mireille] Paris Descartes Univ, UMR 8147, French Natl Ctr Sci Res CNRS, F-75006 Paris, France.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21040900 Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
EM j.lemos@ioc.fiocruz.br; smaniotto@icbs.ufal.br; cmessias@ioc.fiocruz.br;
   otacilio@ioc.fiocruz.br; vca@ioc.fiocruz.br; mireille.dardenne@free.fr;
   savino@fiocruz.br; daniella@ioc.fiocruz.br
RI Cotta-de-Almeida, Vinicius/G-3939-2012; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Moreira, Otacilio/AAS-5839-2020; Smaniotto,
   Salete/AAT-4056-2020; Mendes-da-Cruz, Daniella A/E-7875-2016;
   Cotta-de-Almeida, Vinicius/AAC-3721-2019; da Saude, Programa
   Ciencias/ABF-1705-2020; Smaniotto, Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Moreira,
   Otacilio/0000-0002-5340-8697; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Cotta-de-Almeida, Vinicius/0000-0002-6753-3480;
   Smaniotto, Salete/0000-0003-1527-5894
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Carlos Chagas Filho
   Foundation; Brazilian National Coordination for Advancement of
   University Personnel (CAPES); Mercosur Fund for Structural Convergence
   (FOCEM, Mercosur)
FX This work was funded by the Oswaldo Cruz Foundation (Fiocruz); Brazilian
   National Council for Scientific and Technological Development (CNPq);
   Carlos Chagas Filho Foundation for Funding Research in the State of Rio
   de Janeiro (Faperj); Brazilian National Coordination for Advancement of
   University Personnel (CAPES) and Mercosur Fund for Structural
   Convergence (FOCEM, Mercosur). This work was developed in the framework
   of the Brazilian National Institute of Science and Technology on
   Neuroimmunomodulation. We thank Alexandre Morrot (Federal University of
   Rio de Janeiro, Rio de Janeiro, Brazil) for helping with S1P
   quantitation assays.
CR Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200
   Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643
   Aoki S, 2007, J THROMB HAEMOST, V5, P1292, DOI 10.1111/j.1538-7836.2007.02559.x
   Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300
   Borowsky AD, 2012, J LIPID RES, V53, P1920, DOI 10.1194/jlr.M028084
   Brimmes MK, 2002, J AUTOIMMUN, V19, P203, DOI 10.1006/jaut.2002.0616
   Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006
   Bunting MD, 2011, IMMUNOL CELL BIOL, V89, P185, DOI 10.1038/icb.2010.142
   Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926
   Colomb E, 1996, DIABETES, V45, P1535, DOI 10.2337/diabetes.45.11.1535
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315
   Einicker-Lamas M, 2003, J BIOCHEM, V134, P529, DOI 10.1093/jb/mvg170
   FUJITA T, 1982, BIOMED RES-TOKYO, V3, P429
   Garcia-Bernal D, 2013, J PATHOL, V229, P36, DOI 10.1002/path.4066
   Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272
   Geutskens SB, 2004, SCAND J IMMUNOL, V60, P30, DOI 10.1111/j.0300-9475.2004.01465.x
   Goetzl EJ, 1998, FASEB J, V12, P1589
   Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084
   Lepletier A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003203
   Maeda Y, 2014, INT IMMUNOL, V26, P245, DOI 10.1093/intimm/dxt069
   Makino S, 1981, Jikken Dobutsu, V30, P137
   Makino S, 1980, Jikken Dobutsu, V29, P1
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Messias CV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148137
   OGAWA M, 1985, BIOMED RES-TOKYO, V6, P103
   Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200
   Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24
   SAVINO W, 1991, LAB INVEST, V64, P405
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640
   Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545
   Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8
   Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222
   Zamora-Pineda J, 2016, J EXP MED, V213, P2773, DOI 10.1084/jem.20160287
   Zhang GF, 1999, GENE, V227, P89, DOI 10.1016/S0378-1119(98)00589-7
NR 39
TC 5
Z9 5
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2018
VL 19
IS 5
AR 1446
DI 10.3390/ijms19051446
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA GJ4BO
UT WOS:000435297000182
PM 29757216
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Baronio, D
   Bauer-Negrini, G
   Castro, K
   Nunes, GD
   Riesgo, R
   Mendes-da-Cruz, DA
   Savino, W
   Gottfried, C
   Bambini, V
AF Baronio, Diego
   Bauer-Negrini, Guilherme
   Castro, Kamila
   Nunes, Gustavo Della-Flora
   Riesgo, Rudimar
   Mendes-da-Cruz, Daniella Areas
   Savino, Wilson
   Gottfried, Carmem
   Bambini-Junior, Victorio
TI Reduced CD4 T Lymphocytes in Lymph Nodes of the Mouse Model of Autism
   Induced by Valproic Acid
SO NEUROIMMUNOMODULATION
LA English
DT Article
DE Autism spectrum disorder; Valproic acid; Lymph nodes
ID SPECTRUM DISORDERS; ANIMAL-MODEL; CHILDREN; RISK; CHILDHOOD; RESPONSES;
   BEHAVIOR; EXPOSURE; MEMORY; CELLS
AB Objective: Considering the potential role of lymphocytes in the pathophysiology of autism spectrum disorder (ASD), we aimed to evaluate possible alterations of T cell pools in the lymphoid organs of an animal model of autism induced by valproic acid (VPA). Pregnant Swiss mice received a single intraperitoneal injection of 600 mg/kg of VPA (VPA group) or saline (control group) on day 11 of gestation. Male offspring were euthanized on postnatal day 60 for removal of thymuses, spleens, and a pool of inguinal, axillary and brachial lymph nodes. Cellularity was evaluated, and flow cytometry analysis was performed on cell suspensions incubated with the mouse antibodies anti-CD3-FITC, anti-CD4-PE, and anti-CD8-PE-Cy7. We observed that the prenatal exposure to VPA induced a reduction in the numbers of CD3+CD4+ T cells in their lymph nodes when compared to the control animals. This was specific since it was not seen in the thymus or spleen. The consistent decrease in the number of CD4+ T cells in subcutaneous lymph nodes of mice from the animal model of autism may be related to the allergic symptoms frequently observed in ASD. Further research is necessary to characterize the immunological patterns in ASD and the connection with the pathophysiology of this disorder. (C) 2018 S. Karger AG, Basel
C1 [Baronio, Diego; Bauer-Negrini, Guilherme; Castro, Kamila; Nunes, Gustavo Della-Flora; Riesgo, Rudimar; Gottfried, Carmem; Bambini-Junior, Victorio] Clin Hosp Porto Alegre, Translat Grp Autism Spectrum Disorder GETTEA, Porto Alegre, RS, Brazil.
   [Baronio, Diego; Castro, Kamila; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Clin Hosp Porto Alegre, Child Neurol Unit, Porto Alegre, RS, Brazil.
   [Bauer-Negrini, Guilherme; Nunes, Gustavo Della-Flora; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil.
   [Bauer-Negrini, Guilherme; Riesgo, Rudimar; Mendes-da-Cruz, Daniella Areas; Savino, Wilson; Gottfried, Carmem; Bambini-Junior, Victorio] Brazilian Natl Inst Sci & Technol Neuroimmunomodu, Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Bambini-Junior, Victorio] Univ Cent Lancashire, Sch Pharm & Biomed Sci, Maudland Bldg,MB241, Preston PR1 2XT, Lancs, England.
   [Baronio, Diego] Univ Helsinki, Dept Anat, Haartmaninkatu 8, FI-00014 Helsinki, Finland.
RP Bambini, V (corresponding author), Univ Cent Lancashire, Sch Pharm & Biomed Sci, Maudland Bldg,MB241, Preston PR1 2XT, Lancs, England.; Baronio, D (corresponding author), Univ Helsinki, Dept Anat, Haartmaninkatu 8, FI-00014 Helsinki, Finland.
EM diego.baronio@helsinki.fi; VBambini-Junior@uclan.ac.uk
RI Grokoski, Kamila Castro/M-2068-2015; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella A/E-7875-2016;
   Bambini-Junior, Victorio/O-7563-2014; Gottfried, Carmem/AAG-2355-2019
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Gottfried, Carmem/0000-0001-8838-1300;
   Della-Flora Nunes, Gustavo/0000-0001-9323-3556; Grokoski, Kamila
   Castro/0000-0003-0100-1788
FU Brazilian National Institute of Science and Technology on
   Neuroimmunomodulation (INCT-NIM); Rio de Janeiro; National Council of
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian Coordination
   for the Improvement of Higher Education Personnel (CAPES)CAPES; Rio de
   Janeiro State Foundation for Funding Research (Faperj); Oswaldo Cruz
   Foundation (Fiocruz); Clinical Hospital of Porto Alegre (FIPE-HCPA);
   Fund for Structural Convergence (FOCEM) of MercoSur
FX This work was funded by the Brazilian National Institute of Science and
   Technology on Neuroimmunomodulation (INCT-NIM), Rio de Janeiro, the
   National Council of Scientific and Technological Development (CNPq), the
   Brazilian Coordination for the Improvement of Higher Education Personnel
   (CAPES), the Rio de Janeiro State Foundation for Funding Research
   (Faperj), the Oswaldo Cruz Foundation (Fiocruz), the Clinical Hospital
   of Porto Alegre (FIPE-HCPA), and the Fund for Structural Convergence
   (FOCEM) of MercoSur.
CR Ahmad SF, 2017, MOL NEUROBIOL, V54, P4390, DOI 10.1007/s12035-016-9977-0
   Akintunde ME, 2015, J NEUROIMMUNOL, V286, P33, DOI 10.1016/j.jneuroim.2015.07.003
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V17, P133, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
   Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002
   Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003
   Bambini V, 2014, NEUROSCI LETT, V583, P176, DOI 10.1016/j.neulet.2014.09.039
   Chen MH, 2014, J PSYCHOSOM RES, V77, P316, DOI 10.1016/j.jpsychores.2014.06.006
   Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270
   Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608
   Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419
   Dowdell KC, 2009, EXP HEMATOL, V37, P487, DOI 10.1016/j.exphem.2008.12.002
   Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626
   Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005
   Gottfried C, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00121
   Khakzad MR, 2012, REP BIOCHEM MOL BIOL, V1, P37
   Lucchina L, 2014, AUTISM RES, V7, P273, DOI 10.1002/aur.1338
   Magalhaes ES, 2009, J NEUROIMMUNOL, V216, P108, DOI 10.1016/j.jneuroim.2009.09.015
   Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112
   Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024
   Mostafa GA, 2010, J CHILD NEUROL, V25, P328, DOI 10.1177/0883073809339393
   Mostafa GA, 2008, J CHILD NEUROL, V23, P1413, DOI 10.1177/0883073808319321
   Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79
   Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013
   Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011
   Scifo R, 1996, Ann Ist Super Sanita, V32, P351
   Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420
   WARREN RP, 1986, J AUTISM DEV DISORD, V16, P189, DOI 10.1007/BF01531729
   YONK LJ, 1990, IMMUNOL LETT, V25, P341, DOI 10.1016/0165-2478(90)90205-5
   Zhang Z, 2012, NEUROSCIENCE, V221, P140, DOI 10.1016/j.neuroscience.2012.07.013
NR 29
TC 0
Z9 0
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1021-7401
EI 1423-0216
J9 NEUROIMMUNOMODULAT
JI Neuroimmunomodulation
PY 2018
VL 25
IS 5-6
SI SI
BP 280
EP 284
DI 10.1159/000491395
PG 5
WC Endocrinology & Metabolism; Immunology; Neurosciences
SC Endocrinology & Metabolism; Immunology; Neurosciences & Neurology
GA HM5LD
UT WOS:000459516300004
PM 30121669
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Golbert, DCF
   Santana-Van-Vliet, E
   Ribeiro-Alves, M
   da Fonseca, MMB
   Lepletier, A
   Mendes-da-Cruz, DA
   Loss, G
   Cotta-de-Almeida, V
   Vasconcelos, ATR
   Savino, W
AF Golbert, Daiane Cristina F.
   Santana-Van-Vliet, Eliane
   Ribeiro-Alves, Marcelo
   da Fonseca, Marbella Maria B.
   Lepletier, Ailin
   Mendes-da-Cruz, Daniella Areas
   Loss, Guilherme
   Cotta-de-Almeida, Vinicius
   Vasconcelos, Ana Tereza R.
   Savino, Wilson
TI Small interference ITGA6 gene targeting in the human thymic epithelium
   differentially regulates the expression of immunological synapse-related
   genes
SO CELL ADHESION & MIGRATION
LA English
DT Article
DE extracellular matrix; HLA-ABC; HLA-DR; integrin 6; RNA interference;
   thymic epithelial cells
ID CELLS
AB The thymus supports differentiation of T cell precursors. This process requires relocation of developing thymocytes throughout multiple microenvironments of the organ, mainly with thymic epithelial cells (TEC), which control intrathymic T cell differentiation influencing the formation and maintenance of the immunological synapse. In addition to the proteins of the major histocompatibility complex (MHC), this structure is supported by several adhesion molecules. During the process of thymopoiesis, we previously showed that laminin-mediated interactions are involved in the entrance of T-cell precursors into the thymus, as well as migration of differentiating thymocytes within the organ. Using small interference RNA strategy, we knocked-down the ITGA6 gene (which encodes the CD49f integrin -chain) in cultured human TEC, generating a decrease in the expression of the corresponding CD49f subunit, in addition to modulation in several other genes related to cell adhesion and migration. Thymocyte adhesion to TEC was significantly impaired, comprising both immature and mature thymocyte subsets. Moreover, we found a modulation of the MHC, with a decrease in membrane expression of HLA-ABC, in contrast with increase in the expression of HLA-DR. Interestingly, the knockdown of the B2M gene (encoding the -2 microglobulin of the HLA-ABC complex) increased CD49f expression levels, thus unraveling the existence of a cross-talk event in the reciprocal control of CD49f and HLA-ABC. Our data suggest that the expression levels of CD49f may be relevant in the general control of MHC expression by TEC and consequently the corresponding synapse with developing thymocytes mediated by the T-cell receptor.
C1 [Golbert, Daiane Cristina F.; Santana-Van-Vliet, Eliane; Lepletier, Ailin; Mendes-da-Cruz, Daniella Areas; Cotta-de-Almeida, Vinicius; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Golbert, Daiane Cristina F.; Santana-Van-Vliet, Eliane; Lepletier, Ailin; Mendes-da-Cruz, Daniella Areas; Cotta-de-Almeida, Vinicius; Savino, Wilson] Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Golbert, Daiane Cristina F.; Loss, Guilherme; Vasconcelos, Ana Tereza R.] Natl Lab Sci Computat, Bioinformat Lab, Rio De Janeiro, Brazil.
   [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz, Evandro Chagas Res Inst, Rio De Janeiro, Brazil.
   [da Fonseca, Marbella Maria B.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England.
   [da Fonseca, Marbella Maria B.] Struct Genom Consortium, Old Rd Campus, Oxford, England.
RP Savino, W (corresponding author), Fiocruz Pavilhao Leonidas Deane,Sala 510, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Cotta-de-Almeida,
   Vinicius/G-3939-2012; Cotta-de-Almeida, Vinicius/AAC-3721-2019;
   Vasconcelos, Ana Tereza R/I-1011-2012; Mendes-da-Cruz, Daniella
   A/E-7875-2016
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Cotta-de-Almeida,
   Vinicius/0000-0002-6753-3480; Vasconcelos, Ana Tereza
   R/0000-0002-4632-2086; Mendes-da-Cruz, Daniella A/0000-0003-3697-1506;
   Ribeiro-Alves, Marcelo/0000-0002-8663-3364; Lepletier,
   Ailin/0000-0002-1371-7313
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Carlos Chagas Filho
   Foundation for Funding Research in the State of Rio de Janeiro
   (Faperj)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Brazilian National Coordination for
   Advancement of University Personnel (CAPES); Mercosur Fund for
   Structural Convergence (FOCEM, Mercosur)
FX This work was funded by the Oswaldo Cruz Foundation (Fiocruz); Brazilian
   National Council for Scientific and Technological Development (CNPq);
   Carlos Chagas Filho Foundation for Funding Research in the State of Rio
   de Janeiro (Faperj); Brazilian National Coordination for Advancement of
   University Personnel (CAPES) and Mercosur Fund for Structural
   Convergence (FOCEM, Mercosur).
CR Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005
   Ayres-Martins S, 2004, CELL IMMUNOL, V229, P21, DOI 10.1016/j.cellimm.2004.06.002
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10. 1007/s00441-009-0834-6
   Bernstein FC, 1977, J MOL BIOL, V112, P535, DOI 10. 1016/S0022-2836(77)80200-3
   Cascio G, 2015, J IMMUNOL, V194, P5509, DOI 10. 4049/jimmunol. 1402419
   CHANG AC, 1995, J IMMUNOL, V154, P500
   Ciofani M, 2007, ANN REV CELL DEV BIO, V23, P463, DOI 10. 1146/annurev. cellbio. 23. 090506. 123547
   Constantin G, 2000, IMMUNITY, V13, P759, DOI 10. 1016/S1074-7613(00)00074-1
   De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32
   Dustin ML, 2010, COLD SPRING HARB PER, V2, DOI 10. 1101/cshperspect. a002311
   Dustin ML, 2002, SCIENCE, V298, P785, DOI 10. 1126/science. 1076386
   Eswar N, 2006, CURR PROTOC BIOINFOR
   Fernandez E, 1994, BLOOD, V83, P3245
   Golbert DCF, 2013, BMC GENOMICS S6, V14, pS3, DOI 10. 1186/1471-2164-14-S6-S3
   Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10. 1083/jcb. 200309101
   Gong Y, 2008, FASEB J, V22, P1426, DOI 10. 1096/fj. 07-08792410. 1096/fj. 07-9264com
   Halkias J, 2014, CELL MOL LIFE SCI, V71, P3101, DOI 10. 1007/s00018-014-1607-2
   Kallikourdis M, 2013, BLOOD, V122, P666, DOI 10. 1182/blood-2012-10-461830
   Kallikourdis M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00433
   Kligys KR, 2012, J BIOL CHEM, V287, P17975, DOI 10. 1074/jbc. M111. 310458
   Lannes-Vieira J, 1993, INT IMMUNOL, V5, P1421, DOI 10. 1093/intimm/5. 11. 1421
   Lepelletier Y, 2007, P NATL ACAD SCI US, V104, P5545, DOI 10. 1073/pnas. 0700705104
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Mendes-Da-Cruz DA, 2012, FASEB J, V26, P4390, DOI 10. 1096/fj. 11-202952
   Miller JFAP, 2011, NAT REV IMMUNOL, V11, P489, DOI 10. 1038/nri299310. 1038/nri3010
   Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10. 1034/j. 1600-065X. 2002. 18502. x
   Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10. 1016/S1074-7613(00)80409-4
   Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10. 1016/j. molimm. 2007. 05. 016
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Petrie HT, 2007, ANN REV IMMUNOL, V25, P649, DOI 10. 1146/annurev. immunol. 23. 021704. 115715
   Porter JC, 1997, J CELL BIOL, V138, P1437, DOI 10. 1083/jcb. 138. 6. 1437
   Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10. 1016/S0945-053X(98)00005-5
   R-Development-Core-Team, 2009, R FDN STAT COMP
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULATIO, V10, P142, DOI [10.1159/000067175, 10. 1159/000067175]
   Richie LI, 2002, IMMUNITY, V16, P595, DOI 10. 1016/S1074-7613(02)00299-6
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10. 1093/bioinformatics/btn227
   Ruiz P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10. 1002/eji. 1830250735
   Salomon DR, 1997, BLOOD, V89, P2461
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10. 1016/S1471-4906(02)02224-X
   Savino W, 2004, J LEUKOC BIOL, V75, P951, DOI 10. 1189/jlb. 1003455
   Savino W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00579
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10. 4049/jimmunol. 1302259
   Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10. 1038/ni1194
   Sonnenberg A, 1990, J CELL SCI 2, V96, P207
   Stimamiglio MA, 2010, J LEUKOC BIOL, V88, P483, DOI 10. 1189/jlb. 0210079
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10. 1186/gb-2002-3-7-research0034
   Villa-Verde DM, 1994, EUR J IMMUNOL, V24, P659, DOI 10. 1002/eji. 1830240326
   Viola A, 2006, TRENDS IMMUNOL, V27, P421, DOI 10.1016/j.it.2006.07.004
   Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012
   Zhang X, 2010, SCI SIGNAL, V3, pra85, DOI 10. 1126/scisignal. 200067810. 1126/scisignal. 2001158
   Zhang X, 2012, HUM IMMUNOL, V73, P1239
   Zuidscherwoude M, 2014, J LEUKOC BIOL, V95, P251, DOI 10. 1189/jlb. 0813440
NR 53
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
EI 1933-6926
J9 CELL ADHES MIGR
JI Celll Adhes. Migr.
PY 2018
VL 12
IS 2
BP 152
EP 167
DI 10.1080/19336918.2017.1327513
PG 16
WC Cell Biology
SC Cell Biology
GA GD7SM
UT WOS:000430712900008
PM 28494186
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Passos, GA
   Speck-Hernandez, CA
   Assis, AF
   Mendes-da-Cruz, DA
AF Passos, Geraldo A.
   Speck-Hernandez, Cesar A.
   Assis, Amanda F.
   Mendes-da-Cruz, Daniella A.
TI Update on Aire and thymic negative selection
SO IMMUNOLOGY
LA English
DT Review
DE Aire; autoimmunity; immune tolerance; negative selection; thymus
ID PROMISCUOUS GENE-EXPRESSION; AUTOIMMUNE REGULATOR AIRE; T-CELL
   TOLERANCE; SELF-ANTIGEN EXPRESSION; EPITHELIAL-CELLS; IMMUNE TOLERANCE;
   TRANSCRIPTIONAL ACTIVITY; DIFFERENTIATION PROGRAM;
   IMMUNOLOGICAL-TOLERANCE; SYNDROME TYPE-1
AB Twenty years ago, the autoimmune regulator (Aire) gene was associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, and was cloned and sequenced. Its importance goes beyond its abstract link with human autoimmune disease. Aire identification opened new perspectives to better understand the molecular basis of central tolerance and self-non-self distinction, the main properties of the immune system. Since 1997, a growing number of immunologists and molecular geneticists have made important discoveries about the function of Aire, which is essentially a pleiotropic gene. Aire is one of the functional markers in medullary thymic epithelial cells (mTECs), controlling their differentiation and expression of peripheral tissue antigens (PTAs), mTEC-thymocyte adhesion and the expression of microRNAs, among other functions. With Aire, the immunological tolerance became even more apparent from the molecular genetics point of view. Currently, mTECs represent the most unusual cells because they express almost the entire functional genome but still maintain their identity. Due to the enormous diversity of PTAs, this uncommon gene expression pattern was termed promiscuous gene expression, the interpretation of which is essentially immunological - i.e. it is related to self-representation in the thymus. Therefore, this knowledge is strongly linked to the negative selection of autoreactive thymocytes. In this update, we focus on the most relevant results of Aire as a transcriptional and post-transcriptional controller of PTAs in mTECs, its mechanism of action, and its influence on the negative selection of autoreactive thymocytes as the bases of the induction of central tolerance and prevention of autoimmune diseases.
C1 [Passos, Geraldo A.; Assis, Amanda F.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, Ribeirao Preto, SP, Brazil.
   [Passos, Geraldo A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Genet & Mol Biol, Ribeirao Preto, SP, Brazil.
   [Speck-Hernandez, Cesar A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Grad Programme Basic & Appl Immunol, Ribeirao Preto, SP, Brazil.
   [Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, RJ, Brazil.
   [Mendes-da-Cruz, Daniella A.] Natl Inst Sci & Technol Neuroimmunomodulat, Rio De Janeiro, RJ, Brazil.
RP Passos, GA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, SP, Brazil.
EM passos@usp.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Passos, Geraldo A/A-2899-2008;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; Speck-Hernandez,
   Cesar/S-2240-2018; Passos, Geraldo Aleixo/ABE-3251-2020
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Passos, Geraldo
   A/0000-0002-4408-140X; Mendes-da-Cruz, Daniella/0000-0003-3697-1506;
   Passos, Geraldo Aleixo/0000-0002-4408-140X
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/17481-1]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [306315/2013-0]; Coordenacao de Apoio ao Pessoal de Nivel Superior
   (CAPES)CAPES [88881.068105/2014-01]; Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [218785/2015];
   Fundacao Oswaldo Cruz (Fiocruz); Fondo para la Convergencia Estructural
   de Mercosur [FOCEM - COF 03/11]
FX We thank Dr Danny Altmann, the Editor of Immunology, for the invitation
   to submit this update article. Our laboratories are funded by the
   following agencies; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP grant # 13/17481-1 to GAP), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq grant # 306315/2013-0 to GAP),
   Coordenacao de Apoio ao Pessoal de Nivel Superior (CAPES grant #
   88881.068105/2014-01 to GAP), Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ grant # 218785/2015 to DAMC) and Fundacao Oswaldo
   Cruz (Fiocruz) and Fondo para la Convergencia Estructural de Mercosur
   (FOCEM - COF 03/11 to DAMC).
CR Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786
   AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83
   Abramson J, 2016, IMMUNOL REV, V271, P127, DOI 10.1111/imr.12419
   Abramson J, 2016, EUR J IMMUNOL, V46, P22, DOI 10.1002/eji.201545792
   Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030
   AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x
   Akiyama N, 2016, J EXP MED, V213, P1441, DOI 10.1084/jem.20151780
   Alves NL, 2014, EUR J IMMUNOL, V44, P16, DOI 10.1002/eji.201344110
   Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9
   Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958
   ARULANANTHAM K, 1979, NEW ENGL J MED, V300, P164, DOI 10.1056/NEJM197901253000403
   Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675
   Bichele R, 2016, MOL IMMUNOL, V72, P92, DOI 10.1016/j.molimm.2016.02.015
   Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259
   Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547
   Blechschmidt K, 1999, GENOME RES, V9, P158
   Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246
   Brunk F, 2017, EUR J IMMUNOL, V47, P1153, DOI 10.1002/eji.201747006
   Bruserud O, 2016, CURR OPIN IMMUNOL, V43, P8, DOI 10.1016/j.coi.2016.07.003
   Cardoso RS, 2006, IMMUNOLOGY, V119, P369, DOI 10.1111/j.1365-2567.2006.02441.x
   Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194
   Danan-Gotthold M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1079-9
   De Martino L, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00086
   Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471
   Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
   Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105
   Dragin N, 2016, J CLIN INVEST, V126, P1525, DOI 10.1172/JCI81894
   Fornari TA, 2010, MOL CELL BIOCHEM, V342, P21, DOI 10.1007/s11010-010-0464-z
   Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005
   Gies V, 2017, J ALLERGY CLIN IMMUN
   Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109
   Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111
   Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795
   Haljasorg U, 2015, EUR J IMMUNOL, V45, P3246, DOI 10.1002/eji.201545928
   Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175
   Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438
   Heikkila N, 2016, J CLIN IMMUNOL, V36, P555, DOI 10.1007/s10875-016-0302-5
   Herzig Y, 2017, NAT IMMUNOL, V18, P161, DOI 10.1038/ni.3638
   Hollander GA, 2007, NAT IMMUNOL, V8, P234, DOI 10.1038/ni0307-234
   Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x
   Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824
   Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393
   Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x
   Ilmarinen T, 2008, MOL IMMUNOL, V45, P1847, DOI 10.1016/j.molimm.2007.10.045
   Incani F, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0085-z
   Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007
   Jin R, 2017, ONCOTARGET, V8, P83, DOI 10.18632/oncotarget.13909
   Kawano H, 2015, J IMMUNOL, V195, P5149, DOI 10.4049/jimmunol.1501000
   Keane P, 2015, BIOINFORMATICS, V31, P986, DOI 10.1093/bioinformatics/btu785
   Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2
   Klein L, 2015, CELL, V163, P794, DOI 10.1016/j.cell.2015.10.057
   Koivula TT, 2017, SCAND J IMMUNOL
   Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200
   Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436
   Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2
   Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601
   Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133
   Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104
   Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327
   Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003
   Lima FA, 2011, J IMMUNOL, V187, P3422, DOI 10.4049/jimmunol.1003053
   Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312
   Lopes N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00365
   Lovewell TRJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127476
   Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013
   Magalhaes DAR, 2006, CLIN DEV IMMUNOL, V13, P81, DOI 10.1080/17402520600877091
   Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247
   Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024
   Miller JFAP, 2011, NAT REV IMMUNOL, V11, P489, DOI 10.1038/nri2993
   MIZUOCHI T, 1992, J EXP MED, V175, P1601, DOI 10.1084/jem.175.6.1601
   Mora M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101616
   Musco G, 2008, EPIGENETICS-US, V3, P310, DOI 10.4161/epi.3.6.7182
   Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393
   Nishikawa Y, 2014, J IMMUNOL, V192, P2585, DOI 10.4049/jimmunol.1302786
   Nitta T, 2016, CELL MOL LIFE SCI, V73, P1021, DOI 10.1007/s00018-015-2107-8
   Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021
   Oliveira EH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00526
   Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07
   Passos GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00352
   Perniola R, 2014, BBA-MOL BASIS DIS, V1842, P326, DOI 10.1016/j.bbadis.2013.11.020
   Perri V, 2017, IMMUNOBIOLOGY, V222, P372, DOI 10.1016/j.imbio.2016.09.001
   Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007
   Pezzi N, 2016, MOL IMMUNOL, V77, P157, DOI 10.1016/j.molimm.2016.08.003
   Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110
   Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200
   Rattay K, 2015, J IMMUNOL, V194, P921, DOI 10.4049/jimmunol.1402694
   Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016
   Rodrigues PM, 2017, BLOOD, V130, P478, DOI 10.1182/blood-2016-12-758961
   Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013
   Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Shao W, 2016, J BIOL CHEM, V291, P17953, DOI 10.1074/jbc.M116.724401
   St-Pierre C, 2015, J IMMUNOL, V195, P498, DOI 10.4049/jimmunol.1500558
   Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013
   Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781
   Thorpe jr ES, 1929, AM J DIS CHILD, V38, P328
   Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018
   Ucar O, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00093
   Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105
   Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820
   Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013
   Yanagihara T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9820
   Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046
   Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112
   Zhu ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11350
   Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11
NR 108
TC 20
Z9 20
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD JAN
PY 2018
VL 153
IS 1
BP 10
EP 20
DI 10.1111/imm.12831
PG 11
WC Immunology
SC Immunology
GA FP6UU
UT WOS:000417762800002
PM 28871661
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Losada-Barragan, M
   Umana-Perez, A
   Cuervo-Escobar, S
   Berbert, LR
   Porrozzi, R
   Morgado, FN
   Mendes-Da-Cruz, DA
   Savino, W
   Synchez-Gomez, M
   Cuervo, P
AF Losada-Barragan, Monica
   Umana-Perez, Adriana
   Cuervo-Escobar, Sergio
   Berbert, Luiz Ricardo
   Porrozzi, Renato
   Morgado, Fernanda N.
   Mendes-Da-Cruz, Daniella Areas
   Savino, Wilson
   Synchez-Gomez, Myriam
   Cuervo, Patricia
TI Protein malnutrition promotes dysregulation of molecules involved in T
   cell migration in the thymus of mice infected with Leishmania infantum
   (vol 7, 45991, 2017)
SO SCIENTIFIC REPORTS
LA English
DT Correction
RI Morgado, Fernanda N/K-2527-2013; Mendes-da-Cruz, Daniella/AAN-6644-2020;
   Porrozzi, Renato/U-2166-2019; BERBERT, LUIZ/AAT-4678-2020
OI Morgado, Fernanda N/0000-0002-7188-251X; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Porrozzi, Renato/0000-0003-2167-316X; 
CR Losada-Barragan M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45991
NR 1
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 25
PY 2017
VL 7
AR 46809
DI 10.1038/srep46809
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI0VU
UT WOS:000411648700001
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Losada-Barragan, M
   Umana-Perez, A
   Cuervo-Escobar, S
   Berbert, LR
   Porrozzi, R
   Morgado, FN
   Mendes-da-Cruz, DA
   Savino, W
   Sanchez-Gomez, M
   Cuervo, P
AF Losada-Barragan, Monica
   Umana-Perez, Adriana
   Cuervo-Escobar, Sergio
   Berbert, Luiz Ricardo
   Porrozzi, Renato
   Morgado, Fernanda N.
   Mendes-da-Cruz, Daniella Areas
   Savino, Wilson
   Sanchez-Gomez, Myriam
   Cuervo, Patricia
TI Protein malnutrition promotes dysregulation of molecules involved in T
   cell migration in the thymus of mice infected with Leishmania infantum
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TRYPANOSOMA-CRUZI INFECTION; EXTRACELLULAR-MATRIX; THYMOCYTE MIGRATION;
   VISCERAL LEISHMANIASIS; DONOVANI INFECTION; MEDULLA MIGRATION;
   EPITHELIAL-CELLS; IMMUNE-RESPONSE; CHAGAS-DISEASE; APOPTOSIS
AB Protein malnutrition, the most deleterious cause of malnutrition in developing countries, has been considered a primary risk factor for the development of clinical visceral leishmaniasis (VL). Protein malnutrition and infection with Leishmania infantum leads to lymphoid tissue disorganization, including changes in cellularity and lymphocyte subpopulations in the thymus and spleen. Here we report that protein malnutrition modifies thymic chemotactic factors by diminishing the CCL5, CXCL12, IGF1, CXCL9 and CXCL10 protein levels in infected animals. Nevertheless, T cells preserve their migratory capability, as they were able to migrate ex vivo in response to chemotactic stimuli, indicating that malnutrition may compromise the thymic microenvironment and alter in vivo thymocyte migration. Decrease in chemotactic factors protein levels was accompanied by an early increase in the parasite load of the spleen. These results suggest that the precondition of malnutrition is affecting the cell-mediated immune response to L. infantum by altering T cell migration and interfering with the capacity of protein-deprived animals to control parasite spreading and proliferation. Our data provide evidence for a disturbance of T lymphocyte migration involving both central and peripheral T-cells, which likely contribute to the pathophysiology of VL that occurs in malnourished individuals.
C1 [Losada-Barragan, Monica; Porrozzi, Renato; Morgado, Fernanda N.; Cuervo, Patricia] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, Rio De Janeiro, RJ, Brazil.
   [Umana-Perez, Adriana; Cuervo-Escobar, Sergio; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Sede Bogota, Fac Ciencias, Grp Invest Hormonas,Dept Quim, Bogota, Colombia.
   [Berbert, Luiz Ricardo; Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, RJ, Brazil.
RP Cuervo, P (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, Rio De Janeiro, RJ, Brazil.; Sanchez-Gomez, M (corresponding author), Univ Nacl Colombia, Sede Bogota, Fac Ciencias, Grp Invest Hormonas,Dept Quim, Bogota, Colombia.
EM mysanchezd@unal.edu.co; patricia.cuervo@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Porrozzi, Renato/U-2166-2019;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; Cuervo, Patricia/Y-6048-2019;
   Porrozzi, Renato/U-2059-2019; BERBERT, LUIZ/AAT-4678-2020; Morgado,
   Fernanda Nazare/O-3577-2017; Morgado, Fernanda N/K-2527-2013
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Porrozzi,
   Renato/0000-0003-2167-316X; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Cuervo, Patricia/0000-0002-6245-4185;
   Morgado, Fernanda N/0000-0002-7188-251X; Umana-Perez,
   Adriana/0000-0001-9262-2699; Losada Barragan,
   Monica/0000-0003-1141-1828; Berbert, Luiz Ricardo/0000-0003-0541-4002;
   Sanchez-Gomez, Myriam/0000-0002-9481-7534
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [448007/2014-2, 490560/2013-0]; CNPq-TWAS (Third World Academy of
   Sciences) [190405/2011-2]; FIOCRUZ-CNPqNational Council for Scientific
   and Technological Development (CNPq) [476727/2010-3]; Departamento
   Administrativo de Ciencia, Tecnologia e Innovacion -
   ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [11263-576-2009, 110165843548, 614-2014];
   Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [P.C. JCNE E-26/201.545/2014]
FX We are grateful to the Programa de Computacao Cientifica - Fiocruz/PROCC
   team and Dr. Marcelo Ribeiro-Alves for advice regarding the statistical
   analysis. This work was supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (P.C. Universal grant
   No. 448007/2014-2 and Bilateral grant #490560/2013-0); CNPq-TWAS (Third
   World Academy of Sciences) [M.L.B. scholarship #190405/2011-2],
   FIOCRUZ-CNPq (P.C., R.P., F.N.M. and M.L.B. PROEP grant #476727/2010-3);
   Departamento Administrativo de Ciencia, Tecnologia e Innovacion -
   Colciencias (M.S.G., S.C.E. and A.U.P grants # 11263-576-2009;
   110165843548; 614-2014); Fundacao de Amparo a Pesquisa do Estado de Rio
   de Janeiro - FAPERJ (P.C. JCNE E-26/201.545/2014). P.C. is a CNPq
   PQ-fellow (PQ Process No. 306393/2014-0).
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   CHANDRA RK, 1992, J NUTR, V122, P754, DOI 10.1093/jn/122.suppl_3.754
   Coelho VD, 2010, INT J MED SCI, V7, P1
   Colombara M, 2005, J IMMUNOL, V175, P7021, DOI 10.4049/jimmunol.175.10.7021
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   Cuervo-Escobar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114584
   da Silva SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064220
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Farias-de-Oliveira DA, 2013, J LEUKOCYTE BIOL, V93, P227, DOI 10.1189/jlb.1211589
   Gameiro J, 2010, CELL ADHES MIGR, V4, P382, DOI 10.4161/cam.4.3.11789
   Gameiro J, 2010, IMMUNOLOGY, V129, P248, DOI 10.1111/j.1365-2567.2009.03177.x
   Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013
   Ibrahim MK, 2014, INFECT IMMUN, V82, P3098, DOI 10.1128/IAI.01778-14
   Ibrahim MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002329
   Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Jones KDJ, 2014, PAEDIATR INT CHILD H, V34, pS1, DOI 10.1179/2046904714Z.000000000218
   Khanam S, 2015, PARASITE IMMUNOL, V37, P349, DOI 10.1111/pim.12197
   Kroetz DN, 2011, J IMMUNOL, V186, P5949, DOI 10.4049/jimmunol.1003876
   Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011
   Lepletier A, 2012, ANN NY ACAD SCI, V1262, P45, DOI 10.1111/j.1749-6632.2012.06601.x
   Lorenc VE, 2015, INVEST OPHTH VIS SCI, V56, P6948, DOI 10.1167/iovs.15-17496
   Losada-Barragan M, 2016, VET PARASITOL, V226, P57, DOI 10.1016/j.vetpar.2016.05.022
   LYRA JSPO, 1993, J PATHOL, V171, P231, DOI 10.1002/path.1711710312
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Mejia-Naranjo W, 2003, GROWTH HORM IGF RES, V13, P254, DOI 10.1016/S1096-6374(03)00014-5
   Mendes-da-Cruz DA, 2006, EUR J IMMUNOL, V36, P1486, DOI 10.1002/eji.200535629
   Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383
   Mitsumori K, 1996, ARCH TOXICOL, V70, P809, DOI 10.1007/s002040050343
   MITTAL A, 1988, EXP MOL PATHOL, V48, P226, DOI 10.1016/0014-4800(88)90059-7
   Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412
   Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092
   Ortiz R, 2009, CLIN EXP IMMUNOL, V155, P96, DOI 10.1111/j.1365-2249.2008.03796.x
   Prentice AM, 1999, BRIT J NUTR, V81, P345, DOI 10.1017/S0007114599000628
   REVILLARD JP, 1990, FOOD ADDIT CONTAM, V7, pS82, DOI 10.1080/02652039009373853
   Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Savino W, 2010, P NUTR SOC, V69, P636, DOI 10.1017/S0029665110002545
   Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115
   Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830
   Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643
   Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4
   Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009
   Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265
   Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3
   Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12
   Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036
   Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588
   Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956
NR 60
TC 16
Z9 16
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 11
PY 2017
VL 7
AR 45991
DI 10.1038/srep45991
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER6LG
UT WOS:000398916200001
PM 28397794
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Savino, W
   Messias, CV
   Mendes-da-Cruz, DA
   Passos, P
   Ferreira, ACAF
   Nascimento, OJ
AF Savino, Wilson
   Messias, Carolina V.
   Mendes-da-Cruz, Daniella A.
   Passos, Pamela
   Ferreira, Ana Carolina A. F.
   Nascimento, Osvaldo J.
TI Zika Virus Infection in the Elderly: Possible Relationship with
   Guillain-Barre Syndrome
SO GERONTOLOGY
LA English
DT Article
DE Zika virus; Aging; Guillain-Barre syndrome; Autoimmunity; Vaccine; T
   cells
ID REGULATORY T-CELLS; FRENCH-POLYNESIA; DENGUE VIRUS; TRANSMISSION;
   OUTBREAK; REPERTOIRE; COMPLEMENT; ANTIGEN; BRAZIL; BLOOD
AB The Zika virus (ZIKV) outbreak in French Polynesia, in 2013, and in Brazil, in 2015, was correlated with neurological complications, which comprised, among others, congenital microcephaly and Guillain-Barre syndrome (GBS), which includes a group of acute autoimmune neuropathies generally reported after respiratory or gastrointestinal infectious diseases. Despite being relatively rare, the incidence rate of GBS rises with age, which makes GBS more frequent in the elderly, in whom it is also a more severe disease with slower recovery than in younger patients. Different forms of GBS have been described having diagnostic confirmation of a previous infection with the ZIKV virus. Although we do not have enough evidence that elderly people are a particularly susceptible population to developing GBS following ZIKV infection, this is plausible. We should consider this possibility, particularly taking into account that aging subjects are more susceptible to infections. In this context, a deeper understanding of how the immune system in the elderly functions in relation to ZIKV infection is necessary, as well as an under-standing of what kind of alterations of the nervous system such an infection triggers in the elderly, beyond GBS. This will be relevant for better therapeutic interventions and for designing vaccine candidates that can be applied in an aging population, particularly those prone to develop ZIKV-induced autoimmunity. (C) 2016 S. Karger AG, Basel
C1 [Savino, Wilson; Messias, Carolina V.; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Leonidas Deane Bldg,Room 510,Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Savino, Wilson; Messias, Carolina V.; Mendes-da-Cruz, Daniella A.] Fluminense Fed Univ, Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Niteroi, RJ, Brazil.
   [Passos, Pamela; Ferreira, Ana Carolina A. F.; Nascimento, Osvaldo J.] Fluminense Fed Univ, Dept Neurol, Niteroi, RJ, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Leonidas Deane Bldg,Room 510,Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506
FU Fiocruz Brazil; Faperj BrazilCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CNPq BrazilNational
   Council for Scientific and Technological Development (CNPq); Capes
   BrazilCAPES; FOCEM (Mercosur)
FX This work was done in the framework of funding by Fiocruz, Faperj, CNPq,
   and Capes, Brazil, as well as FOCEM (Mercosur).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brazilian Ministry of Health, 2015, MIN SAUD INV AUM CAS
   Brazilian Ministry of Health, 2016, MICR 1 749 CAS CONF
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cencioni MT, 2009, INT J IMMUNOPATH PH, V22, P1043, DOI 10.1177/039463200902200420
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dunn-Walters DK, 2016, CLIN EXP IMMUNOL, V183, P50, DOI 10.1111/cei.12700
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Han RK, 2014, J CLIN IMMUNOL, V34, P94, DOI 10.1007/s10875-013-9965-3
   Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016
   Jagger A, 2014, GERONTOLOGY, V60, P130, DOI 10.1159/000355303
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller L, 2015, AGEING RES REV, V23, P116, DOI 10.1016/j.arr.2015.01.005
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nyati KK, 2011, ARCH NEUROL-CHICAGO, V68, P445, DOI 10.1001/archneurol.2011.51
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peric S, 2016, J PERIPHER NERV SYST, V21, P105, DOI 10.1111/jns.12163
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schmidt B, 1996, MUSCLE NERVE, V19, P474, DOI 10.1002/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Tabibian-Keissar H, 2016, EUR J IMMUNOL, V46, P480, DOI 10.1002/eji.201545586
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WHO, 2016, WHO DIR GEN SUMM OUT
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2016, GUILLAIN BARRE SYNDR
   Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 50
TC 6
Z9 7
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 2017
VL 63
IS 3
BP 210
EP 215
DI 10.1159/000453579
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA ES9SQ
UT WOS:000399901300002
PM 28002820
DA 2020-12-17
ER

PT J
AU Losada, M
   Umana-Perez, A
   Cuervo-Escobar, S
   Rodriguez, A
   Berbet, L
   Porrozzi, R
   Mendes-da-Cruz, D
   Savino, W
   Carvalho, P
   Sanchez-Gomez, M
AF Losada, Monica
   Umana-Perez, Adriana
   Cuervo-Escobar, Sergio
   Rodriguez, Andres
   Berbet, Luiz
   Porrozzi, Renato
   Mendes-da-Cruz, Daniella
   Savino, Wilson
   Carvalho, Paulo
   Sanchez-Gomez, Myriam
TI SPLENIC INTERSTITIAL FLUID PROTEOMIC PROFILE DURING PROTEIN MALNUTRITION
   AND LEISHMANIA INFANTUM INFECTION
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Meeting Abstract
DE Protein malnutrition; Leishmania infantum; Visceral leishmaniasis;
   Apoptosis; T cell migration
C1 [Losada, Monica; Rodriguez, Andres; Porrozzi, Renato] Fiocruz MS, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil.
   [Umana-Perez, Adriana; Cuervo-Escobar, Sergio; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Lab Hormonas, Bogota, Colombia.
   [Berbet, Luiz; Mendes-da-Cruz, Daniella; Savino, Wilson] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, RJ, Brazil.
   [Carvalho, Paulo] Fiocruz MS, Lab Prote & Engn Prot, Curitiba, Parana, Brazil.
RI Porrozzi, Renato/U-2059-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 71
SU 2
MA 144/2461
BP 1017
EP 1017
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FM9QD
UT WOS:000415605302392
DA 2020-12-17
ER

PT J
AU Savino, W
   Mendes-da-Cruz, DA
   Lepletier, A
   Dardenne, M
AF Savino, Wilson
   Mendes-da-Cruz, Daniella Areas
   Lepletier, Ailin
   Dardenne, Mireille
TI Hormonal control of T-cell development in health and disease
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Review
ID THYMIC EPITHELIAL-CELLS; TRYPANOSOMA-CRUZI INFECTION; PROLACTIN RECEPTOR
   EXPRESSION; MURINE LYMPHOID-CELLS; PROTEIN-KINASE-C; GROWTH-FACTOR-I;
   GLUCOCORTICOID-RECEPTOR; RAT THYMUS; EXTRACELLULAR-MATRIX; THYMOCYTE
   MIGRATION
AB The physiology of the thymus, the primary lymphoid organ in which T cells are generated, is controlled by hormones. Data from animal models indicate that several peptide and nonpeptide hormones act pleiotropically within the thymus to modulate the proliferation, differentiation, migration and death by apoptosis of developing thymocytes. For example, growth hormone and prolactin can enhance thymocyte proliferation and migration, whereas glucocorticoids lead to the apoptosis of these developing cells. The thymus undergoes progressive age-dependent atrophy with a loss of cells being generated and exported, therefore, hormone-based therapies are being developed as an alternative strategy to rejuvenate the organ, as well as to augment thymocyte proliferation and the export of mature T cells to peripheral lymphoid organs. Some hormones (such as growth hormone and progonadoliberin-1) are also being used as therapeutic agents to treat immunodeficiency disorders associated with thymic atrophy, such as HIV infection. In this Review, we discuss the accumulating data that shows the thymus gland is under complex and multifaceted hormonal control that affects the process of T-cell development in health and disease.
C1 [Savino, Wilson; Mendes-da-Cruz, Daniella Areas; Lepletier, Ailin] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Dardenne, Mireille] Univ Paris 05, CNRS, Hop Necker, UMR 8147, F-75015 Paris, France.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Lepletier, Ailin/0000-0002-1371-7313
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); Capes (Brazil)CAPES; Faperj (Brazil)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fiocruz (Brazil); FOCEM (Mercosur countries); CNRS
   (France)Centre National de la Recherche Scientifique (CNRS)
FX Work in the authors' laboratories was supported with grants from CNPq,
   Capes, Faperj and Fiocruz (Brazil), FOCEM (Mercosur countries) and CNRS
   (France). The conjoint work was developed in the framework of the
   Fiocruz-CNRS International Associated Laboratory of Immunology and
   Immunopathology.
CR Ader R, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, pXV, DOI 10.1016/B978-012088576-3/50001-0
   AIRD F, 1993, P NATL ACAD SCI USA, V90, P7104, DOI 10.1073/pnas.90.15.7104
   Alpdogan O, 2003, TRANSPLANTATION, V75, P1977, DOI 10.1097/01.TP.0000070167.81584.A2
   Attaf M, 2015, CELL MOL IMMUNOL, V12, P391, DOI 10.1038/cmi.2014.134
   Aw D, 2008, AGING CELL, V7, P158, DOI 10.1111/j.1474-9726.2007.00365.x
   Aw D, 2009, BIOGERONTOLOGY, V10, P311, DOI 10.1007/s10522-008-9182-2
   AZAD N, 1991, ENDOCRINOLOGY, V128, P1679, DOI 10.1210/endo-128-3-1679
   BARR IG, 1982, J IMMUNOL, V128, P2825
   BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R
   BAZZONI N, 1990, J ENDOCRINOL INVEST, V13, P931, DOI 10.1007/BF03349660
   Belloni AS, 2004, INT J MOL MED, V14, P165
   BEN E, 1991, LIFE SCI, V48, P2141, DOI 10.1016/0024-3205(91)90147-4
   Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463
   BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662
   BESEDOVSKY HO, 1974, NATURE, V249, P356, DOI 10.1038/249356a0
   BLALOCK JE, 1985, CLIN ENDOCRINOL META, V14, P1021
   Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334
   Bouchard B, 1999, J IMMUNOL, V163, P576
   BRTKO J, 1983, ENDOCRINOL EXP, V17, P3
   Carlberg C, 2010, CHROMOSOMA, V119, P479, DOI 10.1007/s00412-010-0283-8
   Carreno PC, 2005, J NEUROIMMUNOL, V160, P135, DOI 10.1016/j.jneuroim.2004.11.008
   Carreno PC, 2004, J NEUROIMMUNOL, V153, P83, DOI 10.1016/j.jneuroim.2004.04.020
   Charlton H, 2008, J NEUROENDOCRINOL, V20, P641, DOI 10.1111/j.1365-2826.2008.01718.x
   Chen YK, 2011, ACAD RADIOL, V18, P1292, DOI 10.1016/j.acra.2011.05.011
   Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509
   Chu YW, 2008, BLOOD, V112, P2836, DOI 10.1182/blood-2008-04-149435
   Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547
   Coelho VDM, 2002, NEUROENDOCRINOLOGY, V75, P139, DOI 10.1159/000048230
   Cohen J J, 1992, Semin Immunol, V4, P363
   Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015
   Correa-de-Santana E, 2009, NEUROIMMUNOMODULAT, V16, P208, DOI 10.1159/000205513
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221
   da Silva SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064220
   DARDENNE M, 1991, P NATL ACAD SCI USA, V88, P9700, DOI 10.1073/pnas.88.21.9700
   DARDENNE M, 1994, ENDOCRINOLOGY, V134, P2108, DOI 10.1210/en.134.5.2108
   DARDENNE M, 1983, J IMMUNOL, V130, P1195
   DARDENNE M, 1986, CELL IMMUNOL, V100, P112, DOI 10.1016/0008-8749(86)90011-0
   DARDENNE M, 1986, J IMMUNOL, V136, P1303
   Dardenne M, 2009, ANN NY ACAD SCI, V1153, P1, DOI 10.1111/j.1749-6632.2008.03977.x
   DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1
   De Mello-Coelho V, 1998, Dev Immunol, V6, P317, DOI 10.1155/1998/89782
   de Mello-Coelho V, 1998, ENDOCRINOLOGY, V139, P3837, DOI 10.1210/en.139.9.3837
   deMelloCoelho V, 1997, J NEUROIMMUNOL, V76, P39, DOI 10.1016/S0165-5728(97)00031-3
   Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
   Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134
   Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248
   Egawa T, 2015, ADV IMMUNOL, V125, P1, DOI 10.1016/bs.ai.2014.09.001
   ELANDS J, 1990, ENDOCRINOLOGY, V126, P2703, DOI 10.1210/endo-126-5-2703
   Feng JC, 1998, LIFE SCI, V63, P111, DOI 10.1016/S0024-3205(98)00246-X
   Foster M, 1998, CELL MOL LIFE SCI, V54, P1076, DOI 10.1007/s000180050236
   French RA, 2002, ENDOCRINOLOGY, V143, P690, DOI 10.1210/en.143.2.690
   Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003
   GAGNERAULT MC, 1993, J IMMUNOL, V150, P5673
   Gagnerault MC, 1996, ENDOCRINOLOGY, V137, P1719, DOI 10.1210/en.137.5.1719
   GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O
   Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531
   GREENSTEIN BD, 1987, J ENDOCRINOL, V112, P345, DOI 10.1677/joe.0.1120345
   Greenwood PL, 2003, REPRODUCTION, P195
   Griffith AV, 2012, AGING CELL, V11, P169, DOI 10.1111/j.1474-9726.2011.00773.x
   GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85
   Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104
   Gruver AL, 2009, J ENDOCRINOL, V203, P75, DOI 10.1677/JOE-09-0179
   Hansenne I, 2004, Clin Dev Immunol, V11, P45, DOI 10.1080/10446670410001670481
   Hansenne I, 2005, J NEUROIMMUNOL, V158, P67, DOI 10.1016/j.jneuroim.2004.08.007
   Hareramadas B, 2005, GEN COMP ENDOCR, V144, P10, DOI 10.1016/j.ygcen.2005.04.016
   Haynes BF, 1999, CLIN IMMUNOL, V92, P3, DOI 10.1006/clim.1999.4738
   Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982
   Herasimtschuk AA, 2013, CLIN EXP IMMUNOL, V173, P444, DOI 10.1111/cei.12141
   Hermann M, 2001, EXP GERONTOL, V36, P1075, DOI 10.1016/S0531-5565(01)00113-9
   Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169
   Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926
   Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974
   Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762
   Hull KL, 1996, CELL TISSUE RES, V286, P69, DOI 10.1007/s004410050676
   Ishibashi H, 2005, CLIN CANCER RES, V11, P6495, DOI 10.1158/1078-0432.CCR-04-2495
   JESSOP DS, 1995, J NEUROIMMUNOL, V60, P29, DOI 10.1016/0165-5728(95)00049-8
   Johnson EW, 2001, J BIOL REG HOMEOS AG, V15, P156
   Jondal M, 2004, TRENDS IMMUNOL, V25, P595, DOI 10.1016/j.it.2004.09.003
   KAWASHIMA I, 1992, THYMUS, V20, P115
   KELLEY KW, 1986, P NATL ACAD SCI USA, V83, P5663, DOI 10.1073/pnas.83.15.5663
   KENDALL MD, 1990, CELL TISSUE RES, V261, P555, DOI 10.1007/BF00313535
   Kermani H, 2012, NEUROIMMUNOMODULAT, V19, P137, DOI 10.1159/000328844
   Kim SY, 2010, BIOCHEM BIOPH RES CO, V394, P562, DOI 10.1016/j.bbrc.2010.03.019
   Kino T, 2009, CELL MOL LIFE SCI, V66, P3435, DOI 10.1007/s00018-009-0098-z
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Kovaiou RD, 2005, INT IMMUNOL, V17, P1359, DOI 10.1093/intimm/dxh314
   Krishnan N, 2003, ENDOCRINOLOGY, V144, P2102, DOI 10.1210/en.2003-0053
   Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326
   LACAZEMASMONTEIL T, 1987, P NATL ACAD SCI USA, V84, P7261, DOI 10.1073/pnas.84.20.7261
   Lechner J, 1997, IMMUNOBIOLOGY, V198, P112, DOI 10.1016/S0171-2985(97)80032-0
   Lechner O, 2000, EUR J IMMUNOL, V30, P337
   Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044
   Lepletier A, 2015, GERONTOLOGY, V61, P504, DOI 10.1159/000375160
   Lepletier A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002470
   Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014
   Lin B, 1997, CELL MOL BIOL, V43, P361
   Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127
   MARCHETTI B, 1989, ENDOCRINOLOGY, V125, P1037, DOI 10.1210/endo-125-2-1037
   Matre V, 2003, BIOCHEM J, V372, P851, DOI 10.1042/BJ20030057
   Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972
   MCGIMSEY WC, 1991, ENDOCRINOLOGY, V129, P3064, DOI 10.1210/endo-129-6-3064
   MELIS MR, 1995, REGUL PEPTIDES, V59, P335, DOI 10.1016/0167-0115(95)00088-S
   MELIS MR, 1993, REGUL PEPTIDES, V45, P269, DOI 10.1016/0167-0115(93)90218-W
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   Mendes-da-Cruz DA, 2006, EUR J IMMUNOL, V36, P1486, DOI 10.1002/eji.200535629
   Michie AM, 2007, INT IMMUNOL, V19, P1421, DOI 10.1093/intimm/dxm113
   Mihara S, 1999, J CLIN ENDOCR METAB, V84, P1378, DOI 10.1210/jc.84.4.1378
   Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139
   Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067
   MOLL UM, 1988, HISTOCHEMISTRY, V89, P385, DOI 10.1007/BF00500641
   Montagne JJ, 1999, ENDOCRINOLOGY, V140, P1054, DOI 10.1210/en.140.3.1054
   Montecino-Rodriguez E, 1998, ENDOCRINOLOGY, V139, P4120, DOI 10.1210/en.139.10.4120
   Montgomery DW, 1998, ENDOCRINOLOGY, V139, P811, DOI 10.1210/en.139.2.811
   MONTGOMERY DW, 1992, ENDOCRINOLOGY, V131, P3019, DOI 10.1210/en.131.6.3019
   Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668
   Morrot A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001268
   Nancy P, 2005, ENDOCRINOLOGY, V146, P2345, DOI 10.1210/en.2004-1003
   Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003
   Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830
   NEZELOF C, 1992, HISTOPATHOLOGY, V21, P499, DOI 10.1111/j.1365-2559.1992.tb00437.x
   Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028
   OLSEN NJ, 1991, ENDOCRINOLOGY, V129, P2471, DOI 10.1210/endo-129-5-2471
   Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278
   Olsen NJ, 1998, ENDOCRINOLOGY, V139, P748, DOI 10.1210/en.139.2.748
   Palinkas L, 2008, IMMUNOBIOLOGY, V213, P39, DOI 10.1016/j.imbio.2007.06.004
   Passos GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00352
   PAWLIKOWSKI M, 1992, NEUROPEPTIDES, V23, P199, DOI 10.1016/0143-4179(92)90123-E
   Pazirandeh A, 2002, FASEB J, V16, P727, DOI 10.1096/fj.01-0891fje
   Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010
   Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004
   Perez AR, 2009, NEUROIMMUNOMODULAT, V16, P96, DOI 10.1159/000180264
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Polgreen L, 2007, GROWTH HORM IGF RES, V17, P41, DOI 10.1016/j.ghir.2006.10.005
   Pugliese-Pires PN, 2010, EUR J ENDOCRINOL, V163, P349, DOI 10.1530/EJE-10-0272
   Purton JF, 2000, IMMUNITY, V13, P179, DOI 10.1016/S1074-7613(00)00018-2
   Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111
   Qiao SJ, 2008, EXP CELL RES, V314, P3027, DOI 10.1016/j.yexcr.2008.06.014
   RANELLETTI FO, 1987, J IMMUNOL, V138, P440
   Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014
   Reggiani P, 2009, HISTOL HISTOPATHOL, V24, P729, DOI 10.14670/HH-24.729
   Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   Roggero E, 2006, J ENDOCRINOL, V190, P495, DOI 10.1677/joe.1.06642
   Rosenfeld RG, 2004, GROWTH HORM IGF RES, V14, pS35, DOI 10.1016/j.ghir.2004.03.009
   Sacedon R, 1999, J NEUROIMMUNOL, V98, P157, DOI 10.1016/S0165-5728(99)00091-0
   SAKABE K, 1994, IMMUNOL CELL BIOL, V72, P193, DOI 10.1038/icb.1994.29
   SALAS MA, 1990, CLIN EXP IMMUNOL, V79, P470
   Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2003, ANN NY ACAD SCI, V992, P179, DOI 10.1111/j.1749-6632.2003.tb03148.x
   SAVINO W, 1995, IMMUNOL TODAY, V16, P318, DOI 10.1016/0167-5699(95)80144-8
   Savino W, 2002, SCAND J IMMUNOL, V55, P442, DOI 10.1046/j.1365-3083.2002.01077.x
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   SAVINO W, 1986, AM J PATHOL, V122, P302
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Savino W, 2012, ANN NY ACAD SCI, V1261, P49, DOI 10.1111/j.1749-6632.2012.06637.x
   Savino W, 2010, NEUROIMMUNOMODULAT, V17, P142, DOI 10.1159/000258708
   SELYE H, 1975, NEW YORK STATE J MED, V75, P2139
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Smaniotto S, 2004, NEUROIMMUNOMODULAT, V11, P299, DOI 10.1159/000079410
   Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014
   Spidale NA, 2014, J IMMUNOL, V193, P21, DOI 10.4049/jimmunol.1400321
   Staples JE, 1999, J IMMUNOL, V163, P4168
   Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922
   Stefan M, 2014, P NATL ACAD SCI USA, V111, P12562, DOI 10.1073/pnas.1408821111
   Talaber G, 2015, FASEB J, V29, P2526, DOI 10.1096/fj.14-268508
   Talaber G, 2011, REJUV RES, V14, P241, DOI 10.1089/rej.2010.1110
   Taub DD, 2010, CURR OPIN PHARMACOL, V10, P408, DOI 10.1016/j.coph.2010.04.015
   Tesselaar K, 2008, J CLIN INVEST, V118, P844, DOI 10.1172/JCI35112
   TIMSIT J, 1992, J CLIN ENDOCR METAB, V75, P183, DOI 10.1210/jc.75.1.183
   TSAWDAROGLOU NG, 1981, EUR J BIOCHEM, V114, P305, DOI 10.1111/j.1432-1033.1981.tb05150.x
   TSUJI Y, 1994, CELL MOL BIOL, V40, P1135
   UTSUYAMA M, 1989, MECH AGEING DEV, V47, P175, DOI 10.1016/0047-6374(89)90030-4
   Vacchio MS, 1999, J IMMUNOL, V163, P1327
   VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835
   van der Weerd K, 2014, THYROID, V24, P1051, DOI 10.1089/thy.2013.0396
   Varas A, 2003, MICROSC RES TECHNIQ, V62, P501, DOI 10.1002/jemt.10411
   Velardi E, 2014, J EXP MED, V211, P2341, DOI 10.1084/jem.20131289
   Ventevogel MS, 2013, CURR OPIN IMMUNOL, V25, P516, DOI 10.1016/j.coi.2013.06.002
   Vilar-Pereira G, 2012, BRAIN BEHAV IMMUN, V26, P1136, DOI 10.1016/j.bbi.2012.07.009
   VILLAVERDE DMS, 1992, ENDOCRINOLOGY, V131, P1313, DOI 10.1210/en.131.3.1313
   VILLAVERDE DMS, 1993, ENDOCRINOLOGY, V133, P867, DOI 10.1210/en.133.2.867
   VISELLI SM, 1995, MOL CELL ENDOCRINOL, V109, P19, DOI 10.1016/0303-7207(95)03479-Q
   Yellayi S, 2000, ENDOCRINE, V12, P207, DOI 10.1385/ENDO:12:3:207
   Youm YH, 2009, J BIOL CHEM, V284, P7068, DOI 10.1074/jbc.M808302200
   Zhao H, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-6
NR 189
TC 50
Z9 51
U1 1
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
EI 1759-5037
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD FEB
PY 2016
VL 12
IS 2
BP 77
EP 89
DI 10.1038/nrendo.2015.168
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DC3JM
UT WOS:000369115600007
PM 26437623
DA 2020-12-17
ER

PT J
AU Messias, CV
   Santana-Van-Vliet, E
   Lemos, JP
   Moreira, OC
   Cotta-de-Almeida, V
   Savino, W
   Mendes-da-Cruz, DA
AF Messias, Carolina V.
   Santana-Van-Vliet, Eliane
   Lemos, Julia P.
   Moreira, Otacilio C.
   Cotta-de-Almeida, Vinicius
   Savino, Wilson
   Mendes-da-Cruz, Daniella Areas
TI Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis
   of T-ALL Blasts through S1P1 Activation
SO PLOS ONE
LA English
DT Article
ID SPHINGOSINE 1-PHOSPHATE RECEPTORS; ACUTE LYMPHOBLASTIC-LEUKEMIA;
   LYMPHOCYTE EGRESS; CELL-MIGRATION; PROMOTES PROLIFERATION;
   PERIPHERAL-BLOOD; ACTIVE MOVEMENT; IN-VITRO; KINASE 1; INVASION
AB Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid involved in several physiological processes including cell migration and differentiation. S1P signaling is mediated through five G protein-coupled receptors (S1P1-S1P5). S1P1 is crucial to the exit of T-lymphocytes from the thymus and peripheral lymphoid organs through a gradient of S1P. We have previously observed that T-ALL and T-LBL blasts express S1P1. Herein we analyzed the role of S1P receptors in the migratory pattern of human T-cell neoplastic blasts. S1P-triggered cell migration was directly related to S1P1 expression. T-ALL blasts expressing low levels of S1P1 mRNA (HPB-ALL) did not migrate toward S1P, whereas those expressing higher levels of S1P1 (MOLT-4, JURKAT and CEM) did migrate. The S1P ligand induced T-ALL cells chemotaxis in concentrations up to 500 nM and induced fugetaxis in higher concentrations (1000-10000 nM) through interactions with S1P1. When S1P1 was specifically blocked by the W146 compound, S1P-induced migration at lower concentrations was reduced, whereas higher concentrations induced cell migration. Furthermore, we observed that S1P/S1P1 interactions induced ERK and AKT phosphorylation, and modulation of Rac1 activity. Responding T-ALL blasts also expressed S1P3 mRNA but blockage of this receptor did not modify migratory responses. Our results indicate that S1P is involved in the migration of TALL/LBL blasts, which is dependent on S1P1 expression. Moreover, S1P concentrations in the given microenvironment might induce dose-dependent chemotaxis or fugetaxis of TALL blasts.
C1 [Messias, Carolina V.; Santana-Van-Vliet, Eliane; Lemos, Julia P.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Moreira, Otacilio C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
EM daniella@ioc.fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Cotta-de-Almeida,
   Vinicius/G-3939-2012; Moreira, Otacilio/AAS-5839-2020; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Cotta-de-Almeida, Vinicius/AAC-3721-2019
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Moreira,
   Otacilio/0000-0002-5340-8697; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Cotta-de-Almeida,
   Vinicius/0000-0002-6753-3480
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FaperjCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Fiocruz; FOCEM-Mercosur
FX This work was supported by CNPq, Faperj, Fiocruz, and FOCEM-Mercosur.
CR Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200
   Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x
   Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654
   Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136
   Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300
   Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006
   Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307
   Cuvillier O, 2012, M S-MED SCI, V28, P951, DOI 10.1051/medsci/20122811013
   Di JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12363
   EPSTEIN AL, 1974, CANCER-AM CANCER SOC, V34, P1851, DOI 10.1002/1097-0142(197412)34:6<1851::AID-CNCR2820340602>3.0.CO;2-4
   Evangelisti C, 2014, ONCOTARGET, V5, P7886, DOI 10.18632/oncotarget.2318
   Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009
   FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J
   Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035
   Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/nchembio.392, 10.1038/NCHEMBIO.392]
   Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336
   Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783
   Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200
   Grahler MH, 2005, J IMMUNOL, V174, P1997
   Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048
   Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009
   He SQ, 2015, INT J CLIN EXP PATHO, V8, P5175
   Iino J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-150
   Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474
   Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678
   Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05
   Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832
   Lee CJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1580-7
   Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025
   Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509
   Malet-Engra G, 2015, CURR BIOL, V25, P242, DOI 10.1016/j.cub.2014.11.030
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429
   McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006
   Mendes-da-Cruz DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103405
   MINOWADA J, 1972, J NATL CANCER I, V49, P891
   MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207
   Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14
   Onciu M, 2009, HEMATOL ONCOL CLIN N, V23, P655, DOI 10.1016/j.hoc.2009.04.009
   Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005
   Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221
   Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112
   Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702
   Poznansky MC, 2000, NAT MED, V6, P543
   Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI13853
   Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001
   Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650
   Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003
   Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272
   Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804
   Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5
   SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505
   Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640
   Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285
   Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002
   Strub GM, 2010, ADV EXP MED BIOL, V688, P141
   Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391
   Tabasinezhad M, 2013, J CANCER RES THER, V9, P556, DOI 10.4103/0973-1482.126446
   Tarrason G, 2011, INT IMMUNOPHARMACOL, V11, P1773, DOI 10.1016/j.intimp.2011.07.004
   Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516
   Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8
   Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222
NR 62
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 29
PY 2016
VL 11
IS 1
AR e0148137
DI 10.1371/journal.pone.0148137
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9GH
UT WOS:000369528600104
PM 26824863
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Passos, GA
   Mendes-da-Cruz, DA
   Oliveira, EH
AF Passos, Geraldo Aleixo
   Mendes-da-Cruz, Daniella Areas
   Oliveira, Ernna Herida
TI Editorial: The Role of Aire, microRNAs and Cell-Cell Interactions on
   Thymic Architecture and Induction of Tolerance
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Editorial Material
DE Thymus gland; central tolerance; Aire gene; miRNAs; cell-cell
   interactions; Coxsackievirus; exosomes; chemokines
C1 [Passos, Geraldo Aleixo; Oliveira, Ernna Herida] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, BR-14049 Ribeirao Preto, Brazil.
   [Passos, Geraldo Aleixo] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Genet, BR-14049 Ribeirao Preto, Brazil.
   [Passos, Geraldo Aleixo] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Mol Biol, BR-14049 Ribeirao Preto, Brazil.
   [Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
RP Passos, GA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, BR-14049 Ribeirao Preto, Brazil.
EM passos@usp.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella
   A/E-7875-2016; Passos, Geraldo Aleixo/ABE-3251-2020; Passos, Geraldo
   A/A-2899-2008
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Passos, Geraldo Aleixo/0000-0002-4408-140X;
   Passos, Geraldo A/0000-0002-4408-140X
CR Akiyama T, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00461
   Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320
   Caramalho I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00395
   Gallo V, 2013, EXPERT REV CLIN IMMU, V9, P43, DOI 10.1586/eci.12.88
   Garcia-Ceca J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00333
   Hu ZC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00398
   Jurberg AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00442
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326
   Linhares-Lacerda L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00428
   Lopes N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00365
   Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532
   Michaux H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00338
   Passos GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00352
   Skogberg G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00366
   Ucar O, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00093
   Yamano T, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00376
NR 17
TC 2
Z9 2
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 14
PY 2015
VL 6
BP 1
EP 3
AR 615
DI 10.3389/fimmu.2015.00615
PG 3
WC Immunology
SC Immunology
GA CZ1BP
UT WOS:000366841000001
PM 26697011
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Savino, W
   Mendes-da-Cruz, DA
   Golbert, DCF
   Riederer, I
   Cotta-De-Almeida, V
AF Savino, Wilson
   Mendes-da-Cruz, Daniella Areas
   Ferreira Golbert, Daiane Cristina
   Riederer, Ingo
   Cotta-de-Almeida, Vinicius
TI Laminin-Mediated interactions in Thymocyte Migration and Development
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE thymus; T-cell development; T-cell migration; thymic epithelial cells;
   extracellular matrix; laminin isoforms; integrins; chemokines
ID EXTRACELLULAR-MATRIX COMPONENTS; MOUSE THYMUS MICROENVIRONMENT;
   TRYPANOSOMA-CRUZI INFECTION; CELLULAR PRION PROTEIN; BASEMENT-MEMBRANES;
   RESTRICTED DISTRIBUTION; NEUROENDOCRINE CONTROL; REGULATED EXPRESSION;
   GLOBULAR DOMAIN; ALPHA-1 CHAIN
AB Intrathymic T-cell differentiation is a key process for the development and maintenance of cell-mediated immunity, and occurs concomitantly to highly regulated migratory events. We have proposed a multivectorial model for describing intrathymic thymocyte migration. One of the individual vectors comprises interactions mediated by laminins (LMs), a heterotrimeric protein family of the extracellular matrix. Several LMs are expressed in the thymus, being produced by microenvironmental cells, particularly thymic epithelial cells (TECs). Also, thymocytes and epithelial cells express integrin-type LM receptors. Functionally, it has been reported that the dy/dy mutant mouse (lacking the LM isoform 211) exhibits defective thymocyte differentiation. Several data show haptotactic effects of LMs upon thymocytes, as well as their adhesion on TECs; both effects being prevented by anti-LM or anti-LM receptor antibodies. Interestingly, LM synergizes with chemokines to enhance thymocyte migration, whereas classe-3 semaphorins and B ephrins, which exhibit chemorepulsive effects in the thymus, downregulate LM-mediated migratory responses of thymocytes. More recently, we showed that knocking down the ITGA6 gene (which encodes the alpha 6 integrin chain of LM receptors) in human TECs modulates a large number of cell migration-related genes and results in changes of adhesion pattern of thymocytes onto the thymic epithelium. Overall, LM-mediated interactions can be placed at the cross-road of the multivectorial process of thymocyte migration, with a direct influence peryse, as well as by modulating other molecular interactions associated with the intrathymic-trafficking events.
C1 [Savino, Wilson; Mendes-da-Cruz, Daniella Areas; Ferreira Golbert, Daiane Cristina; Riederer, Ingo; Cotta-de-Almeida, Vinicius] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Cotta-de-Almeida, Vinicius/AAC-3721-2019; Riederer, Ingo/M-6372-2019;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Cotta-de-Almeida, Vinicius/G-3939-2012;
   Riederer, Ingo/O-1444-2017
OI Cotta-de-Almeida, Vinicius/0000-0002-6753-3480; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506;
   Riederer, Ingo/0000-0001-7171-9977
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CapesCAPES; FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fiocruz (Brazil); Focem
   (Mercosur)
FX This work was financially supported by grants from CNPq, Capes, Faperj,
   and Fiocruz (Brazil), and Focem (Mercosur).
CR Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826
   Ayres-Martins S, 2004, CELL IMMUNOL, V229, P21, DOI 10.1016/j.cellimm.2004.06.002
   Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O
   Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653
   BERRIH S, 1985, J HISTOCHEM CYTOCHEM, V33, P655, DOI 10.1177/33.7.3891843
   Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001
   BOFILL M, 1985, AM J PATHOL, V119, P462
   Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4
   CHANG AC, 1995, J IMMUNOL, V154, P500
   CHANG AC, 1993, J IMMUNOL, V151, P1789
   Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547
   Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x
   Colognato H, 2007, DEVELOPMENT, V134, P1723, DOI 10.1242/dev.02819
   Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   Cowan JE, 2015, EUR J IMMUNOL, V45, P652, DOI 10.1002/eji.201445108
   deMelloCoelho V, 1997, J NEUROIMMUNOL, V76, P39, DOI 10.1016/S0165-5728(97)00031-3
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   Doliana R, 1997, FEBS LETT, V417, P65, DOI 10.1016/S0014-5793(97)01251-9
   Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750
   Drumea-Mirancea M, 2006, J CELL SCI, V119, P1396, DOI 10.1242/jcs.02840
   DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3
   Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2
   Emre Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3842
   Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5
   Farias-de-Oliveira DA, 2013, MEM I OSWALDO CRUZ, V108, P825, DOI 10.1590/0074-0276130071
   Farias-de-Oliveira DA, 2013, J LEUKOCYTE BIOL, V93, P227, DOI 10.1189/jlb.1211589
   Golbert DCF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S6-S3
   Gameiro J, 2010, IMMUNOLOGY, V129, P248, DOI 10.1111/j.1365-2567.2009.03177.x
   Garcia F, 2012, J LEUKOCYTE BIOL, V91, P7, DOI 10.1189/jlb.0111031
   Gawlik KI, 2006, HUM MOL GENET, V15, P2690, DOI 10.1093/hmg/ddl201
   Golbert DCF, 2014, NUCLEIC ACIDS RES, V42, pD426, DOI 10.1093/nar/gkt901
   Golbert DCF, 2011, NUCLEIC ACIDS RES, V39, pD320, DOI 10.1093/nar/gkq1055
   Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048
   Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4
   Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024
   Guo XK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/462152
   Halkias J, 2014, CELL MOL LIFE SCI, V71, P3101, DOI 10.1007/s00018-014-1607-2
   Hirosaki T, 2002, J BIOL CHEM, V277, P49287, DOI 10.1074/jbc.M111096200
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831
   Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618
   Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200
   Ishikawa T, 2014, MATRIX BIOL, V36, P5, DOI 10.1016/j.matbio.2014.03.003
   Iwao M, 2000, IMMUNOLOGY, V99, P481, DOI 10.1046/j.1365-2567.2000.00990.x
   Munoz JJ, 2009, ANN NY ACAD SCI, V1153, P14, DOI 10.1111/j.1749-6632.2008.03965.x
   Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490
   Karaoz E, 1996, ANN ANAT, V178, P33, DOI 10.1016/S0940-9602(96)80009-4
   Kikkawa Y, 2000, J CELL SCI, V113, P869
   Kim MG, 2000, J IMMUNOL, V165, P192, DOI 10.4049/jimmunol.165.1.192
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020
   Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4
   Kutlesa S, 2002, IMMUNOLOGY, V105, P407, DOI 10.1046/j.1365-2567.2002.01384.x
   LagrotaCandido JM, 1996, CELL IMMUNOL, V170, P235, DOI 10.1006/cimm.1996.0157
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LANNESVIEIRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P1539, DOI 10.1177/39.11.1918928
   LEITEDEMORAES MC, 1992, IMMUNOLOGY, V77, P95
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Lepletier A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003203
   Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943
   Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mendes-da-Cruz DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103405
   Mendes-da-Cruz DA, 2012, FASEB J, V26, P4390, DOI 10.1096/fj.11-202952
   Mendes-da-Cruz DA, 2012, EXP PHYSIOL, V97, P1146, DOI 10.1113/expphysiol.2011.061515
   MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X
   Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434
   Miller JFAP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00411
   Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979
   MOJCIK CF, 1995, BLOOD, V86, P4206, DOI 10.1182/blood.V86.11.4206.bloodjournal86114206
   Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041
   Morrot A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001268
   Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215
   Nagib PRA, 2010, IMMUNOBIOLOGY, V215, P971, DOI 10.1016/j.imbio.2010.02.001
   Nieto-Ceron S, 2005, J NEUROCHEM, V95, P1035, DOI 10.1111/j.1471-4159.2005.03433.x
   Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nunes-Alves C, 2013, TRENDS IMMUNOL, V34, P502, DOI 10.1016/j.it.2013.06.004
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236
   Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x
   RUIZ P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10.1002/eji.1830250735
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   SAVINO W, 1991, LAB INVEST, V64, P405
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880
   Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259
   Siler U, 2002, BRIT J HAEMATOL, V119, P212, DOI 10.1046/j.1365-2141.2002.03800.x
   Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Smaniotto S, 2004, NEUROIMMUNOMODULAT, V11, P299, DOI 10.1159/000079410
   Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   Spessotto P, 2003, MATRIX BIOL, V22, P351, DOI 10.1016/S0945-053X(03)00050-7
   Stimamiglio MA, 2010, J LEUKOCYTE BIOL, V88, P483, DOI 10.1189/jlb.0210079
   Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781
   Terra-Granado E, 2007, NEUROIMMUNOMODULAT, V14, P213, DOI 10.1159/000110649
   Timpl R, 1985, Prog Clin Biol Res, V171, P63
   Ucar O, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00093
   VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907
   VILLAVERDE DMS, 1994, EUR J IMMUNOL, V24, P659, DOI 10.1002/eji.1830240326
   VILLAVERDE DMS, 1993, ENDOCRINOLOGY, V133, P867, DOI 10.1210/en.133.2.867
   Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883
   Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563
   Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397
   WADSWORTH S, 1992, J IMMUNOL, V149, P421
   Wondimu Z, 2004, BLOOD, V104, P1859, DOI 10.1182/blood-2004-01-0396
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680
   Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702
   ZUTTER MM, 1990, AM J PATHOL, V137, P113
NR 129
TC 11
Z9 11
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 17
PY 2015
VL 6
AR 579
DI 10.3389/fimmu.2015.00579
PG 13
WC Immunology
SC Immunology
GA CY0TG
UT WOS:000366118400002
PM 26635793
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Passos, GA
   Mendes-da-Cruz, DA
   Oliveira, EH
AF Passos, Geraldo Aleixo
   Mendes-da-Cruz, Danielle Areas
   Oliveira, Ernna Herida
TI The thymic orchestration involving Aire, miRNAs, and cell-cell
   interactions during the induction of central tolerance
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE AIRE; miRNA; MTEC; thymus gland; thymocytes; cell adhesion; promiscuous
   gene expression; central tolerance
ID PROMISCUOUS GENE-EXPRESSION; CANDIDIASIS-ECTODERMAL DYSTROPHY;
   EPITHELIAL-CELLS; AUTOIMMUNE REGULATOR; ANTIGEN PRESENTATION;
   DOWN-SYNDROME; T-CELLS; IMMUNOLOGICAL-TOLERANCE; EXTRACELLULAR-MATRIX;
   NEGATIVE SELECTION
AB Developing thymocytes interact sequentially with two distinct structures within the thymus: the cortex and medulla. Surviving single-positive and double-positive thymocytes from the cortex migrate into the medulla, where they interact with medullary thymic epithelial cells (mTECs). These cells ectopically express a vast set of peripheral tissue antigens (PTAs), a property termed promiscuous gene expression that is associated with the presentation of PTAs by mTECs to thymocytes. Thymocyte clones that have a high affinity for PTAs are eliminated by apoptosis in a process termed negative selection, which is essential for tolerance induction. The Aire gene is an important factor that controls the expression of a large set of PTAs. In addition to PTAs, Aire also controls the expression of miRNAs in mTECs. These miRNAs are important in the organization of the thymic architecture and act as posttranscriptional controllers of PTAs. Herein, we discuss recent discoveries and highlight open questions regarding the migration and interaction of developing thymocytes with thymic stroma, the ectopic expression of PTAs by mTECs, the association between Aire and miRNAs and its effects on central tolerance.
C1 [Passos, Geraldo Aleixo; Oliveira, Ernna Herida] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, BR-14049900 Sao Paulo, Brazil.
   [Passos, Geraldo Aleixo] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Genet, BR-14049900 Sao Paulo, Brazil.
   [Passos, Geraldo Aleixo] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Mol Biol, BR-14049900 Sao Paulo, Brazil.
   [Mendes-da-Cruz, Danielle Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
RP Passos, GA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Via Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM passos@usp.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Passos, Geraldo A/A-2899-2008;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Passos, Geraldo
   Aleixo/ABE-3251-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Passos, Geraldo
   A/0000-0002-4408-140X; Mendes-da-Cruz, Daniella A/0000-0003-3697-1506;
   Passos, Geraldo Aleixo/0000-0002-4408-140X
FU Sao Paulo State Research Foundation (Fapesp)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [13/17481-1, 13/08216-2];
   National Council for Research and Technology (CNPq, Brasilia)
   [306315/2013-0]; CAPES Foundation (Brasilia) [88881.06105/2014-01];
   Oswaldo Cruz Foundation; Rio de Janeiro State Research Foundation
   (Faperj, Rio de Janeiro); CNPqNational Council for Scientific and
   Technological Development (CNPq) [150103/2014-0]
FX The authors thank the following funding agencies: the Sao Paulo State
   Research Foundation (Fapesp) through grant Nos. 13/17481-1 (to GP) and
   13/08216-2 (Cepid-Fapesp to Fernando Q. Cunha), the National Council for
   Research and Technology (CNPq, Brasilia) through grant No. 306315/2013-0
   (to GP), the CAPES Foundation (Brasilia) through grant No.
   88881.06105/2014-01 (to GP), the Oswaldo Cruz Foundation and Rio de
   Janeiro State Research Foundation (Faperj, Rio de Janeiro to DM). EHO
   was supported by CNPq through post-doctoral fellowship No.
   150103/2014-0.
CR Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399
   Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187
   Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765
   Bui Thi V, 2010, Genes Cancer, V1, P568
   Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14
   Capalbo D, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/353250
   Cardoso RS, 2006, IMMUNOLOGY, V119, P369, DOI 10.1111/j.1365-2567.2006.02441.x
   Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166
   Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471
   Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
   Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003
   Donate PB, 2011, IMMUNOBIOLOGY, V216, P591, DOI 10.1016/j.imbio.2010.09.007
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Fornari TA, 2010, MOL CELL BIOCHEM, V342, P21, DOI 10.1007/s11010-010-0464-z
   Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589
   Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131
   Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x
   Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457
   Gallo V, 2013, EXPERT REV CLIN IMMU, V9, P43, DOI 10.1586/eci.12.88
   Gimenez-Barcons M, 2014, J IMMUNOL, V193, P3872, DOI 10.4049/jimmunol.1400223
   Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109
   Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677
   Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687
   Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6
   Hollander GA, 2007, NAT IMMUNOL, V8, P234, DOI 10.1038/ni0307-234
   Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393
   Huibregtse KE, 2014, J PEDIATR ENDOCR MET, V27, P1257, DOI 10.1515/jpem-2013-0328
   Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007
   Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002
   Jin P, 2014, J ENDOCRINOL INVEST, V37, P941, DOI 10.1007/s40618-014-0120-7
   Keane P, 2015, BIOINFORMATICS, V31, P986, DOI 10.1093/bioinformatics/btu785
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669
   Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105
   Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107
   Kont V, 2011, MOL IMMUNOL, V49, P518, DOI 10.1016/j.molimm.2011.09.022
   Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999
   Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436
   Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2
   Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601
   Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326
   Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133
   Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476
   Lima FA, 2011, J IMMUNOL, V187, P3422, DOI 10.4049/jimmunol.1003053
   Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127
   Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369
   Lo WL, 2014, CURR TOP MICROBIOL, V373, P49, DOI 10.1007/82_2013_319
   Ma DY, 2013, DEV COMP IMMUNOL, V39, P91, DOI 10.1016/j.dci.2011.12.013
   Macedo C, 2015, IMMUNOBIOLOGY, V220, P93, DOI 10.1016/j.imbio.2014.08.015
   Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013
   Magalhaes DAR, 2006, CLIN DEV IMMUNOL, V13, P81, DOI 10.1080/17402520600877091
   Marrella V, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00259
   Mathis D, 2007, NAT REV IMMUNOL, V7, DOI 10.1038/nri2136-c2
   Mathis D, 2010, NAT IMMUNOL, V11, P3, DOI 10.1038/ni.1833
   Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383
   MIZUOCHI T, 1992, J EXP MED, V175, P1601, DOI 10.1084/jem.175.6.1601
   Mouchess ML, 2014, CURR TOP MICROBIOL, V373, P69, DOI 10.1007/82_2013_321
   Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393
   Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353
   Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]
   Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193
   Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611
   Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110
   Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029
   Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564
   Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103
   Segerer S, 2007, J AM SOC NEPHROL, V18, P1835, DOI 10.1681/ASN.2006080837
   Skogberg G, 2014, J IMMUNOL, V193, P2187, DOI 10.4049/jimmunol.1400742
   Takada K, 2014, CURR TOP MICROBIOL, V373, P1, DOI 10.1007/82_2013_322
   Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781
   Taniguchi RT, 2011, IMMUNOL CELL BIOL, V89, P40, DOI 10.1038/icb.2010.132
   Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018
   Ucar O, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00093
   Ucar O, 2013, EUR J IMMUNOL, V43, P1769, DOI 10.1002/eji.201343343
   Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105
   Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891
   Yamaguchi Y, 2014, BIOL OPEN, V3, P1071, DOI 10.1242/bio.201410173
   Yamaguchi Y, 2011, EXP CELL RES, V317, P2019, DOI 10.1016/j.yexcr.2011.05.002
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Zhang SL, 2014, CURR TOP MICROBIOL, V373, P87, DOI 10.1007/82_2013_324
   Zuklys S, 2012, J IMMUNOL, V189, P3894, DOI 10.4049/jimmunol.1200783
NR 90
TC 17
Z9 17
U1 0
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 14
PY 2015
VL 6
AR 352
DI 10.3389/fimmu.2015.00352
PG 7
WC Immunology
SC Immunology
GA CO1YU
UT WOS:000358953100001
PM 26236310
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Mendes-da-Cruz, DA
   Brignier, AC
   Asnafi, V
   Baleydier, F
   Messias, CV
   Lepelletier, Y
   Bedjaoui, N
   Renand, A
   Smaniotto, S
   Canioni, D
   Milpied, P
   Balabanian, K
   Bousso, P
   Lepretre, S
   Bertrand, Y
   Dombret, H
   Ifrah, N
   Dardenne, M
   Macintyre, E
   Savino, W
   Hermine, O
AF Mendes-da-Cruz, Daniella Areas
   Brignier, Anne Colette
   Asnafi, Vahid
   Baleydier, Frederic
   Messias, Carolina Valenca
   Lepelletier, Yves
   Bedjaoui, Nawel
   Renand, Amedee
   Smaniotto, Salete
   Canioni, Danielle
   Milpied, Pierre
   Balabanian, Karl
   Bousso, Philippe
   Lepretre, Stephane
   Bertrand, Yves
   Dombret, Herve
   Ifrah, Norbert
   Dardenne, Mireille
   Macintyre, Elizabeth
   Savino, Wilson
   Hermine, Olivier
TI Semaphorin 3F and Neuropilin-2 Control the Migration of Human T-Cell
   Precursors
SO PLOS ONE
LA English
DT Article
ID SPHINGOSINE 1-PHOSPHATE RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN
   THYMOCYTE MIGRATION; LYMPHOCYTE EGRESS; THYMUS; EXPRESSION; EMIGRATION;
   CHEMOKINE; GRADIENTS; TISSUES
AB Neuropilins and semaphorins are known as modulators of axon guidance, angiogenesis, and organogenesis in the developing nervous system, but have been recently evidenced as also playing a role in the immune system. Here we describe the expression and role of semaphorin 3F (SEMA3F) and its receptor neuropilin-2 (NRP2) in human T cell precursors. NRP2 and SEMA3F are expressed in the human thymus, in both lymphoid and non-lymphoid compartments. SEMA3F have a repulsive effect on thymocyte migration and inhibited CXCL12- and sphingosine-1-phosphate (S1P)-induced thymocyte migration by inhibiting cytoskeleton reorganization prior to stimuli. Moreover, NRP2 and SEMA3F are expressed in human T-cell acute lymphoblastic leukemia/lymphoma primary cells. In these tumor cells, SEMA3F also blocks their migration induced by CXCL12 and S1P. Our data show that SEMA3F and NRP2 are further regulators of human thymocyte migration in physiological and pathological conditions.
C1 [Mendes-da-Cruz, Daniella Areas; Brignier, Anne Colette; Lepelletier, Yves; Renand, Amedee; Milpied, Pierre; Dardenne, Mireille; Hermine, Olivier] Paris Descartes Univ, CNRS UMR8147, Paris, France.
   [Mendes-da-Cruz, Daniella Areas; Messias, Carolina Valenca; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Brignier, Anne Colette] Necker Childrens Hosp, AP HP, Dept Clin Hematol, Paris, France.
   [Asnafi, Vahid; Baleydier, Frederic; Bedjaoui, Nawel; Canioni, Danielle; Macintyre, Elizabeth; Hermine, Olivier] Necker Childrens Hosp, AP HP, Lab Oncohematol, INSERM U1151, Paris, France.
   [Lepelletier, Yves; Hermine, Olivier] Imagine Inst, INSERM U1163, CNRS ERL 8254, Lab Cellular & Mol Basis Hematol Disorders & Thei, Paris, France.
   [Smaniotto, Salete; Canioni, Danielle] Univ Fed Alagoas, Dept Morphol, Maceio, Brazil.
   Hop Necker Enfants Malad, Dept Pathol, Paris, France.
   [Balabanian, Karl] Inst Pasteur, INSERM U819, Paris, France.
   [Bousso, Philippe] Inst Pasteur, INSERM U668, Paris, France.
   [Lepretre, Stephane] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France.
   [Bertrand, Yves] Hop Debrousse, Serv Pediat Hematol, Lyon, France.
   [Dombret, Herve] Univ Paris 07, Hop St Louis, AP HP, Paris, France.
   [Dombret, Herve] Univ Paris 07, Inst Univ Hematol EA3518, Paris, France.
   [Ifrah, Norbert] Ctr Hosp Univ Nantes, Univ Angers, Serv Malad, Pole Rech & Enseignement Super, Angers, France.
   [Ifrah, Norbert] INSERM U892, Angers, France.
RP Mendes-da-Cruz, DA (corresponding author), Paris Descartes Univ, CNRS UMR8147, Paris, France.
EM daniella@ioc.fiocruz.br; ohermine@gmail.com
RI BOUSSO, Philippe/M-6547-2014; Smaniotto, Salete/AAT-4056-2020;
   Baleydier, Frederic/AAX-2554-2020; Renand, Amedee/A-9884-2018;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Balabanian, Karl/I-2990-2016;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; lepelletier, yves/AAF-1546-2020;
   Ifrah, Norbert/L-5238-2015; Balabanian, Karl/S-6250-2019; Milpied,
   Pierre J/Q-1380-2015; Smaniotto, Salete/T-3796-2017
OI BOUSSO, Philippe/0000-0002-6362-561X; Renand,
   Amedee/0000-0003-2265-549X; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Balabanian, Karl/0000-0002-0534-3198;
   Mendes-da-Cruz, Daniella/0000-0003-3697-1506; lepelletier,
   yves/0000-0001-7746-5170; Balabanian, Karl/0000-0002-0534-3198; Milpied,
   Pierre J/0000-0003-1873-5358; Hermine, Olivier/0000-0003-2574-3874;
   Smaniotto, Salete/0000-0003-1527-5894; IFRAH,
   Norbert/0000-0003-3063-850X
FU CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology;
   CNRS/Fiocruz French/Brazilian conjoint programCentre National de la
   Recherche Scientifique (CNRS); CNRSCentre National de la Recherche
   Scientifique (CNRS); Foundation for Medical Research (FRM - France);
   National League against the Cancer (France); National Cancer Institute
   (France)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute
   (NCI)Institut National du Cancer (INCA) France; Fiocruz (Brazil); CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq); Faperj (Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fund for Structural
   Convergence of Mercosur (FOCEM/Mercosur)
FX This work was developed in the context of the CNRS-Fiocruz Associated
   Laboratory of Immunology and Immunopathology. It was partially funded
   with grants by CNRS/Fiocruz French/Brazilian conjoint program, CNRS, The
   Foundation for Medical Research (FRM - France), The National League
   against the Cancer (France), The National Cancer Institute (France);
   Fiocruz, CNPq, Faperj and CAPES (Brazil); Fund for Structural
   Convergence of Mercosur (FOCEM/Mercosur). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Atwal JK, 2003, J NEUROSCI, V23, P7602
   Chalasani SH, 2003, J NEUROSCI, V23, P1360
   Chiba K, 2006, CELL MOL IMMUNOL, V3, P11
   Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x
   CRIST WM, 1988, BLOOD, V72, P1891
   de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001
   Dzhagalov I, 2012, CELL MOL LIFE SCI, V69, P663, DOI 10.1007/s00018-011-0791-6
   Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538
   Garcia F, 2011, J LEUKOC BIOL
   Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810
   Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X
   Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175
   Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236
   Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x
   Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404
   Pascual M, 2005, HIPPOCAMPUS, V15, P184, DOI 10.1002/hipo.20040
   Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI13853
   Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247
   Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640
   Stepanova OI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1194, DOI 10.1134/S0006297907110041
   Takahashi K, 2008, DEV DYNAM, V237, P1699, DOI 10.1002/dvdy.21556
   Uckun FM, 1998, BLOOD, V91, P735
   Vianello F, 2005, J IMMUNOL, V175, P5115, DOI 10.4049/jimmunol.175.8.5115
   Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x
NR 30
TC 29
Z9 29
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2014
VL 9
IS 7
AR e103405
DI 10.1371/journal.pone.0103405
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM6RZ
UT WOS:000339993700067
PM 25068647
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Mendes-da-Cruz, DA
   Stimamiglio, MA
   Munoz, JJ
   Alfaro, D
   Terra-Granado, E
   Garcia-Ceca, J
   Alonso-Colmenar, LM
   Savino, W
   Zapata, AG
AF Mendes-da-Cruz, Daniella Areas
   Augusto Stimamiglio, Marco
   Jose Munoz, Juan
   Alfaro, David
   Terra-Granado, Eugenia
   Garcia-Ceca, Javier
   Miguel Alonso-Colmenar, Luis
   Savino, Wilson
   Zapata, Agustin G.
TI Developing T-cell migration: role of semaphorins and ephrins
SO FASEB JOURNAL
LA English
DT Review
DE thymus; thymic epithelial cells; thymocyte migration; neuropilins; ephs
ID HUMAN THYMOCYTE MIGRATION; HEMATOPOIETIC PROGENITORS; AXON GUIDANCE;
   EPH; RECEPTOR; THYMUS; EXPRESSION; ADHESION; NEUROPILIN-1; FAMILY
AB Cell migration is a crucial event for normal T-cell development, and various ligand/receptor pairs have been implicated. Most of them, including chemokines and extracellular matrix proteins, have attractant properties on thymocytes. We discuss herein two further groups of ligand/receptor pairs, semaphorins/neuropilins and ephs/ephrins, which are constitutively expressed by thymocytes and thymic microenvironmental cells. Evidence shows that the corresponding interactions are relevant for developing T-cell migration, including the entry of bone marrow progenitor cells, migration of CD4/CD8-defined thymocyte subpopulations triggered by chemokines and/or extracellular matrix proteins, and thymocyte export. Conceptually, the data summarized here show that thymocyte migration results from a complex network of molecular interactions, which generate not only attraction, but also repulsion of migrating T-cell precursors.-Mendes-da-Cruz, D. A., Stimamiglio, M. A., Munoz, J. J., Alfaro, D., Terra-Granado, E., Garcia-Ceca, J., Alonso-Colmenar, L. M., Savino, W., Zapata, A. G. Developing T-cell migration: role of semaphorins and ephrins. FASEB J. 26, 4390-4399 (2012). www.fasebj.org
C1 [Mendes-da-Cruz, Daniella Areas; Augusto Stimamiglio, Marco; Terra-Granado, Eugenia; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21040360 Rio De Janeiro, Brazil.
   [Augusto Stimamiglio, Marco] Fundacao Oswaldo Cruz, Carlos Chagas Inst, Lab Regulat Gene Express, Curitiba, Parana, Brazil.
   [Augusto Stimamiglio, Marco; Alfaro, David; Terra-Granado, Eugenia; Garcia-Ceca, Javier; Zapata, Agustin G.] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain.
   [Jose Munoz, Juan; Miguel Alonso-Colmenar, Luis; Zapata, Agustin G.] Univ Complutense, Ctr Cytometry & Fluorescence Microscopy, E-28040 Madrid, Spain.
   [Terra-Granado, Eugenia] Natl Canc Inst, Res Ctr, Pediat Hematol & Oncol Program, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Alonso-Colmenar, Luis
   Miguel/K-6957-2018; Stimamiglio, Marco Augusto/AAA-8129-2019; Sanchez,
   David Alfaro/E-5155-2016; Stimamiglio, Marco Augusto A/D-6239-2013;
   Garcia-Ceca, Javier/J-1803-2016; Mendes-da-Cruz, Daniella A/E-7875-2016
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Alonso-Colmenar, Luis
   Miguel/0000-0003-3869-6309; Stimamiglio, Marco
   Augusto/0000-0001-8537-2812; Sanchez, David Alfaro/0000-0003-2139-9818;
   Stimamiglio, Marco Augusto A/0000-0001-8537-2812; Garcia-Ceca,
   Javier/0000-0002-0940-455X; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Zapata, Agustin G/0000-0003-0576-2672;
   Terra-Granado, Eugenia/0000-0002-3616-140X
FU Spanish Ministry of Education and ScienceSpanish Government [BFU
   2007-65520, BFU 2010-18250]; Spanish Ministry of Health and Consumption
   [RD06/0010/0003]; CELLCAM-CM from the regional government of Madrid
   [S-BIO/0204/2006, GR74/910552/2007, S2010/BMD-2420]; Oswaldo Cruz
   Foundation (Fiocruz); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) of BrazilCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants BFU 2007-65520 and BFU 2010-18250 from
   the Spanish Ministry of Education and Science; RD06/0010/0003 from the
   Spanish Ministry of Health and Consumption; S-BIO/0204/2006,
   GR74/910552/2007, and S2010/BMD-2420 CELLCAM-CM from the regional
   government of Madrid; and also the Oswaldo Cruz Foundation (Fiocruz),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   of Brazil.
CR Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981
   Alfaro D, 2008, IMMUNOLOGY, V125, P131, DOI 10.1111/j.1365-2567.2008.02828.x
   Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097
   Alfaro D, 2011, IMMUNOL CELL BIOL, V89, P844, DOI 10.1038/icb.2010.172
   Alonso LM, 2009, LEUKEMIA RES, V33, P395, DOI 10.1016/j.leukres.2008.08.010
   Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408
   Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799
   Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4
   Cejalvo T., 2011, THESIS COMPLUTENSE U
   Chan B, 2009, THROMB RES, V123, P745, DOI 10.1016/j.thromres.2008.07.010
   Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008
   Corbel C, 2007, DEV COMP IMMUNOL, V31, P1082, DOI 10.1016/j.dci.2007.01.009
   de Saint-Vis B, 2003, BLOOD, V102, P4431, DOI 10.1182/blood-2003-02-0500
   de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001
   Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106
   Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020
   Foster KE, 2010, P NATL ACAD SCI USA, V107, P13414, DOI 10.1073/pnas.1003747107
   Freywald A, 2003, J BIOL CHEM, V278, P10150, DOI 10.1074/jbc.M208179200
   Freywald A, 2006, J IMMUNOL, V176, P4066, DOI 10.4049/jimmunol.176.7.4066
   Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376
   Garcia F, 2012, J LEUKOCYTE BIOL, V91, P7, DOI 10.1189/jlb.0111031
   Garcia-Ceca J, 2009, INT J DEV BIOL, V53, P971, DOI 10.1387/ijdb.082702jg
   Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1
   Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013
   Gossens K, 2009, J EXP MED, V206, P761, DOI 10.1084/jem.20082502
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Ikegami R, 2004, DEV CELL, V6, P383, DOI 10.1016/S1534-5807(04)00057-7
   Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004
   Jenkinson WE, 2007, EUR J IMMUNOL, V37, P2090, DOI 10.1002/eji.200737212
   Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921
   Kawakami N, 1999, J IMMUNOL, V163, P3211
   Khounlotham M, 2009, J INFECT DIS, V199, P1797, DOI 10.1086/599096
   Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007
   KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z
   Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721
   Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740
   Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2
   Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256
   Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761
   Lei Y, 2009, EUR J IMMUNOL, V39, P2695, DOI 10.1002/eji.200939630
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200
   Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x
   MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X
   Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008
   Milpied P, 2011, BLOOD, V118, P2993, DOI 10.1182/blood-2011-01-329268
   Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040
   Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x
   Munoz J. J., 2009, INMUNOLOGIA, V28, P19, DOI DOI 10.1016/S0213-9626(09)70024-1
   Munoz JJ, 2002, J IMMUNOL, V169, P177, DOI 10.4049/jimmunol.169.1.177
   Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804
   Nakao F, 2007, GENETICS, V176, P1591, DOI 10.1534/genetics.106.067116
   Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015
   Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2
   Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3
   Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1
   Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003
   Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011
   Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151
   Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102
   Prockop Susan E, 2004, Clin Dev Immunol, V11, P135, DOI 10.1080/10446670410001722212
   Saran N, 2010, BLOOD, V115, P1137, DOI 10.1182/blood-2009-07-230821
   Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103
   Sharfe N, 2002, EUR J IMMUNOL, V32, P3745, DOI 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M
   Sharfe N, 2008, MOL IMMUNOL, V45, P1208, DOI 10.1016/j.molimm.2007.09.019
   Stimamiglio MA, 2010, J LEUKOCYTE BIOL, V88, P483, DOI 10.1189/jlb.0210079
   Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652
   Takahashi K, 2008, DEV DYNAM, V237, P1699, DOI 10.1002/dvdy.21556
   Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008
   Trinidad EM, 2010, CELL ADHES MIGR, V4, P363, DOI 10.4161/cam.4.3.11586
   Trinidad EM, 2009, BLOOD, V114, P5081, DOI 10.1182/blood-2009-03-210617
   Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650
   Wada K, 1996, CELL IMMUNOL, V170, P11, DOI 10.1006/cimm.1996.0128
   Wang LH, 1997, J NEUROCHEM, V69, P2261
   Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160
   Yamada A, 1999, J IMMUNOL, V162, P4094
   Yamamoto T, 2010, INT J RADIAT ONCOL, V77, P235, DOI 10.1016/j.ijrobp.2009.11.005
   Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211
   Yuan L, 2002, DEVELOPMENT, V129, P4797
   Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784
NR 82
TC 13
Z9 13
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD NOV
PY 2012
VL 26
IS 11
BP 4390
EP 4399
DI 10.1096/fj.11-202952
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 030MG
UT WOS:000310574200003
PM 22815386
DA 2020-12-17
ER

PT J
AU Mendes-da-Cruz, DA
   Linhares-Lacerda, L
   Smaniotto, S
   Dardenne, M
   Savino, W
AF Mendes-da-Cruz, Daniella Areas
   Linhares-Lacerda, Leandra
   Smaniotto, Salete
   Dardenne, Mireille
   Savino, Wilson
TI Semaphorins and neuropilins: new players in the neuroendocrine control
   of the intrathymic T-cell migration in humans
SO EXPERIMENTAL PHYSIOLOGY
LA English
DT Article
ID FETAL THYMUS COLONIZATION; HUMAN THYMOCYTE MIGRATION; AXON GUIDANCE;
   EXPRESSION; RECEPTORS; ADHESION; ANGIOGENESIS; VEGF
AB Cell migration is a key event for proper intrathymic T-cell differentiation, and several ligandreceptor interactions contribute to the well-co ordinated movement of developing thymocytes within the thymic lobules. Herein we summarize recent data that place semaphorin 3A (Sema3A) and its receptor neuropilin 1 (NRP1) as further players in the physiological process of cell migration in the human thymus. These molecules, as well as class A plexins (necessary for the intracellular signalling transduction triggered by Sema3ANRP1 ligation), are constitutively expressed by both developing thymocytes and components of the thymic microenvironment, including epithelial and dendritic cells. Functionally, Sema3A decreases the adhesion of human thymocytes on thymic epithelial cell monolayers and exerts per se a dose-dependent chemorepulsive effect on human thymocytes. Moreover, Sema3A inhibits chemoattractant migratory responses induced by other ligands, including fibronectin, laminin and CXCL12 (chemokine CXC motif ligand 12). These data should be placed in the context of the concept that migration of developing T cells is a multivectorial system, in which the resulting migration vector derives from a balance of several simultaneous and/or sequential ligandreceptor pair interactions. Accordingly, semaphorins and neuropilins can be considered as further players in the system.
C1 [Savino, Wilson] Fundacao Oswaldo Cruz, Lab Thymus Res, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Smaniotto, Salete] Univ Fed Alagoas, Dept Morphol, Maceio, Brazil.
   [Dardenne, Mireille] Paris Descartes Univ, CNRS, UMR8147, Paris, France.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Lab Thymus Res, Inst Oswaldo Cruz, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Smaniotto, Salete/AAT-4056-2020;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Smaniotto, Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Smaniotto, Salete/0000-0003-1527-5894
FU CNRS (France)Centre National de la Recherche Scientifique (CNRS);
   Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fapeal (Brazil)
FX This work was developed in the context of the CNRS-Fiocruz Associated
   Laboratory of Immunology and Immunopathology, with additional funding by
   CNRS (France), Fiocruz, CNPq, Faperj and Fapeal (Brazil).
CR Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200
   Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006
   Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4
   Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008
   de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001
   Garcia F, 2012, J LEUKOCYTE BIOL, V91, P7, DOI 10.1189/jlb.0111031
   Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Jenkinson WE, 2007, EUR J IMMUNOL, V37, P2090, DOI 10.1002/eji.200737212
   Munoz JJ, 2009, ANN NY ACAD SCI, V1153, P14, DOI 10.1111/j.1749-6632.2008.03965.x
   Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921
   Kawakami N, 1999, J IMMUNOL, V163, P3211
   Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Medina S, 1998, MECH AGEING DEV, V102, P249, DOI 10.1016/S0047-6374(98)00014-1
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x
   Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2
   Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Stimamiglio MA, 2010, J LEUKOCYTE BIOL, V88, P483, DOI 10.1189/jlb.0210079
   Terra-Granado E, 2007, NEUROIMMUNOMODULAT, V14, P213, DOI 10.1159/000110649
   Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004
   Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025
   Wada K, 1996, CELL IMMUNOL, V170, P11, DOI 10.1006/cimm.1996.0128
   Yasuoka H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-220
   Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211
   Younan S, 2011, LEUKEMIA RES, V36, P169
NR 31
TC 10
Z9 11
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0958-0670
J9 EXP PHYSIOL
JI Exp. Physiol.
PD NOV
PY 2012
VL 97
IS 11
SI SI
BP 1146
EP 1150
DI 10.1113/expphysiol.2011.061515
PG 5
WC Physiology
SC Physiology
GA 029FH
UT WOS:000310479700002
PM 22327328
DA 2020-12-17
ER

PT S
AU Savino, W
   Smaniotto, S
   Mendes-da-Cruz, DA
   Dardenne, M
AF Savino, Wilson
   Smaniotto, Salete
   Mendes-da-Cruz, Daniella Areas
   Dardenne, Mireille
BE DelRey, A
   Welsh, CJ
   Schwarz, MJ
   Besedovsky, HO
TI Growth hormone modulates migration of thymocytes and peripheral T cells
SO NEUROIMMUNOMODULATION IN HEALTH AND DISEASE I
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 8th Congress of the International-Society-for-Neuroimmunomodulation
   (ISNIM)/German Endocrine-Brain-Immune Network (GEBIN)
CY OCT 20-22, 2011
CL Dresden, GERMANY
SP Int Soc Neuro Immuno Modulat (ISNIM), German Endocrine Brain Immune Network (GEBIN)
DE Growth hormone; thymocytes; cell migration; integrins; chemokines; lymph
   nodes
ID IN-VIVO; THYMUS; GHRELIN; MATRIX
AB In the context of immunoneuroendocrine cross talk, growth hormone (GH) exerts pleiotropic effects in the immune system. For example, GH-transgenic mice, as well as animals and humans treated with GH, exhibit enhanced cellularity in the thymus. GH also stimulates the thymic microenvironment, augmenting chemokine and extracellular matrix (ECM) production, with consequent increase in ECM- and chemokine-driven thymocyte migratory responses. Peripheral T cell migration triggered by laminin or fibronectin was enhanced in cells from GH-transgenic versus wild-type control adult mice, as seen for CD4(+) and CD8(+) T cells from mesenteric lymph nodes. Migration of these T lymphocytes, triggered by the chemokine CXCL12, in conjunction with laminin or fibronectin, was also enhanced compared with control counterparts. Considering that GH can be used as an adjuvant therapy in immunodeficiencies, including AIDS, the concepts defined herein, that GH enhances developing and peripheral T cell migration, provide new clues for future GH-related immune interventions.
C1 [Savino, Wilson; Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Lab Thymus Res, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Savino, Wilson; Smaniotto, Salete; Mendes-da-Cruz, Daniella Areas; Dardenne, Mireille] Fiocruz MS, CNRS Int Lab Immunol & Immunopathol, BR-21045900 Rio De Janeiro, Brazil.
   [Smaniotto, Salete] Univ Fed Alagoas, Lab Immunohistol, Inst Biol & Hlth Sci, Maceio, Brazil.
   [Dardenne, Mireille] Univ Paris 05, CNRS UMR 8147, Paris, France.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Lab Thymus Res, Inst Oswaldo Cruz, Ave Brasil 4365, Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Smaniotto, Salete/AAT-4056-2020; Mendes-da-Cruz, Daniella/AAN-6644-2020;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Smaniotto, Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Smaniotto, Salete/0000-0003-1527-5894
FU Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Fapeal (Brazil); CNRS
   (France)Centre National de la Recherche Scientifique (CNRS)
FX This work was partially funded with grants from Fiocruz, CNPq, Faperj,
   Fapeal (Brazil), and CNRS (France).
CR Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547
   Colao A, 2002, J ENDOCRINOL INVEST, V25, P125, DOI 10.1007/BF03343975
   deMelloCoelho V, 1997, J NEUROIMMUNOL, V76, P39, DOI 10.1016/S0165-5728(97)00031-3
   Garcia F, 2012, J LEUKOCYTE BIOL, V91, P7, DOI 10.1189/jlb.0111031
   Hansen BR, 2009, AIDS, V23, P2123, DOI 10.1097/QAD.0b013e3283303307
   Hattori N, 2009, GROWTH HORM IGF RES, V19, P187, DOI 10.1016/j.ghir.2008.12.001
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   MELLOCOELHO V, 2002, NEUROENDOCRINOLOGY, V75, P139
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x
   Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003
   Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650
   Savino W, 2003, ANN NY ACAD SCI, V992, P179, DOI 10.1111/j.1749-6632.2003.tb03148.x
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Savino W., 2004, J LEUKOCYTE BIOL, V75, P1
   Savino W, 2010, CURR OPIN PHARMACOL, V10, P434, DOI 10.1016/j.coph.2010.04.002
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Smaniotto S, 2004, NEUROIMMUNOMODULAT, V11, P299, DOI 10.1159/000079410
   Smaniotto S, 2011, NEUROIMMUNOMODULAT, V18, P309, DOI 10.1159/000329497
   Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014
   Stimamiglio MA, 2010, J LEUKOCYTE BIOL, V88, P483, DOI 10.1189/jlb.0210079
   TAUB DD, 1994, J CLIN INVEST, V94, P293, DOI 10.1172/JCI117320
   Taub DD, 2010, CURR OPIN PHARMACOL, V10, P408, DOI 10.1016/j.coph.2010.04.015
   Vigano A, 2004, J PEDIATR-US, V145, P542, DOI 10.1016/j.jpeds.2004.06.027
   Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016
NR 28
TC 10
Z9 12
U1 0
U2 9
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
SN 0077-8923
BN 978-1-57331-868-6
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2012
VL 1261
BP 49
EP 54
DI 10.1111/j.1749-6632.2012.06637.x
PG 6
WC Immunology; Multidisciplinary Sciences; Neurosciences
SC Immunology; Science & Technology - Other Topics; Neurosciences &
   Neurology
GA BDC07
UT WOS:000312537900008
PM 22823393
DA 2020-12-17
ER

PT J
AU Linhares-Lacerda, L
   Ribeiro-Alves, M
   Nogueira, ACMD
   Mendes-da-Cruz, DA
   Magalhaes, DA
   Dardenne, M
   Passos, GA
   Savino, W
AF Linhares-Lacerda, Leandra
   Ribeiro-Alves, Marcelo
   Martins de Almeida Nogueira, Ana Cristina
   Mendes-da-Cruz, Daniella Areas
   Magalhaes, Danielle Aparecida
   Dardenne, Mireille
   Passos, Geraldo Aleixo
   Savino, Wilson
TI RNA interference-mediated knockdown of CD49e (alpha 5 integrin chain) in
   human thymic epithelial cells modulates the expression of multiple genes
   and decreases thymocyte adhesion
SO BMC GENOMICS
LA English
DT Article; Proceedings Paper
CT 5th International Conference of the
   Brazilian-Association-for-Bioinformatics-and-Computational-Biology
CY OCT 18-22, 2009
CL Angra dos Reis, BRAZIL
SP Brazilian Assoc Bioinformat & Computational Biol
ID EXTRACELLULAR-MATRIX COMPONENTS; DIFFERENTIAL EXPRESSION; TGF-BETA;
   MIGRATION; MOLECULE; MICROENVIRONMENT; FIBRONECTIN; RECEPTORS; LIGANDS;
   PROTEIN
AB Background: The thymus is a central lymphoid organ, in which bone marrow-derived T cell precursors undergo a complex process of maturation. Developing thymocytes interact with thymic microenvironment in a defined spatial order. A component of thymic microenvironment, the thymic epithelial cells, is crucial for the maturation of T-lymphocytes through cell-cell contact, cell matrix interactions and secretory of cytokines/chemokines. There is evidence that extracellular matrix molecules play a fundamental role in guiding differentiating thymocytes in both cortical and medullary regions of the thymic lobules. The interaction between the integrin alpha 5 beta 1 (CD49e/CD29; VLA-5) and fibronectin is relevant for thymocyte adhesion and migration within the thymic tissue. Our previous results have shown that adhesion of thymocytes to cultured TEC line is enhanced in the presence of fibronectin, and can be blocked with anti-VLA-5 antibody.
   Results: Herein, we studied the role of CD49e expressed by the human thymic epithelium. For this purpose we knocked down the CD49e by means of RNA interference. This procedure resulted in the modulation of more than 100 genes, some of them coding for other proteins also involved in adhesion of thymocytes; others related to signaling pathways triggered after integrin activation, or even involved in the control of F-actin stress fiber formation. Functionally, we demonstrated that disruption of VLA-5 in human TEC by CD49e-siRNA-induced gene knockdown decreased the ability of TEC to promote thymocyte adhesion. Such a decrease comprised all CD4/CD8-defined thymocyte subsets.
   Conclusion: Conceptually, our findings unravel the complexity of gene regulation, as regards key genes involved in the heterocellular cell adhesion between developing thymocytes and the major component of the thymic microenvironment, an interaction that is a mandatory event for proper intrathymic T cell differentiation.
C1 [Linhares-Lacerda, Leandra; Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21040360 Rio De Janeiro, Brazil.
   [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, BR-21040360 Rio De Janeiro, Brazil.
   [Martins de Almeida Nogueira, Ana Cristina] Fundacao Oswaldo Cruz, Natl Inst Qual Control Hlth, Dept Immunol, BR-21040360 Rio De Janeiro, Brazil.
   [Dardenne, Mireille] Univ Paris 05, Hop Necker Enfants Malad, CNRS, UMR 8147, F-75743 Paris, France.
   [Magalhaes, Danielle Aparecida; Passos, Geraldo Aleixo] Univ Sao Paulo, Sch Med, Dept Genet, Mol Immunogenet Grp, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21040360 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella
   A/E-7875-2016; Passos, Geraldo A/A-2899-2008; Nogueira, Ana Cristina M
   A/C-2200-2013; Passos, Geraldo Aleixo/ABE-3251-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Passos, Geraldo A/0000-0002-4408-140X; Passos,
   Geraldo Aleixo/0000-0002-4408-140X; Ribeiro-Alves,
   Marcelo/0000-0002-8663-3364
CR Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73
   Ayres-Martins S, 2004, CELL IMMUNOL, V229, P21, DOI 10.1016/j.cellimm.2004.06.002
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BERRIH S, 1985, J HISTOCHEM CYTOCHEM, V33, P655, DOI 10.1177/33.7.3891843
   Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329
   Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   DESOUZA LRM, 1993, DEV IMMUNOL, V3, P123, DOI 10.1155/1993/48056
   Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567
   FERNANDEZ E, 1994, BLOOD, V83, P3245
   Gonzalez AM, 2010, CELL SIGNAL, V22, P578, DOI 10.1016/j.cellsig.2009.10.009
   Grumet M, 1997, CELL TISSUE RES, V290, P423, DOI 10.1007/s004410050949
   Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01
   LagrotaCandido JM, 1996, CELL IMMUNOL, V170, P235, DOI 10.1006/cimm.1996.0157
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010
   Matsumoto N, 2003, BIOCHEM BIOPH RES CO, V305, P815, DOI 10.1016/S0006-291X(03)00860-X
   Mendes-da-Cruz DA, 2009, ANN NY ACAD SCI, V1153, P20, DOI 10.1111/j.1749-6632.2008.03980.x
   MOJCIK CF, 1995, BLOOD, V86, P4206, DOI 10.1182/blood.V86.11.4206.bloodjournal86114206
   MOULD AP, 1990, J BIOL CHEM, V265, P4020
   Nieto M, 1996, CLIN EXP IMMUNOL, V106, P170
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621
   Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V75, P139
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Savino W, 1996, IMMUNOL TODAY, V17, P97, DOI 10.1016/0167-5699(96)80587-1
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270
   Team RDC, 2008, R LANG ENV STAT COMP
   Thacker E, 2004, EUR J CELL BIOL, V83, P541, DOI 10.1078/0171-9335-00416
   Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770
   Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756
NR 37
TC 14
Z9 14
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD DEC 22
PY 2010
VL 11
SU 5
AR S2
DI 10.1186/1471-2164-11-S5-S2
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 729AA
UT WOS:000287915800002
PM 21210968
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Smaniotto, S
   Mendes-da-Cruz, DA
   Carvalho-Pinto, CE
   Araujo, LM
   Dardenne, M
   Savino, W
AF Smaniotto, Salete
   Mendes-da-Cruz, Daniella Areas
   Carvalho-Pinto, Carla Eponina
   Araujo, Luiza M.
   Dardenne, Mireille
   Savino, Wilson
TI Combined role of extracellular matrix and chemokines on peripheral
   lymphocyte migration in growth hormone transgenic mice
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Lymph nodes; Spleen; Extracellular matrix; Integrins; Chemokines
ID IN-VIVO; HIV-1-INFECTED ADULTS; CELL MIGRATION; DIFFERENTIATION;
   HEMATOPOIESIS; THYMOCYTES; RECEPTORS; PROTEINS; THYMUS; VITRO
AB Previous evidence indicated that growth hormone (GH) modulates cell migration in the thymus, and that extracellular matrix and chemokines are involved. Herein, we studied migration of peripheral lymphocytes derived from spleen and lymph nodes of GH-transgenic (GH-Tg) mice. We initially found that the relative cell numbers (normalized per gram of body weight) in lymph nodes and spleens from GH-Tg were higher at all ages tested (2-3, 7 and 12 months), as compared to wild type age-matched controls. Functionally, we found that lymphocyte migration triggered by laminin or fibronectin was enhanced in cells from GH-Tg versus control mice, independent of the organ from which the cells were derived (as ascertained in young adult animals). However, such an enhancement in migration was statistically significant only for CD4(+) and CD8(+) T cells from mesenteric lymph nodes. Migration of lymphocytes from mesenteric lymph nodes of GH-Tg mice, triggered by the chemokine CXCL12, in conjunction with laminin or fibronectin, was enhanced compared to lymphocytes from control mice. Rather surprisingly, the membrane levels of the corresponding extracellular matrix or chemokine receptors in peripheral lymphoid organs of GH-Tg mice did not necessarily correlate with the changes seen in migratory responses. In conclusion, our data show for the first time that GH alters lymphocyte migration in the periphery of the immune system. Considering that GH is used as an adjuvant therapeutic agent in immunodeficiencies, including AIDS, the concepts defined herein provide relevant background knowledge for future GH-related immune interventions. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Smaniotto, Salete; Mendes-da-Cruz, Daniella Areas; Carvalho-Pinto, Carla Eponina; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   [Smaniotto, Salete; Mendes-da-Cruz, Daniella Areas; Araujo, Luiza M.; Dardenne, Mireille] Univ Paris 05, CNRS, UMR 8147, Hop Necker, Paris, France.
   [Smaniotto, Salete] Univ Fed Alagoas, Inst Biol & Hlth Sci, Lab Immunohistol, Maceio, Brazil.
   [Carvalho-Pinto, Carla Eponina] Univ Fed Fluminense, Inst Biol, Dept Immunol, Niteroi, RJ, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Smaniotto, Salete/AAT-4056-2020;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; Smaniotto, Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Smaniotto, Salete/0000-0003-1527-5894
FU CNRS-Fiocruz Associated Laboratory of Immunology/Immunopatholog;
   Capes/Cofecub French/BrazilianCAPES; CNRS (France)Centre National de la
   Recherche Scientifique (CNRS); Fiocruz; CNPqNational Council for
   Scientific and Technological Development (CNPq); Faperj and Fapeal
   (Brazil)
FX This work was developed in the context of the CNRS-Fiocruz Associated
   Laboratory of Immunology/Immunopathology, being also funded by the
   Capes/Cofecub French/Brazilian conjoint program, as well as CNRS
   (France), Fiocruz, CNPq, Faperj and Fapeal (Brazil). The authors
   disclose any conflict of interest.
CR Arnold RE, 2004, NEUROIMMUNOMODULAT, V11, P149, DOI 10.1159/000076764
   BLAZAR BR, 1995, EXP HEMATOL, V23, P1397
   Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012
   Carvalho-Pinto C, 2004, EUR J IMMUNOL, V34, P548, DOI 10.1002/eji.200324285
   CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845
   Colao A, 2002, J ENDOCRINOL INVEST, V25, P125, DOI 10.1007/BF03343975
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   DAVILA DR, 1987, J NEUROSCI RES, V18, P108, DOI 10.1002/jnr.490180118
   Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040
   KNAPP JR, 1994, J ANIM SCI, V72, P2812, DOI 10.2527/1994.72112812x
   MELLOCOELHO V, 1998, ENDOCRINOLOGY, V139, P3837
   MELLOCOELHO V, 1997, J NEUROIMMUNOL, V76, P39
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003
   Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830
   Savino W, 2005, ADV EXP MED BIOL, V567, P167
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2003, ANN NY ACAD SCI, V992, P179, DOI 10.1111/j.1749-6632.2003.tb03148.x
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Smaniotto S, 2004, NEUROIMMUNOMODULAT, V11, P299, DOI 10.1159/000079410
   Sotelo AI, 1998, J ENDOCRINOL, V158, P53, DOI 10.1677/joe.0.1580053
   Sumita K, 2005, J PHARMACOL SCI, V97, P408, DOI 10.1254/jphs.FPJ04054X
   TAUB DD, 1994, J CLIN INVEST, V94, P293, DOI 10.1172/JCI117320
   Vigano A, 2004, J PEDIATR-US, V145, P542, DOI 10.1016/j.jpeds.2004.06.027
   Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016
NR 28
TC 18
Z9 19
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
EI 1090-2139
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD MAR
PY 2010
VL 24
IS 3
BP 451
EP 461
DI 10.1016/j.bbi.2009.11.014
PG 11
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA 564LZ
UT WOS:000275217300017
PM 19948213
DA 2020-12-17
ER

PT J
AU Milpied, P
   Renand, A
   Bruneau, J
   Mendes-Da-Cruz, DA
   Jacquelin, S
   Asnafi, V
   Rubio, MT
   MacIntyre, E
   Lepelletier, Y
   Hermine, O
AF Milpied, Pierre
   Renand, Amedee
   Bruneau, Julie
   Mendes-Da-Cruz, Daniella A.
   Jacquelin, Sebastien
   Asnafi, Vahid
   Rubio, Marie-Therese
   MacIntyre, Elizabeth
   Lepelletier, Yves
   Hermine, Olivier
TI Neuropilin-1 is not a marker of human Foxp3(+) Treg
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Human; Lymphoid organs; Mouse; Neuropilin-1; Treg
ID REGULATORY T-CELLS; ENDOTHELIAL GROWTH-FACTOR; DENDRITIC CELLS;
   SURFACE-MARKERS; TUMOR-CELLS; EXPRESSION; RECEPTOR; SEMAPHORIN-3A;
   THERAPY
AB Treg are immune cells that play a critical role in the regulation of the immune response. Although the transcription factor Foxp3 is widely accepted as the standard marker of Treg, specific surface markers are needed to better characterize these cells and decipher their mechanisms of action. Neuropilin-1 (Nrp-1), a membrane protein primarily involved in the nervous system, was identified as a specific marker of murine Treg, but its expression has not been rigorously investigated in human Treg. Here we show that in contrast to murine Treg and regardless of their origins (blood, thymus, spleen, lymph node or tonsil), human Foxp3(+) Treg do not specifically express Nrp-1. However, a population of Foxp3(-) Nrp-1(+) T cells can be detected in human secondary lymphoid organs, and Nrp-1 expression is induced on peripheral blood T lymphocytes upon in vitro activation. We conclude that Nrp-1 cannot be used as a specific marker of human Treg, but might represent a novel activation marker of human T cells both in vitro and in vivo.
C1 [Milpied, Pierre; Renand, Amedee; Mendes-Da-Cruz, Daniella A.; Jacquelin, Sebastien; Rubio, Marie-Therese; Lepelletier, Yves; Hermine, Olivier] Univ Paris 05, CNRS, UMR 8147, Hop Necker,Assistance Publ Hop Paris, F-75743 Paris 15, France.
   [Bruneau, Julie; Asnafi, Vahid; MacIntyre, Elizabeth] Univ Paris 05, INSERM, EMI0210, Hop Necker,Assistance Publ Hop Paris, F-75743 Paris 15, France.
   [Hermine, Olivier] Univ Paris 05, Serv Hematol Clin, Hop Necker,Assistance Publ Hop Paris, F-75743 Paris 15, France.
RP Hermine, O (corresponding author), Univ Paris 05, CNRS, UMR 8147, Hop Necker,Assistance Publ Hop Paris, Batiment Sevres Porte S2,161 Rue Sevres, F-75743 Paris 15, France.
EM hermine@necker.fr
RI Mendes-da-Cruz, Daniella A/E-7875-2016; lepelletier, yves/AAF-1546-2020;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; Milpied, Pierre J/Q-1380-2015;
   Renand, Amedee/A-9884-2018
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; lepelletier,
   yves/0000-0001-7746-5170; Mendes-da-Cruz, Daniella/0000-0003-3697-1506;
   Milpied, Pierre J/0000-0003-1873-5358; Renand,
   Amedee/0000-0003-2265-549X; Bruneau, Julie/0000-0001-5519-8489;
   Jacquelin, Sebastien/0000-0001-5087-3641; Hermine,
   Olivier/0000-0003-2574-3874
FU Ligue Nationale contre le Cancer (LNCC, France); Association pour la
   Recherche contre le Cancer (ARC, France)Fondation ARC pour la Recherche
   sur le Cancer; Fondation pour la Recherche Medicale (FRM,
   France)Fondation pour la Recherche Medicale; INCa (France)Institut
   National du Cancer (INCA) France; ANR (France)French National Research
   Agency (ANR); Canceropole (France); Fondation de France
   (France)Fondation de France
FX P. Milpied and A. Renand are recipients of grants from Ministere de la
   Recherche and Ligue Nationale contre le Cancer, respectively. This work
   was supported by grants from Ligue Nationale contre le Cancer (LNCC,
   France), Association pour la Recherche contre le Cancer (ARC, France),
   Fondation pour la Recherche Medicale (FRM, France), INCa (France), ANR
   (France), Canceropole (France) and the Fondation de France (France). We
   wish to thank Dr. F. Audat and Dr. J. A. Ribeil (Department of
   Biotherapy, Hopital Necker) for providing us with blood samples. We
   thank Dr. O. Devergne (CNRS UMR 8147, Hopital Necker) for providing us
   with tonsils.
CR Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x
   Battaglia A, 2009, CANCER IMMUNOL IMMUN, V58, P1363, DOI 10.1007/s00262-008-0646-7
   Bourbie-Vaudaine S, 2006, J IMMUNOL, V177, P1460, DOI 10.4049/jimmunol.177.3.1460
   Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799
   Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445
   Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0
   Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8
   Glinka Y, 2008, J LEUKOC BIOL
   Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
   Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8
   Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601
   Lim AYF, 2006, IMMUNOL CELL BIOL, V84, P530, DOI 10.1111/j.1440-1711.2006.01467.x
   Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009
   Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012
   Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083
   Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
   Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789
   Zhou H, 2007, TRANSPL P, V39, P81, DOI 10.1016/j.transproceed.2006.10.221
NR 18
TC 81
Z9 84
U1 1
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JUN
PY 2009
VL 39
IS 6
BP 1466
EP 1471
DI 10.1002/eji.200839040
PG 6
WC Immunology
SC Immunology
GA 464CC
UT WOS:000267481400004
PM 19499532
OA Bronze
DA 2020-12-17
ER

PT S
AU Mendes-da-Cruz, DA
   Lepelletier, Y
   Brignier, AC
   Smaniotto, S
   Renand, A
   Milpied, P
   Dardenne, M
   Hermine, O
   Savino, W
AF Mendes-da-Cruz, Daniella Areas
   Lepelletier, Yves
   Brignier, Anne C.
   Smaniotto, Salete
   Renand, Amedee
   Milpied, Pierre
   Dardenne, Mireille
   Hermine, Olivier
   Savino, Wilson
BE Savino, W
   Silva, PO
   Besedovsky, H
TI Neuropilins, Semaphorins, and Their Role in Thymocyte Development
SO NEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 7th Congress of the International-Society-for-Neuroimmunomodulation
CY APR 14-27, 2008
CL Rio de Janerio, BRAZIL
SP Int Soc Neuroimmunomoduat
DE semaphorins; neuropilins; thymus; thymocyte migration; thymocyte
   development
ID T-CELL DEVELOPMENT; EXTRACELLULAR-MATRIX; PRION PROTEIN; MOUSE THYMUS;
   MIGRATION; CHEMOKINES; CHEMOTAXIS; EXPRESSION; VEGF; DIFFERENTIATION
AB Some molecules described in the nervous system are also expressed in cells involved in the control of the immune response, suggesting they have a role as common mechanisms between neuroendocrine and immune systems. In this review, we focus on the expression and role of neuropilins (NPs) and their soluble ligands class 3 semaphorins in thymus physiology, particularly migration of developing thymocytes. We also discuss the concept of multivectorial thymocyte migration, including semaphorins, as a new individual cell migration vector.
C1 [Mendes-da-Cruz, Daniella Areas; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   [Mendes-da-Cruz, Daniella Areas; Lepelletier, Yves; Brignier, Anne C.; Renand, Amedee; Milpied, Pierre; Dardenne, Mireille; Hermine, Olivier] Paris Descartes Univ, CNRS, Unite Mixte Rech 8147, Necker Hosp, Paris, France.
   [Smaniotto, Salete] Univ Fed Alagoas, Inst Biomed & Hlth Sci, Maceio, Brazil.
   [Hermine, Olivier] Hop Paris, Paris, France.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM daniella@ioc.fiocruz.br; savino@fiocruz.br; savino@fiocruz.br
RI Smaniotto, Salete/AAT-4056-2020; Mendes-da-Cruz, Daniella A/E-7875-2016;
   lepelletier, yves/AAF-1546-2020; Milpied, Pierre J/Q-1380-2015; Renand,
   Amedee/A-9884-2018; Mendes-da-Cruz, Daniella/AAN-6644-2020; Smaniotto,
   Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; lepelletier,
   yves/0000-0001-7746-5170; Milpied, Pierre J/0000-0003-1873-5358; Renand,
   Amedee/0000-0003-2265-549X; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Smaniotto, Salete/0000-0003-1527-5894;
   Hermine, Olivier/0000-0003-2574-3874
FU CNRS/Fiocruz French/BrazilianCentre National de la Recherche
   Scientifique (CNRS); Foundation for Medical Research; National League
   against CancerLigue nationale contre le cancer; National Cancer
   Institute (France)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI)Institut National du Cancer (INCA) France; Fiocruz
   (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq; Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES; Brazil)CAPES
FX This work was developed in the context of the Centre National de la
   Recherche Scientifique (CNRS)-Fiocruz Associated Laboratory of
   Immunology and Immunopathology. It was partially funded with grants by
   CNRS/Fiocruz French/Brazilian conjoint program, CNRS, The Foundation for
   Medical Research, The National League against Cancer, The National
   Cancer Institute (France); and Fiocruz (Brazil), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq; Brazil), and Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil).
CR Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097
   Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Bachelder RE, 2003, CANCER RES, V63, P5230
   Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799
   Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4
   Cimpean AM, 2008, ANN ANAT, V190, P238, DOI 10.1016/j.aanat.2007.05.003
   Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547
   Corbel C, 2007, DEV COMP IMMUNOL, V31, P1082, DOI 10.1016/j.dci.2007.01.009
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001
   Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348
   Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538
   Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376
   Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x
   Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490
   Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   MALEFIJT RD, 1986, LAB INVEST, V55, P25
   Medina S, 1998, MECH AGEING DEV, V102, P249, DOI 10.1016/S0047-6374(98)00014-1
   Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639
   Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x
   Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804
   Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2
   Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404
   Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3
   Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956
   Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003
   Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011
   Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Sharfe N, 2002, EUR J IMMUNOL, V32, P3745, DOI 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M
   Silva AB, 2006, IMMUNOLOGY, V118, P131, DOI 10.1111/j.1365-2567.2006.02351.x
   SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0
   Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652
   Takahashi K, 2008, DEV DYNAM, V237, P1699, DOI 10.1002/dvdy.21556
   Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416
   Terra-Granado E, 2007, NEUROIMMUNOMODULAT, V14, P213, DOI 10.1159/000110649
   VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907
   Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650
   Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397
   Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Yuan L, 2002, DEVELOPMENT, V129, P4797
NR 50
TC 22
Z9 24
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-746-7
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2009
VL 1153
BP 20
EP 28
DI 10.1111/j.1749-6632.2008.03980.x
PG 9
WC Multidisciplinary Sciences; Neurosciences
SC Science & Technology - Other Topics; Neurosciences & Neurology
GA BIY82
UT WOS:000263827300004
PM 19236324
DA 2020-12-17
ER

PT J
AU Michel, ML
   Mendes-Da-Cruz, D
   Keller, AC
   Lochner, M
   Schneider, E
   Dy, M
   Eberl, G
   Leite-De-Moraes, MC
AF Michel, Marie-Laure
   Mendes-da-Cruz, Daniella
   Keller, Alexandre Castro
   Lochner, Matthias
   Schneider, Elke
   Dy, Michel
   Eberl, Gerard
   Leite-de-Moraes, Maria C.
TI Critical role of ROR-gamma t in a new thymic pathway leading to
   IL-17-producing invariant NKT cell differentiation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE thymic precursors; alpha-GalCer; CD1d; cytokines
ID PROINFLAMMATORY IL-17(+); AIRWAY HYPERREACTIVITY; CUTTING EDGE; IN-VIVO;
   LINEAGE; POPULATION; IDENTIFICATION; INFLAMMATION; ACTIVATION;
   THYMOCYTES
AB Invariant natural killer T (iNKT) cells constitute a subpopulation of T cells that recognize glycolipids presented by CD1d molecules. They are characterized by their prompt production of interleukin-4 (IL-4) and interferon-gamma (IFN-gamma), which enables them to modulate diverse immune responses. Recently, we enlarged this concept by identifying a distinct IL-17-producing iNKT cell subset, named iNKT17 cells. The mechanisms leading to the acquisition of this new iNKT cell activity are unknown. Herein we show that IL-17-producing iNKT cells are already present in the thymus, predominantly among a subset regarded so far as an immature stage of thymic iNKT cell development, the CD1d tetramer(pos)CD44(pos)NK1.1(neg)CD4(neg) cells. Using EGFP reporter mice, we demonstrate that the transcription factor ROR-gamma t is critical for the thymic differentiation of this subset because only ROR-gamma t(pos) iNKT cells are capable of massively secreting IL-17. Moreover, IL-17-producing CD1d tetramer(pos)CD44(pos)NK1.1(neg)CD4(neg) thymic iNKT cells have reached a mature differentiation stage because they fail to generate other cell subsets in fetal thymic organ culture. Conversely, thymic ROR-gamma t(neg) iNKT cell precursors give rise to progeny, but acquire neither ROR-gamma t expression nor the ability to secrete IL-17. In conclusion, our findings demonstrate an alternative thymic pathway leading to the development of iNKT17 cells that requires ROR-gamma t expression.
C1 [Michel, Marie-Laure; Mendes-da-Cruz, Daniella; Keller, Alexandre Castro; Schneider, Elke; Dy, Michel; Leite-de-Moraes, Maria C.] Univ Paris 05, Hop Necker Enfants Malad, CNRS, Fac Med,UMR 8147, F-75743 Paris 15, France.
   [Lochner, Matthias; Eberl, Gerard] Inst Pasteur, CNRS, URA 1961, Lab Lymphoid Tissue Dev, F-75724 Paris, France.
RP Leite-De-Moraes, MC (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, CNRS, Fac Med,UMR 8147, 161 Rue Sevres, F-75743 Paris 15, France.
EM leite.de.moraes@necker.fr
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Lochner, Matthias/L-6963-2015;
   Keller, Alexandre C/E-4621-2012; Mendes-da-Cruz, Daniella A/E-7875-2016;
   Eberl, Gerard/A-1160-2013; de Moraes, Maria Leite/AAV-9159-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Lochner,
   Matthias/0000-0002-7979-5613; Keller, Alexandre C/0000-0002-7827-0292;
   Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; de Moraes, Maria
   Leite/0000-0002-2891-2269; Michel, Marie-Laure/0000-0003-2657-4662;
   Eberl, Gerard/0000-0002-1119-5638
FU Centre National de la Recherche ScientifiqueCentre National de la
   Recherche Scientifique (CNRS); Universite Rene Descartes - Paris V;
   Agence Nationale de Recherches Microbiologie-Maladie EmergentesFrench
   National Research Agency (ANR) [ASTHMA-IL-17]; Fondation pour la
   Recherche MedicaleFondation pour la Recherche Medicale; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq)
FX We thank Sylvain Latour, Agnes Lehuen, and Kamel Benlagha for
   discussion, Rachel Bricard for technical assistance, and Jerome Megret
   and Corinne Garcia-Cordier for cell sorting. We also thank the National
   Institutes of Health Tetramer facilities for providing CD1d/PBS57
   tetramers. This work was supported by the Centre National de la
   Recherche Scientifique, Universite Rene Descartes - Paris V, and the
   Agence Nationale de Recherches Microbiologie-Maladie Emergentes
   ASTHMA-IL-17 (M.C.L.d.-M.). A.C.K. received a postdoctoral fellowship
   from the Fondation pour la Recherche Medicale and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico.
CR Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851
   BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091
   Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711
   Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456
   Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017
   Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102
   Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105
   Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623
   Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011
   Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019
   Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626
   Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742
   Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257
   Leite-de-Moraes MC, 2002, EUR J IMMUNOL, V32, P1897, DOI 10.1002/1521-4141(200207)32:7<1897::AID-IMMU1897>3.0.CO;2-Y
   Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637
   Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034
   McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001
   Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544
   Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507
   Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167
   Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057
   Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057
   VICARI A, 1994, J EXP MED, V180, P653, DOI 10.1084/jem.180.2.653
   Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557
   Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002
NR 30
TC 177
Z9 184
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 16
PY 2008
VL 105
IS 50
BP 19845
EP 19850
DI 10.1073/pnas.0806472105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 385GI
UT WOS:000261802300050
PM 19057011
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Belaid-Choucair, Z
   Lepelletier, Y
   Poncin, G
   Thiry, A
   Humblet, C
   Maachi, M
   Beaulieu, A
   Schneider, E
   Briquet, A
   Mineur, P
   Lambert, C
   Mendes-Da-Cruz, D
   Ahui, ML
   Asnafi, V
   Dy, M
   Boniver, J
   Nusgens, BV
   Hermine, O
   Defresne, MP
AF Belaid-Choucair, Zakia
   Lepelletier, Yves
   Poncin, Geraldine
   Thiry, Albert
   Humblet, Chantal
   Maachi, Mustapha
   Beaulieu, Aurore
   Schneider, Elke
   Briquet, Alexandra
   Mineur, Pierre
   Lambert, Charles
   Mendes-Da-Cruz, Daniella
   Ahui, Marie Louise
   Asnafi, Vahid
   Dy, Michel
   Boniver, Jacques
   Nusgens, Betty V.
   Hermine, Olivier
   Defresne, Marie Paule
TI Human bone marrow adipocytes block granulopoiesis through
   neuropilin-1-induced granulocyte colony-stimulating factor inhibition
SO STEM CELLS
LA English
DT Article
DE adult human bone marrow; granulopoiesis; stem cell-microenvironment
   interactions; bone marrow stromal cells; in vitro differentiation; bone
   marrow adipocytes; neuropilin-1; macrophages
ID ENDOTHELIAL GROWTH-FACTOR; WHITE ADIPOSE-TISSUE; HEMATOPOIETIC
   STEM-CELLS; UNILOCULAR FAT-CELLS; GENE-EXPRESSION; STROMAL CELLS;
   IN-VIVO; SUBCUTANEOUS ADIPOSE; MACROPHAGE INFILTRATION; CARCINOMA-CELLS
AB Adipocytes are part of hematopoietic microenvironment, even though up to now in humans, their role in hematopoiesis is still questioned. We have previously shown that accumulation of fat cells in femoral bone marrow (BM) coincides with increased expression of neuropilin-1 (NP-1), while it is weakly expressed in hematopoietic iliac crest BM. Starting from this observation, we postulated that adipocytes might exert a negative effect on hematopoiesis mediated through NP-1. To test this hypothesis, we set up BM adipocytes differentiated into fibroblast-like fat cells (FLFC), which share the major characteristics of primitive unilocular fat cells, as an experimental model. As expected, FLFCs constitutively produced macrophage colony stimulating factor and induced CD34(+) differentiation into macrophages independently of cell-to-cell contact. By contrast, granulopoiesis was hampered by cell-to-cell contact but could be restored in transwell culture conditions, together with granulocyte colony stimulating factor production. Both functions were also recovered when FLFCs cultured in contact with CD34(+) cells were treated with an antibody neutralizing NP-1, which proved its critical implication in contact inhibition. An inflammatory cytokine such as interleukin-1 beta or dexamethasone modulates FLFC properties to restore granulopoiesis. Our data provide the first evidence that primary adipocytes exert regulatory functions during hematopoiesis that might be implicated in some pathological processes.
C1 [Belaid-Choucair, Zakia; Poncin, Geraldine; Thiry, Albert; Humblet, Chantal; Beaulieu, Aurore; Boniver, Jacques; Defresne, Marie Paule] Univ Liege, Dept Cytol & Histol, Grp Interdisciplinaire Genoproteom Appliquee Rech, B-4000 Liege, Belgium.
   [Belaid-Choucair, Zakia; Poncin, Geraldine; Thiry, Albert; Humblet, Chantal; Beaulieu, Aurore; Boniver, Jacques; Defresne, Marie Paule] Univ Liege, Dept Pathol Anat, Grp Interdisciplinaire Genoproteom Appliquee Rech, B-4000 Liege, Belgium.
   [Belaid-Choucair, Zakia; Lepelletier, Yves; Schneider, Elke; Mendes-Da-Cruz, Daniella; Ahui, Marie Louise; Dy, Michel; Hermine, Olivier] Univ Paris 05, Unite Mixte Rech, Ctr Natl Rech Sci, Paris, France.
   [Asnafi, Vahid] Univ Paris 05, Hematol Lab, Assistance Publ Hop Paris, Paris, France.
   [Hermine, Olivier] Univ Paris 05, Dept Clin Hematol, Assistance Publ Hop Paris, Paris, France.
   [Maachi, Mustapha] Hop Tenon, Serv Biochim & Hormonol, F-75970 Paris, France.
   Univ Liege, Grp Interdisciplinaire Genoprot Appliquee Rech, Liege, Belgium.
RP Defresne, MP (corresponding author), Univ Liege, Dept Cytol & Histol, Grp Interdisciplinaire Genoproteom Appliquee Rech, CHU-B23, B-4000 Liege, Belgium.
EM hermine@necker.fr; mp.defresne@ulg.ac.be
RI lepelletier, yves/AAF-1546-2020; Mendes-da-Cruz, Daniella A/E-7875-2016;
   Mendes-da-Cruz, Daniella/AAN-6644-2020
OI lepelletier, yves/0000-0001-7746-5170; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506;
   Hermine, Olivier/0000-0003-2574-3874
CR AGLIETTA M, 1993, STEM CELLS, V11, P83
   Aoki S, 2004, MOL BIOL CELL, V15, P4647, DOI 10.1091/mbc.E04-01-0038
   Bachelder RE, 2001, CANCER RES, V61, P5736
   Bachelder RE, 2003, CANCER RES, V63, P5230
   Baratta Mario, 2002, Med Sci Monit, V8, pRA282
   Belaid Z, 2005, HAEMATOLOGICA, V90, P400
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   BONNIER S, 1991, PATHOL BIOL, V39, P271
   Bornstein SR, 2000, DIABETES, V49, P532, DOI 10.2337/diabetes.49.4.532
   Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277
   Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x
   Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655
   Fruhbeck G, 2001, CELL SIGNAL, V13, P827, DOI 10.1016/S0898-6568(01)00211-X
   Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA
   Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X
   Gregoire FM, 2001, EXP BIOL MED, V226, P997
   Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001
   Hattori H, 2006, BIOCHEM BIOPH RES CO, V343, P1118, DOI 10.1016/j.bbrc.2006.03.061
   Hattori K, 2004, INT J MOL MED, V13, P395
   He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6
   HEYWORTH CM, 1992, BLOOD, V80, P2230
   Hubin F, 2005, STEM CELLS, V23, P1626, DOI 10.1634/stemcells.2005-0041
   Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025
   Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028
   Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231
   Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004
   Jacobsen K, 1996, BLOOD, V87, P73
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004
   Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8
   Kume K, 2002, J HISTOCHEM CYTOCHEM, V50, P159, DOI 10.1177/002215540205000204
   LEE MY, 1991, BLOOD, V77, P2135
   Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104
   Levine JA, 1998, J CLIN INVEST, V101, P1557, DOI 10.1172/JCI2293
   LIESCHKE GJ, 1994, BLOOD, V84, P1737
   Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X
   MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021
   Mackay DL, 2006, J CELL PHYSIOL, V207, P722, DOI 10.1002/jcp.20617
   Matthies AM, 2002, AM J PATHOL, V160, P289, DOI 10.1016/S0002-9440(10)64372-6
   Metcalf Donald, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P860
   Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196
   Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598
   NAKAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P1103, DOI 10.1006/bbrc.1993.1935
   Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2
   NICOLA NA, 1979, BLOOD, V54, P614
   OGAWA M, 1993, BLOOD, V81, P2844
   Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399
   Rafii S, 2003, ANN NY ACAD SCI, V996, P49, DOI 10.1111/j.1749-6632.2003.tb03232.x
   Rodrigue-Way A, 2007, ENDOCRINOLOGY, V148, P1009, DOI 10.1210/en.2006-0975
   Ruge T, 2006, EUR J CLIN INVEST, V36, P16, DOI 10.1111/j.1365-2362.2006.01584.x
   Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004
   Sell H, 2006, BIOCHEM BIOPH RES CO, V343, P700, DOI 10.1016/j.bbrc.2006.03.010
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
   Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3
   SUGIHARA H, 1987, J LIPID RES, V28, P1038
   SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x
   TAVASSOLI M, 1970, SCIENCE, V169, P291, DOI 10.1126/science.169.3942.291
   TAVASSOLI M, 1989, HDB HEMATOPOIETIC MI, P157
   Tordjman R, 1999, BLOOD, V94, P2301, DOI 10.1182/blood.V94.7.2301.419k24_2301_2309
   Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789
   Urs S, 2004, J NUTR, V134, P762
   Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8
   Zhou X, 2007, J LIPID RES, V48, P1701, DOI 10.1194/jlr.M600525-JLR200
NR 65
TC 47
Z9 51
U1 0
U2 1
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PD JUN
PY 2008
VL 26
IS 6
BP 1556
EP 1564
DI 10.1634/stemcells.2008-0068
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 315VF
UT WOS:000256907600019
PM 18388301
OA Bronze
DA 2020-12-17
ER

PT J
AU Mendes-Da-Cruz, DA
   Smaniotto, S
   Keller, AC
   Dardenne, M
   Savino, W
AF Mendes-da-Cruz, Daniella A.
   Smaniotto, Salete
   Keller, Alexandre C.
   Dardenne, Mireille
   Savino, Wilson
TI Multivectorial abnormal cell migration in the NOD mouse thymus
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID REGULATORY T-CELLS; EXTRACELLULAR-MATRIX; TRANSENDOTHELIAL MIGRATION;
   THYMOCYTE MIGRATION; PERIVASCULAR SPACE; MICE; FIBRONECTIN; CHEMOKINES;
   EMIGRATION; ADHESION
AB We previously described a fibronectin/VLA-5-dependent impairment of NOD thymocyte migration, correlated with partial thymocyte arrest within thymic perivascular spaces. Yet, NOD thymocytes still emigrate, suggesting the involvement of other cell migration-related alterations. In this context, the aim of this work was to study the role of extracellular matrix ligands, alone or in combination with the chemokine CXCL12, in NOD thymocyte migration. Intrathymic contents of CXCL12, fibronectin, and laminin were evaluated by immunohistochemistry while the expression of corresponding receptors was ascertained by flow cytometry. Thymocyte migration was measured using Transwell chambers and transendothelial migration was evaluated in the same system, but using an endothelial cell monolayer within the chambers. NOD thymocytes express much lower VLA-5 than C57BL/6 thymocytes. This defect was particularly severe in CD4(+) thymocytes expressing Foxp3, thus in keeping with the arrest of Foxp3(+) cells within the NOD giant perivascular spaces. We observed an enhancement in CXCL12, laminin, and fibronectin deposition and colocalization in the NOD thymus. Furthermore, we detected altered expression of the CXCL12 receptor CXCR4 and the laminin receptor VLA-6, as well as enhanced migratory capacity of NOD thymocytes toward these molecules, combined or alone. Moreover, transendothelial migration of NOD thymocytes was diminished in the presence of exogenous fibronectin. Our data unravel the existence of multiple cell migration-related abnormalities in NOD thymocytes, comprising both down- and up-regulation of specific responses. Although remaining to be experimentally demonstrated, these events may have consequences on the appearance of autoimmunity in NOD mice.
C1 [Mendes-da-Cruz, Daniella A.; Keller, Alexandre C.; Dardenne, Mireille] Univ Paris 05, Necker Hosp, CNRS, Unite Mixte Rech 8147, F-75743 Paris 15, France.
   [Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Lab Thymus Res, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Smaniotto, Salete] Fed Unic Alagoas, Inst Biomed & Hlth Sci, Maceio, Brazil.
RP Mendes-Da-Cruz, DA (corresponding author), Univ Paris 05, Necker Hosp, CNRS, Unite Mixte Rech 8147, 161 Rue Sevres, F-75743 Paris 15, France.
EM mendes-da-cruz@necker.fr; savino@fiocruz.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella
   A/E-7875-2016; Smaniotto, Salete/AAT-4056-2020; Keller, Alexandre
   C/E-4621-2012; Smaniotto, Salete/T-3796-2017
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Keller, Alexandre C/0000-0002-7827-0292;
   Smaniotto, Salete/0000-0003-1527-5894
CR Atlan-Gepner C, 1999, AUTOIMMUNITY, V31, P249, DOI 10.3109/08916939908994070
   BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516
   Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Chatenoud L, 2005, INT REV IMMUNOL, V24, P247, DOI 10.1080/08830180590934994
   Colomb E, 1996, DIABETES, V45, P1535, DOI 10.2337/diabetes.45.11.1535
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214
   DARDENNE M, 1989, EUR J IMMUNOL, V19, P889, DOI 10.1002/eji.1830190516
   Flores KG, 1999, J CLIN INVEST, V104, P1031, DOI 10.1172/JCI7558
   Geutskens SB, 2004, SCAND J IMMUNOL, V60, P30, DOI 10.1111/j.0300-9475.2004.01465.x
   Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098
   Kwon H, 2005, J AUTOIMMUN, V24, P11, DOI 10.1016/j.jaut.2004.10.002
   Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005
   Mendes-da-Cruz DA, 2006, EUR J IMMUNOL, V36, P1486, DOI 10.1002/eji.200535629
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Piccirillo CA, 2005, ANN NY ACAD SCI, V1051, P72, DOI 10.1196/annals.1361.048
   Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI13853
   Rosmalen JGM, 2002, TRENDS IMMUNOL, V23, P40, DOI 10.1016/S1471-4906(01)02088-9
   Sato T, 2004, EUR J IMMUNOL, V34, P3346, DOI 10.1002/eji.200425373
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   SAVINO W, 1991, LAB INVEST, V64, P405
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Vianello F, 2005, J IMMUNOL, V175, P5115, DOI 10.4049/jimmunol.175.8.5115
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547
NR 28
TC 30
Z9 31
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2008
VL 180
IS 7
BP 4639
EP 4647
DI 10.4049/jimmunol.180.7.4639
PG 9
WC Immunology
SC Immunology
GA 324GT
UT WOS:000257506700036
PM 18354187
OA Bronze
DA 2020-12-17
ER

PT J
AU Savino, W
   Villa-Verde, DMS
   Mendes-da-Cruz, DA
   Silva-Monteiro, E
   Perez, AR
   Aoki, MD
   Bottasso, O
   Guinazu, N
   Silva-Barbosa, SD
   Gea, S
AF Savino, Wilson
   Villa-Verde, Dea Maria S.
   Mendes-da-Cruz, Daniella Areas
   Silva-Monteiro, Elizangela
   Perez, Ana Rosa
   Aoki, Maria del Pilar
   Bottasso, Oscar
   Guinazu, Natalia
   Silva-Barbosa, Suse Dayse
   Gea, Susana
TI Cytokines and cell adhesion receptors in the regulation of immunity to
   Trypanosoma cruzi
SO CYTOKINE & GROWTH FACTOR REVIEWS
LA English
DT Review
DE Chagas' disease; macrophages; lymphocytes; cytokines; chemokines;
   extracellular matrix; integrins
ID PRO-INFLAMMATORY CYTOKINES; DOUBLE-POSITIVE THYMOCYTES; CHRONIC
   CHAGAS-DISEASE; HEART GRAFT-REJECTION; NITRIC-OXIDE SYNTHASE; TOLL-LIKE
   RECEPTOR-2; T-CELL; EXTRACELLULAR-MATRIX; ALTERNATIVE ACTIVATION; ACUTE
   INFECTION
AB Pathophysiology of Chagas' disease is not completely defined, although innate and adaptative immune responses are crucial. In acute infection some parasite antigens can activate macrophages, and this may result in pro-inflammatory cytokine production, nitric oxide synthesis, and consequent control of parasitemia and mortality. Cell-mediated immunity in Trypanosoma cruzi infection is also modulated by cytokines, but in addition to parasite-specific responses, autoimmunity can be also triggered. Importantly, cytokines may also play a role in the cell-mediated immunity of infected subjects. Finally, leukocyte influx towards target tissues is regulated by cytokines, chemokines, and extracellular matrix components which may represent potential therapeutic targets in infected patients. Here we will discuss recent findings on the role of cytokines, chemokines and extracellular matrix components in the regulation of innate and adaptive immunity during T cruzi infection. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   Natl Univ Rosario, Sch Med Sci, Inst Immunol, Rosario, Santa Fe, Argentina.
   Natl Univ Cordoba, Fac Chem Sci, Dept Clin Biochem, RA-5016 Cordoba, Argentina.
   Natl Canc Inst, Ctr Bone Marrow Transplantat, Rio De Janeiro, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Ave Brasil 3465, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br; Bottasso@uolsinectis.com.ar; sgea@mail.fcq.unc.edu.ar
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Villa-Verde, Dea M.S./Q-1238-2016
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Villa-Verde, Dea M.S./0000-0002-2685-5512;
   Perez, Ana Rosa/0000-0002-1636-7523; Aoki, Maria/0000-0002-6897-7702;
   Guinazu, Natalia/0000-0002-1215-6796; Silva,
   Elisangela/0000-0001-9833-1825
CR Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109
   ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Antunez MI, 1997, EXP PARASITOL, V87, P58, DOI 10.1006/expr.1997.4171
   Aoki MP, 2004, AM J PHYSIOL-CELL PH, V286, pC206, DOI 10.1152/ajpcell.00282.2003
   Aparicio IM, 2004, INFECT IMMUN, V72, P5892, DOI 10.1128/IAI.72.10.5892-5902.2004
   Arzt E, 1999, FRONT NEUROENDOCRIN, V20, P71, DOI 10.1006/frne.1998.0176
   Battaglia M, 2002, MICROBES INFECT, V4, P559, DOI 10.1016/S1286-4579(02)01573-3
   Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64
   BOTTASSO OA, 1993, IMMUNOL LETT, V37, P175, DOI 10.1016/0165-2478(93)90028-Z
   Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668
   Calvet CM, 2004, EXP PARASITOL, V107, P20, DOI 10.1016/j.exppara.2004.04.003
   Camargo MM, 1997, J IMMUNOL, V158, P5890
   Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249
   Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711
   Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416
   Cardillo F, 1998, INT IMMUNOL, V10, P107, DOI 10.1093/intimm/10.2.107
   Cardoni RL, 1996, CELL IMMUNOL, V169, P238, DOI 10.1006/cimm.1996.0114
   Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995
   Chandrasekar B, 1998, AM J PATHOL, V152, P925
   Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015
   CORREADESANTANA E, 2006, ANN NY ACAD SCI, V88, P274
   Costa RP, 2000, SCAND J IMMUNOL, V51, P511, DOI 10.1046/j.1365-3083.2000.00706.x
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   CUNHANETO EIL, 2004, AUTOIMMUNITY CHAGAS
   daSilva AC, 1996, INT IMMUNOL, V8, P1213, DOI 10.1093/intimm/8.8.1213
   de Meis J, 2006, MICROBES INFECT, V8, P221, DOI 10.1016/j.micinf.2005.06.027
   de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1016/S0002-9270(98)00151-8
   Aoki MD, 2006, MICROBES INFECT, V8, P1723, DOI 10.1016/j.micinf.2006.02.010
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   DEMORAES MDCL, 1994, SCAND J IMMUNOL, V39, P51
   DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29
   Fernandez-Gomez R, 1998, J IMMUNOL, V160, P3471
   Ferreira MS, 1997, CLIN INFECT DIS, V25, P1397, DOI 10.1086/516130
   Fichera LE, 2004, INFECT IMMUN, V72, P359, DOI 10.1128/IAI.72.1.359-363.2004
   Fukumori T, 2003, CANCER RES, V63, P8302
   Giordanengo L, 2000, EUR J IMMUNOL, V30, P3181, DOI 10.1002/1521-4141(200011)30:11&lt;3181::AID-IMMU3181&gt;3.0.CO;2-A
   Giordanengo L, 2002, EUR J IMMUNOL, V32, P1003, DOI 10.1002/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P
   Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x
   Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461
   Girones N, 2005, CURR TOP MICROBIOL, V296, P89
   Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5
   Girones N, 2001, CLIN DIAGN LAB IMMUN, V8, P1039, DOI 10.1128/CDLI.8.6.1039-1043.2001
   Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X
   Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005
   GONCALVESDACOST.SC, 1991, PATHOL BIOL, V39, P91
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Guinazu N, 2004, MICROBES INFECT, V6, P1250, DOI 10.1016/j.micinf.2004.07.010
   Hardison JL, 2006, INFECT IMMUN, V74, P125, DOI 10.1128/IAI.74.1.125-134.2006
   Henriques-Pons A, 2004, EXP PARASITOL, V107, P1, DOI 10.1016/j.exppara.2004.04.010
   HERSHKOVIZ R, 1993, IMMUNOLOGY, V78, P50
   Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4
   Hoft DF, 2005, INFECT IMMUN, V73, P4934, DOI 10.1128/IAI.73.8.4934-4940.2005
   Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000
   Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x
   Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9
   Hunter CA, 1997, J IMMUNOL, V158, P3311
   JUNQUEIRA LF, 1992, CARDIOVASC RES, V26, P324, DOI 10.1093/cvr/26.4.324
   Kierszenbaum F, 2003, FEMS IMMUNOL MED MIC, V37, P1, DOI 10.1016/S0928-8244(03)00097-X
   Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004
   Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957
   Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006
   Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682
   LEITEDEMORAES MC, 1992, IMMUNOLOGY, V77, P95
   Li YQ, 1998, IMMUNOLOGY, V93, P455
   Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003
   Machado FS, 2005, J INFECT DIS, V191, P627, DOI 10.1086/427515
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantuano-Barradas M, 2003, MICROBES INFECT, V5, P1363, DOI 10.1016/j.micinf.2003.09.017
   Marino APMP, 2004, CIRCULATION, V110, P1443, DOI 10.1161/01.CIR.0000141561.15939.EC
   Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050
   Marroquin-Quelopana M, 2004, BIOCHEM BIOPH RES CO, V325, P612, DOI 10.1016/j.bbrc.2004.10.068
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   Mendes-da-Cruz DA, 2006, EUR J IMMUNOL, V36, P1486, DOI 10.1002/eji.200535629
   Michailowsky V, 2004, J IMMUNOL, V173, P463, DOI 10.4049/jimmunol.173.1.463
   Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002
   MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P661, DOI 10.1111/j.1365-3083.1986.tb02185.x
   Moody TN, 2000, FEBS LETT, V470, P305, DOI 10.1016/S0014-5793(00)01347-8
   Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735
   Mucci J, 2005, J IMMUNOL, V174, P4545, DOI 10.4049/jimmunol.174.8.4545
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   Nakai K, 2003, OPT REV, V10, P267, DOI 10.1007/s10043-003-0267-5
   Nanki T, 2000, ARTHRITIS RES, V2, P415, DOI 10.1186/ar120
   Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006
   Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004
   Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261
   Olivieri BP, 2005, ANTIMICROB AGENTS CH, V49, P1981, DOI 10.1128/AAC.49.5.1981-1987.2005
   Ouaissi A, 2002, J IMMUNOL, V168, P6366, DOI 10.4049/jimmunol.168.12.6366
   OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Perez AR, 2005, LIFE SCI, V77, P1945, DOI 10.1016/j.lfs.2005.01.025
   Petray P, 2002, ACTA TROP, V83, P205, DOI 10.1016/S0001-706X(02)00131-6
   Planelles L, 2003, CLIN EXP IMMUNOL, V131, P41, DOI 10.1046/j.1365-2249.2003.02022.x
   Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422
   Quanquin NM, 1999, INFECT IMMUN, V67, P4603, DOI 10.1128/IAI.67.9.4603-4612.1999
   Rabinovich GA, 2005, PARASITE IMMUNOL, V27, P103, DOI 10.1111/j.1365-3024.2005.00749.x
   REZENDE JM, 2000, TRYPANOSOMA CRUZI DO, P153
   RIVERA MT, 1995, INFECT IMMUN, V63, P591, DOI 10.1128/IAI.63.2.591-595.1995
   Roffe E, 2003, J NEUROIMMUNOL, V142, P17, DOI 10.1016/S0165-5728(03)00254-6
   Roggero E, 2004, FEMS IMMUNOL MED MIC, V41, P123, DOI 10.1016/j.femsim.2004.02.003
   Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x
   Roggero E, 2006, J ENDOCRINOL, V190, P495, DOI 10.1677/joe.1.06642
   Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592
   Saoudi A, 1996, J EXP MED, V184, P2393, DOI 10.1084/jem.184.6.2393
   Sartori AMC, 1998, CLIN INFECT DIS, V26, P177, DOI 10.1086/516257
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   SAVINO W, 1993, IMMUNOL TODAY, V14, P158, DOI 10.1016/0167-5699(93)90278-S
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062
   Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712
   Silva AA, 1999, CLIN IMMUNOL, V92, P56, DOI 10.1006/clim.1999.4716
   SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169
   Silva-Barbosa SD, 2001, TRANSPLANTATION, V72, P172, DOI 10.1097/00007890-200107150-00034
   Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389
   SilvaBarbosa SD, 1997, J IMMUNOL, V159, P997
   Simmons KJ, 2006, FEBS LETT, V580, P2365, DOI 10.1016/j.febslet.2006.03.054
   Smith RM, 2002, CARDIOVASC RES, V55, P474, DOI 10.1016/S0008-6363(02)00288-2
   Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727
   Stempin CC, 2004, EUR J IMMUNOL, V34, P200, DOI 10.1002/eji.200324313
   Sterin-Borda L, 2003, EUR J IMMUNOL, V33, P2459, DOI 10.1002/eji.200324009
   Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8
   Truyens C, 1995, PARASITE IMMUNOL, V17, P561, DOI 10.1111/j.1365-3024.1995.tb00999.x
   Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885
   Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M
   Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998
   Villalta F, 1998, BIOCHEM BIOPH RES CO, V249, P247, DOI 10.1006/bbrc.1998.9127
   Vray B, 2004, GLYCOBIOLOGY, V14, P647, DOI 10.1093/glycob/cwh068
   WRIGHTSMAN R, 1982, INFECT IMMUN, V36, P637, DOI 10.1128/IAI.36.2.637-644.1982
   Zhang L, 1996, EUR J IMMUNOL, V26, P102, DOI 10.1002/eji.1830260116
NR 132
TC 68
Z9 68
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6101
EI 1879-0305
J9 CYTOKINE GROWTH F R
JI Cytokine Growth Factor Rev.
PD FEB-APR
PY 2007
VL 18
IS 1-2
BP 107
EP 124
DI 10.1016/j.cytogfr.2007.01.010
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 158FN
UT WOS:000245777100010
PM 17339126
DA 2020-12-17
ER

PT J
AU Mendes-da-Cruz, DA
   Silva, JS
   Cotta-de-Almeida, V
   Savino, W
AF Mendes-da-Cruz, Daniella Areas
   Silva, Joao Santana
   Cotta-de-Almeida, Vinicius
   Savino, Wilson
TI Altered thymocyte migration during experimental acute Trypanosoma cruzi
   infection: combined role of fibronectin and the chemokines CXCL12 and
   CCL4
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE chemokines; extracellular matrix; thymocyte migration; thymus;
   Trypanosoma cruzi
ID HUMAN CHAGAS-DISEASE; T-CELL REPERTOIRE; EXTRACELLULAR-MATRIX; THYMUS;
   AUTOIMMUNITY; MICE; LYMPHOCYTES; MYOCARDITIS; CHEMOTAXIS; ACTIVATION
AB We previously showed migration disturbances in the thymus during experimental infection with Trypanosoma cruzi, the causative agent of Chagas disease. These changes were related to the enhanced expression of extracellular matrix ligands and receptors, leading to the escape of immature cells to the periphery. Here, we analyzed the expression and role of selected chemokines (CXCL12 and CCL4) and their receptors (CXCR4 and CCR5) in regulating thymocyte migration in conjunction with extracellular matrix during acute T cruzi infection. We found increased chemokine deposition in the thymus of infected mice when compared to controls, accompanied by enhanced colocalization with fibronectin as well as up-regulated surface expression of CXCR4 and CCR5 in thymocytes. We also noticed altered thymocyte migration towards the chemokines analyzed. Such an enhancement was even more prominent when fibronectin was added as a haptotatic stimulus in combination with a given chemokine. Our findings suggest that thymocyte migration results from a combined action of chemokines and extracellular matrix (ECM), which can be altered during pathological conditions such as T. cruzi infection, and may be at the origin of the changes in the T cell repertoire seen in this pathological process.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultrastruct & Cell Biol, Cell Biol Lab, BR-21045900 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Cotta-de-Almeida, Vinicius/G-3939-2012; Silva, Joao S/A-4484-2008;
   Mendes-da-Cruz, Daniella/AAN-6644-2020; Mendes-da-Cruz, Daniella
   A/E-7875-2016; Cotta-de-Almeida, Vinicius/AAC-3721-2019
OI Silva, Joao S/0000-0002-3410-3927; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Cotta-de-Almeida, Vinicius/0000-0002-6753-3480
CR Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Costa RP, 2000, SCAND J IMMUNOL, V51, P511, DOI 10.1046/j.1365-3083.2000.00706.x
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   Dairaghi DJ, 1998, BLOOD, V91, P2905, DOI 10.1182/blood.V91.8.2905.2905_2905_2913
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   Engman DM, 2002, ACTA TROP, V81, P123, DOI 10.1016/S0001-706X(01)00202-9
   Fernandez-Mestre MT, 2002, TISSUE ANTIGENS, V60, P10, DOI 10.1034/j.1399-0039.2002.600102.x
   Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258
   Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   Machado FS, 2005, J INFECT DIS, V191, P627, DOI 10.1086/427515
   Marino APMP, 2004, CIRCULATION, V110, P1443, DOI 10.1161/01.CIR.0000141561.15939.EC
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455
   Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709
   Tarleton RL, 2003, TRENDS PARASITOL, V19, P447, DOI 10.1016/j.pt.2003.08.008
   Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3
   Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   ZAITSEVA M, 2002, J LEUKOCYTE BIOL, V72, P1206
NR 29
TC 41
Z9 42
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JUN
PY 2006
VL 36
IS 6
BP 1486
EP 1493
DI 10.1002/eji.200535629
PG 8
WC Immunology
SC Immunology
GA 054UW
UT WOS:000238405100014
PM 16637021
OA Bronze
DA 2020-12-17
ER

PT J
AU de Meis, J
   Mendes-Da-Cruz, DA
   Farias-de-Oliveira, DA
   Correa-De-Santana, E
   Pinto-Mariz, F
   Cotta-de-Almeida, V
   Bonomo, A
   Savino, W
AF de Meis, J
   Mendes-Da-Cruz, DA
   Farias-de-Oliveira, DA
   Correa-De-Santana, E
   Pinto-Mariz, F
   Cotta-de-Almeida, V
   Bonomo, A
   Savino, W
TI Atrophy of mesenteric lymph nodes in experimental Chagas' disease:
   differential role of Fas/Fas-L and TNFRI/TNF pathways
SO MICROBES AND INFECTION
LA English
DT Article
DE Trypanosoma cruzi; lymph nodes; apoptosis; cytotoxicity
ID TRYPANOSOMA-CRUZI INFECTION; TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH;
   CYTOTOXIC T-LYMPHOCYTES; FAS LIGAND; CASPASE ACTIVATION;
   TRANS-SIALIDASE; IMMUNE-SYSTEM; FACTOR-ALPHA; IN-VIVO
AB It is currently accepted that experimental acute infection by Trypanosoma cruzi. promotes changes in secondary lymphoid organs. with general T and B lymphocyte polyclonal activation. Here we show that mesenteric lymph nodes (MLN) of acutely infected mice show severe atrophy due to extensive lymphocyte apoptosis. Accordingly, clusters of apoptotic cells are detected in the initial phase of infection in MLN but not in subcutaneous nodes. Moreover, such atrophy is independent of the infection route, parasite load or the mouse strain used. Studies in Fas-L deficient (BALB gld/gld(+/+)) and in TNF type 1 receptor (p55(-/-)) knockout mice indicate that both molecules are involved in MLN atrophy: Fas-L participates in cell death of CD4(+) as well as B lymphocytes, whereas the TNF type I receptor is important for the apoptosis of CD4(+) and CD8(+) T lymphocytes. In contrast, perform does not play a role, as lymph nodes from perforin-deficient mice do not behave differently from the corresponding wild types. Our data support the concept that, even in a systemic infection, differential (even opposing) responses can be found in different lymph node chains. (c) 2005 Elsevier SAS. All rights reserved.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultrastruct & Cell Biol, Cell Biol Lab, BR-21045900 Rio De Janeiro, Brazil.
   Natl Inst Canc, Div Expt Med, Av Andre Cavalcanti 37, BR-20231050 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, CCS, Inst Microbiol, Dept Immunol, BR-21941 Rio De Janeiro, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Ave Brasil 4365,Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI De Meis, Juliana/B-2211-2013; Cotta-de-Almeida, Vinicius/AAC-3721-2019;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Cotta-de-Almeida, Vinicius/G-3939-2012
OI Cotta-de-Almeida, Vinicius/0000-0002-6753-3480; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506; 
CR ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955
   ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71
   Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819
   Beisner DR, 2003, J IMMUNOL, V171, P247, DOI 10.4049/jimmunol.171.1.247
   Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009
   Borges MM, 1998, IMMUNOL LETT, V63, P1, DOI 10.1016/S0165-2478(98)00034-0
   Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653
   Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8
   Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924
   Chen L, 2003, EUR J IMMUNOL, V33, P769, DOI 10.1002/eji.200323783
   Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29
   Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757
   Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208
   Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000
   Hunter CA, 1996, INFECT IMMUN, V64, P2381, DOI 10.1128/IAI.64.7.2381-2386.1996
   Janssen O, 2000, CELL TISSUE RES, V301, P85, DOI 10.1007/s004419900155
   JORGE TA, 1993, PARASITE IMMUNOL, V15, P539, DOI 10.1111/j.1365-3024.1993.tb00642.x
   Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891
   Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728
   Laucella S, 1996, AM J TROP MED HYG, V55, P629, DOI 10.4269/ajtmh.1996.55.629
   Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5
   Leguizamon MS, 1999, J INFECT DIS, V180, P1398, DOI 10.1086/315001
   Lima ECS, 1997, INFECT IMMUN, V65, P457, DOI 10.1128/IAI.65.2.457-465.1997
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Lopes MF, 1999, EUR J IMMUNOL, V29, P81, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;81::AID-IMMU81&gt;3.0.CO;2-Y
   LOPES MF, 1995, J IMMUNOL, V154, P744
   Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1
   MACARIO AJL, 1980, CLIN EXP IMMUNOL, V41, P415
   Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x
   Martins GA, 2001, IMMUNOLOGY, V103, P122, DOI 10.1046/j.1365-2567.2001.01216.x
   Minoprio P, 2001, INT J PARASITOL, V31, P588, DOI 10.1016/S0020-7519(01)00171-0
   MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P669, DOI 10.1111/j.1365-3083.1986.tb02186.x
   MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P661, DOI 10.1111/j.1365-3083.1986.tb02185.x
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   Nunes MP, 1998, J IMMUNOL, V160, P1313
   OKABE K, 1980, CLIN IMMUNOL IMMUNOP, V16, P344, DOI 10.1016/0090-1229(80)90140-3
   Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244
   ROTTENBERG ME, 1995, IMMUNOL LETT, V45, P53, DOI 10.1016/0165-2478(94)00221-C
   ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993
   Sartorius U, 2001, CHEMBIOCHEM, V2, P20, DOI 10.1002/1439-7633(20010105)2:1<20::AID-CBIC20>3.0.CO;2-X
   SCOTT MT, 1984, CLIN EXP IMMUNOL, V58, P372
   Spaner D, 1998, J IMMUNOL, V160, P2655
   Spaner D, 1999, J IMMUNOL, V162, P1192
   TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992
   TARLETON RL, 1988, CLIN EXP IMMUNOL, V73, P186
   TARLETON RL, 1988, J IMMUNOL, V140, P2769
   TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0
   TONKONOGY SL, 1993, IMMUNOLOGY, V80, P574
   VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227
   ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0
   Zheng LX, 1998, J IMMUNOL, V160, P763
   Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x
   Zuniga E, 2002, J IMMUNOL, V168, P3965, DOI 10.4049/jimmunol.168.8.3965
NR 55
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2006
VL 8
IS 1
BP 221
EP 231
DI 10.1016/j.micinf.2005.06.027
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 013WW
UT WOS:000235441700025
PM 16239119
DA 2020-12-17
ER

PT J
AU Geutskens, SB
   Mendes-da-Cruz, DA
   Dardenne, M
   Savino, W
AF Geutskens, SB
   Mendes-da-Cruz, DA
   Dardenne, M
   Savino, W
TI Fibronectin receptor defects in NOD mouse leucocytes: Possible
   consequences for type 1 diabetes
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Review
ID ANTIGEN-PRESENTING CELLS; EXTRACELLULAR-MATRIX; IMPAIRED MIGRATION;
   DENDRITIC CELL; L-SELECTIN; T-CELLS; INTEGRIN; MICE; MACROPHAGES;
   ADHESION
AB Integrins of the very late antigen (VLA) family mediate leucocyte traffic to lymphoid organs under physiological conditions and in chronic inflammatory situations such as autoimmunity. Accordingly, the current thinking is of a positive correlation between VLA expression and capability of the generation of autoimmunity. Herein we discuss recent findings on the defective expression of integrin-type fibronectin receptors alpha4beta1 (VLA-4) and alpha5beta1 (VLA-5) in the non-obese diabetic (NOD) mouse, a murine model of autoimmune insulin-dependent diabetes mellitus. As compared with normal animals, NOD thymocytes (including the CD4(+)CD25(+) regulatory T cells) exhibit a decrease in the membrane expression of alpha5beta1, resulting in a functional impairment of fibronectin-mediated interactions, including cell migration. Interestingly, thymocytes that are trapped within the giant perivascular spaces seen in NOD thymus are consistently alpha5beta1 negative, suggesting that the progressive arrest of mature cells can be related to the alpha5beta1 defect. Peripheral T cells also exhibit decreased alpha5beta1 membrane expression and impaired fibronectin-driven migration. Additionally, we observed a defect in alpha4beta1 fibronectin receptor expression in NOD macrophages. Peritoneal, bone marrow-derived-precursor, as well as thymic macrophages of NOD mice showed an impaired upregulation of alpha4-integrin chain expression, dependent on the level of macrophage maturation. Overall these data lead to the notion that NOD leucocytes bear distinct fibronectin receptor-mediated cell migration defects, which may be involved in the pathogenesis and/or pathophysiology of the autoimmune events seen in NOD mice. Further studies will be helpful to define whether or not this concept can be applied for other autoimmune diseases.
C1 Univ Paris 05, Hop Necker, CNRS, UMR 8147, Paris, France.
   Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   Fundacao Oswaldo Cruz, Lab Thymus Res, Dept Immunol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Dardenne, M (corresponding author), Hop Necker Enfants Malad, CNRS, UMR 8147, 161 Rue Sevres, F-75743 Paris 15, France.
EM dardenne@necker.fr
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506
CR Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4
   Arroyo AG, 2000, J IMMUNOL, V165, P4667, DOI 10.4049/jimmunol.165.8.4667
   Atlan-Gepner C, 1999, AUTOIMMUNITY, V31, P249, DOI 10.3109/08916939908994070
   BEDNARCZYK JL, 1992, J LEUKOCYTE BIOL, V52, P456
   BERNARD NF, 1992, DIABETES, V41, P40, DOI 10.2337/diabetes.41.1.40
   Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874
   Bradley LM, 1999, J IMMUNOL, V162, P2511
   BURKLY LC, 1994, DIABETES, V43, P529, DOI 10.2337/diabetes.43.4.529
   Carvalho-Pinto C, 2004, EUR J IMMUNOL, V34, P548, DOI 10.1002/eji.200324285
   Charre S, 2002, HISTOL HISTOPATHOL, V17, P393, DOI 10.14670/HH-17.393
   Colomb E, 1996, DIABETES, V45, P1535, DOI 10.2337/diabetes.45.11.1535
   Cotta-De-Almeida V, 2004, EUR J IMMUNOL, V34, P1578, DOI 10.1002/eji.200324765
   Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655
   FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896
   Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4
   FOULIS AK, 1991, J PATHOL, V165, P97, DOI 10.1002/path.1711650203
   GOILLOT E, 1991, CLIN IMMUNOL IMMUNOP, V59, P462, DOI 10.1016/0090-1229(91)90041-8
   Hangan-Steinman D, 1999, BIOCHEM CELL BIOL, V77, P409, DOI 10.1139/bcb-77-5-409
   Hanukoglu A, 2003, DIABETES CARE, V26, P1235, DOI 10.2337/diacare.26.4.1235
   Hemler M E, 1995, Curr Opin Hematol, V2, P61
   Herbelin A, 1998, J IMMUNOL, V161, P2620
   Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0
   HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0
   IHM SH, 1990, DIABETES, V39, P1273, DOI 10.2337/diabetes.39.10.1273
   JANSEN A, 1995, LANCET, V345, P491, DOI 10.1016/S0140-6736(95)90586-3
   JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667
   Johnson JD, 2003, J LEUKOCYTE BIOL, V74, P810, DOI 10.1189/jlb.0303092
   Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256
   Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240
   LERNMARK A, 1995, VIRCHOWS ARCH, V425, P631
   MATSUYAMA T, 1989, J EXP MED, V170, P1133, DOI 10.1084/jem.170.4.1133
   Mo RR, 2003, J IMMUNOL, V171, P745, DOI 10.4049/jimmunol.171.2.745
   NOJIMA Y, 1990, J EXP MED, V172, P1185, DOI 10.1084/jem.172.4.1185
   O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481
   OREILLY LA, 1994, IMMUNOLOGY, V82, P275
   Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223
   Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212
   POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M
   SAVINO W, 1991, LAB INVEST, V64, P405
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   SAVINO W, 2000, DEV IMMUNOL, V7, P19
   SAVINO W, 2004, IN PRESS J LEUKOC BI
   SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625
   SERREZE DV, 1993, J IMMUNOL, V150, P2534
   SHIMA M, 1995, P NATL ACAD SCI USA, V92, P5179, DOI 10.1073/pnas.92.11.5179
   Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105
   Strid J, 2001, CLIN EXP IMMUNOL, V123, P375, DOI 10.1046/j.1365-2249.2001.01473.x
   TAKAHASHI H, 1992, EUR J IMMUNOL, V22, P2879, DOI 10.1002/eji.1830221119
   Takayama E, 1998, IMMUNOLOGY, V95, P553
   Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1
   Uniyal S, 1999, J AUTOIMMUN, V12, P167, DOI 10.1006/jaut.1998.0268
   VILLAVERDE DMS, 1994, EUR J IMMUNOL, V24, P659, DOI 10.1002/eji.1830240326
   YANG JT, 1995, DEVELOPMENT, V121, P549
   YANG JT, 1993, DEVELOPMENT, V119, P1093
   YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604
   YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494
   YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0
   Yoshida K, 2000, Rev Immunogenet, V2, P140
NR 59
TC 6
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD AUG
PY 2004
VL 60
IS 1-2
BP 30
EP 38
DI 10.1111/j.0300-9475.2004.01465.x
PG 9
WC Immunology
SC Immunology
GA 835DK
UT WOS:000222460200008
PM 15238071
OA Bronze
DA 2020-12-17
ER

PT J
AU Savino, W
   Mendes-Da-Cruz, DA
   Smaniotto, S
   Silva-Monteiro, E
   Villa-Verde, DMS
AF Savino, W
   Mendes-Da-Cruz, DA
   Smaniotto, S
   Silva-Monteiro, E
   Villa-Verde, DMS
TI Molecular mechanisms governing thymocyte migration: combined role of
   chemokines and extracellular matrix
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Review
DE thymocyte migration; integrins; galectins; thymic epithelial cells;
   thymic nurse cells
ID THYMIC EPITHELIAL-CELLS; RECEPTOR CXCR4; NURSE CELLS; MEDIATED
   INTERACTIONS; REGULATED EXPRESSION; POSITIVE THYMOCYTES; ENDOGENOUS
   LECTIN; CD34(+) CELLS; BONE-MARROW; IN-VITRO
AB Cell migration is crucial for thymocyte differentiation, and the cellular interactions involved now begin to be unraveled, with chemokines, extracellular matrix (ECM) proteins, and their corresponding receptors being relevant in such oriented movement of thymocytes. This notion derives from in vitro, ex vivo, and in vivo experimental data, including those obtained in genetically engineered and spontaneous mutant mice. Thymic microenvironmental cells produce both groups of molecules, whereas developing thymocytes express chemokine and ECM receptors. It is important that although chemokines and ECM proteins can drive thymocyte migration per se, a combined role of these molecules likely concurs for the resulting migration patterns of thymocytes in their various differentiation stages. In this respect, among ECM moieties, there are proteins with opposing functions, such as laminin or fibronectin versus galectin-3, which promote, respectively, adhesion and de-adhesion of thymocytes to the thymic microenvironment. How chemokines and ECM are produced and degraded remains to be more clearly defined. Nevertheless, matrix metalloproteinases (MMPs) likely play a role in the intrathymic ECM breakdown. It is interesting that these molecules also degrade chemokines. Thus, the physiological migration of thymocytes should be conceived as a resulting vector of multiple, simultaneous, or sequential stimuli, involving chemokines, adhesive, and de-adhesive ECM proteins. Moreover, these interactions may be physiologically regulated in situ by matrix MMPs and are influenced by hormones. Accordingly, one can predict that pathological changes in any of these loops may result in abnormal thymocyte migration. This actually occurs in the murine infection by the protozoan Trypanosoma cruzi, the causative agent of Chagas disease. In this model, the abnormal release of immature thymocytes to peripheral lymphoid organs is correlated with the higher migratory response to ECM and chemokines. Lastly, the fine dissection of the mechanisms governing thymocyte migration will provide new clues for designing therapeutic strategies targeting developing T cells. The most important function of the thymus is to generate T lymphocytes, which once leaving the organ, are able to colonize specific regions of peripheral lymphoid organs, the T cell zones, where they can mount and regulate cell-mediated, immune responses. This intrathymic T cell differentiation is a complex sequence of biological events, comprising cell proliferation, differential membrane protein expression, gene rearrangements, massive programmed cell death, and cell migration. In this review, we will focus on the mechanisms involved in controlling the migration of thymocytes, from the entrance of cell precursors into the organ to the exit of mature T cells toward peripheral lymphoid organs. Nevertheless, to better comprehend this issue, it appeared worthwhile to briefly comment on some key aspects of thymocyte differentiation and the tissue context in which it takes place, the thymic microenvironment.
C1 Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.
   Univ Paris 05, Hop Necker, CNRS, FRE 2444, Paris, France.
   Univ Fed Alagoas, Dept Morphol, Lab Immunomorphol, Maceio, Brazil.
RP Savino, W (corresponding author), Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Oswaldo Cruz Fdn, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Smaniotto, Salete/AAT-4056-2020; Villa-Verde, Dea M.S./Q-1238-2016;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Smaniotto, Salete/T-3796-2017
OI Villa-Verde, Dea M.S./0000-0002-2685-5512; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506;
   Smaniotto, Salete/0000-0003-1527-5894; Silva,
   Elisangela/0000-0001-9833-1825
CR Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500
   Anderson G, 2000, IMMUNOLOGY, V100, P405, DOI 10.1046/j.1365-2567.2000.00067.x
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Aoudjit F, 1999, INT J CANCER, V82, P743, DOI 10.1002/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6
   Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649
   Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149
   BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877
   BERRIH S, 1985, J HISTOCHEM CYTOCHEM, V33, P655, DOI 10.1177/33.7.3891843
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850
   CHANPALAY V, 1993, DEMENTIA, V4, P1, DOI 10.1159/000107290
   Cotta-De-Almeida V, 2003, EUR J IMMUNOL, V33, P2439, DOI 10.1002/eji.200323860
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   deMelloCoelho V, 1997, J NEUROIMMUNOL, V76, P39, DOI 10.1016/S0165-5728(97)00031-3
   DESOUZA LRM, 1993, DEV IMMUNOL, V3, P123, DOI 10.1155/1993/48056
   Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365
   Guyden JC, 2003, INT REV CYTOL, V223, P1
   Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271
   HENRY L, 1967, J PATHOL BACTERIOL, V93, P661, DOI 10.1002/path.1700930227
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419
   Kim MG, 2000, J IMMUNOL, V165, P192, DOI 10.4049/jimmunol.165.1.192
   LagrotaCandido JM, 1996, CELL IMMUNOL, V170, P235, DOI 10.1006/cimm.1996.0157
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LANNESVIEIRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P1539, DOI 10.1177/39.11.1918928
   Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6
   Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1
   Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943
   Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931
   MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x
   McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202
   Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4
   NEVESDOSSANTOS S, 2002, 2 INT S EXTR MAT ANG, pA5
   Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851
   Pezzano M, 2001, MICROBIOL MOL BIOL R, V65, P390, DOI 10.1128/MMBR.65.3.390-403.2001
   Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521
   Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837
   Power CA, 2003, J IMMUNOL METHODS, V273, P73, DOI 10.1016/S0022-1759(02)00419-2
   Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI13853
   Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9
   Ramarli D, 1998, BLOOD, V92, P3745, DOI 10.1182/blood.V92.10.3745.422a25_3745_3755
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   SALOMON DR, 1994, J EXP MED, V179, P1573, DOI 10.1084/jem.179.5.1573
   Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156
   Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346
   SAVINO W, 1991, LAB INVEST, V64, P405
   Savino W, 2003, BRAZ J MED BIOL RES, V36, P1015, DOI 10.1590/S0100-879X2003000800007
   SAVINO W, 1993, IMMUNOL TODAY, V14, P158, DOI 10.1016/0167-5699(93)90278-S
   Savino W, 2000, Dev Immunol, V7, P279, DOI 10.1155/2000/60247
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   SAVINO W, 1982, ANAT ANZEIGER, V151, P70
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Suzuki G, 1999, J IMMUNOL, V162, P5981
   TAUB DD, 1994, J CLIN INVEST, V94, P293, DOI 10.1172/JCI117320
   Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811
   Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4
   UNIYAL S, 1998, IMMUNOLOGIST S, V1, P255
   UTSUMI K, 1991, P NATL ACAD SCI USA, V88, P5685, DOI 10.1073/pnas.88.13.5685
   Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x
   Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2
   Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M
   VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907
   VILLAVERDE DMS, 1994, EUR J IMMUNOL, V24, P659, DOI 10.1002/eji.1830240326
   VILLAVERDE DMS, 1993, ENDOCRINOLOGY, V133, P867, DOI 10.1210/en.133.2.867
   Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563
   Voermans C, 1999, EXP HEMATOL, V27, P1806, DOI 10.1016/S0301-472X(99)00113-7
   Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429
   Werneck CC, 2000, J CELL PHYSIOL, V185, P68
   Werneck CC, 1999, J CELL PHYSIOL, V178, P51, DOI 10.1002/(SICI)1097-4652(199901)178:1<51::AID-JCP7>3.3.CO;2-K
   Wilkinson B, 1999, J IMMUNOL, V162, P3873
   Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737
   Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
NR 81
TC 98
Z9 98
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-5400
EI 1938-3673
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD JUN
PY 2004
VL 75
IS 6
BP 951
EP 961
DI 10.1189/jlb.1003455
PG 11
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA 827RS
UT WOS:000221918800002
PM 15020651
OA Bronze
DA 2020-12-17
ER

PT J
AU Cotta-De-Almeida, V
   Bonomo, A
   Mendes-Da-Cruz, DA
   Riederer, I
   de Meis, J
   Lima-Quaresma, KRF
   Vieira-De-Abreu, A
   Villa-Verde, DMS
   Savino, W
AF Cotta-De-Almeida, V
   Bonomo, A
   Mendes-Da-Cruz, DA
   Riederer, I
   de Meis, J
   Lima-Quaresma, KRF
   Vieira-De-Abreu, A
   Villa-Verde, DMS
   Savino, W
TI Trypanosoma cruzi infection modulates intrathymic contents of
   extracellular matrix ligands and receptors and alters thymocyte
   migration
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Chagas disease; thymus; cell migration; extracellular matrix
ID THYMIC EPITHELIAL-CELLS; POST-THYMECTOMY AUTOIMMUNITY; T-CELL;
   CHAGAS-DISEASE; MOUSE THYMUS; NURSE-CELLS; FIBRONECTIN RECEPTORS;
   MONOCLONAL-ANTIBODIES; IMMATURE THYMOCYTES; INDUCED APOPTOSIS
AB Several T cell abnormalities have been described in the course of acute Trypanosoma cruzi infection in mice, including severe effects on the thymus. In the present study, looking at the expression of extracellular matrix ligands in the thymus, we observed that deposits of fibronectin and laminin increased progressively during the course of infection, reaching a maximum at the peak of parasitemia and thymic atrophy. Concomitantly, membrane expression of fibronectin and laminin receptors (VLA-4, VLA-5 and VLA-6) was also enhanced on thymocyte subsets of infected mice. These results correlated with changes in intrathymic thymocyte migration ability during the acute phase of infection, when a higher fibronectin-dependent transmigratory activity of CD4(+)CD8(+) thymocytes was observed. Strikingly, we detected higher frequency of immature and high VLA-expressing CD4(+)CD8(+) T cells in the peripheral lymphoid organs of infected mice at the peak of parasitemia. These cells seemed to be thymus dependent, since significantly lower amounts of them were found in thymectomized mice, and some of them carry "prohibited" Vbeta segments of the TCR. Our data suggest an imbalance in the intrathymic cell trafficking following acute T. Cruzi infection, likely due to dysregulated extracellular matrix-dependent interactions.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultrastruct & Cell Biol, Lab Cell Biol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Immunol, Rio De Janeiro, Brazil.
   Estacio de Sa Univ, Sch Med, Rio De Janeiro, Brazil.
   Hop Necker Enfants Malad, CNRS, FRE 2444, Paris, France.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Immunol, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@fiocruz.br
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; De Meis, Juliana/B-2211-2013; Villa-Verde, Dea
   M.S./Q-1238-2016; Riederer, Ingo/O-1444-2017; Cotta-de-Almeida,
   Vinicius/G-3939-2012; Riederer, Ingo/M-6372-2019; Cotta-de-Almeida,
   Vinicius/AAC-3721-2019
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Villa-Verde, Dea M.S./0000-0002-2685-5512;
   Riederer, Ingo/0000-0001-7171-9977; Cotta-de-Almeida,
   Vinicius/0000-0002-6753-3480
CR Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73
   Antica M, 1999, J IMMUNOL, V163, P206
   Antonica A, 1996, J NEUROIMMUNOL, V64, P115, DOI 10.1016/0165-5728(95)00157-3
   BERRIH S, 1985, J HISTOCHEM CYTOCHEM, V33, P655, DOI 10.1177/33.7.3891843
   BONOMO A, 1995, IMMUNOL TODAY, V16, P61, DOI 10.1016/0167-5699(95)80089-1
   BONOMO A, 1995, J IMMUNOL, V154, P6602
   BONOMO A, 1994, J IMMUNOL, V152, P1509
   CARDARELLI PM, 1987, J CELL BIOL, V105, P499, DOI 10.1083/jcb.105.1.499
   CARLOW DA, 1992, J IMMUNOL, V148, P1595
   CHANG AC, 1995, J IMMUNOL, V154, P500
   CHENWOAN M, 1991, TRANSPLANTATION, V51, P661, DOI 10.1097/00007890-199103000-00023
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   DEMORAES MDCL, 1994, SCAND J IMMUNOL, V39, P51
   DENNING SM, 1987, J IMMUNOL, V139, P2573
   DONNENBERG AD, 1987, TRANSPLANT P, V19, P144
   DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29
   FINE JS, 1991, J IMMUNOL, V147, P2852
   FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4
   GODDEN U, 1985, TRANSPLANTATION, V39, P624, DOI 10.1097/00007890-198506000-00010
   Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LANNESVIEIRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P1539, DOI 10.1177/39.11.1918928
   LEITEDEMORAES MC, 1992, IMMUNOLOGY, V77, P95
   LOPES MF, 1994, INFECT IMMUN, V62, P1484, DOI 10.1128/IAI.62.4.1484-1488.1994
   LOPES MF, 1995, J IMMUNOL, V154, P744
   Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943
   MARTIN A, 1995, IMMUNOBIOLOGY, V192, P231, DOI 10.1016/S0171-2985(11)80100-2
   MENDESDACRUZ DA, 2003, IN PRESS MICROBES IN
   MINOPRIO P, 1989, IMMUNOL REV, V112, P183, DOI 10.1111/j.1600-065X.1989.tb00558.x
   MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P661, DOI 10.1111/j.1365-3083.1986.tb02185.x
   MORALE MC, 1995, ENDOCRINOLOGY, V136, P3949, DOI 10.1210/en.136.9.3949
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   MURPHY WJ, 1992, J IMMUNOL, V149, P3851
   PRUDHOMME GJ, 1991, AUTOIMMUNITY, V9, P345, DOI 10.3109/08916939108997137
   Reed SG, 1998, CHEM IMMUNOL, V70, P124
   RUIZ P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10.1002/eji.1830250735
   SALOMON DR, 1994, J EXP MED, V179, P1573, DOI 10.1084/jem.179.5.1573
   Salomon DR, 1997, BLOOD, V89, P2461, DOI 10.1182/blood.V89.7.2461
   SAVINO W, 1992, MEM I OSWALDO CRUZ, V87, P73, DOI 10.1590/S0074-02761992000900010
   SAVINO W, 1993, IMMUNOL TODAY, V14, P158, DOI 10.1016/0167-5699(93)90278-S
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   SAWADA M, 1992, J IMMUNOL, V149, P3517
   SINGER KH, 1990, J IMMUNOL, V144, P2931
   SJODIN K, 1963, TRANSPLANTATION, V1, P521, DOI 10.1097/00007890-196301040-00011
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051
   Takayama E, 1998, IMMUNOLOGY, V95, P553
   TAKLE GB, 1989, CURR TOP MICROBIOL, V145, P79
   TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992
   TARLETON RL, 1995, PARASITOL TODAY, V11, P7, DOI 10.1016/0169-4758(95)80095-6
   Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8
   Tchilian EZ, 1997, IMMUNOLOGY, V92, P321, DOI 10.1046/j.1365-2567.1997.00351.x
   UTSUMI K, 1991, P NATL ACAD SCI USA, V88, P5685, DOI 10.1073/pnas.88.13.5685
   VILLAVERDE DMS, 1994, EUR J IMMUNOL, V24, P659, DOI 10.1002/eji.1830240326
   VOLLGER LW, 1987, J IMMUNOL, V138, P358
   Zaitseva MB, 1998, INT IMMUNOL, V10, P1551, DOI 10.1093/intimm/10.10.1551
NR 63
TC 44
Z9 45
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD SEP
PY 2003
VL 33
IS 9
BP 2439
EP 2448
DI 10.1002/eji.200323860
PG 10
WC Immunology
SC Immunology
GA 721NV
UT WOS:000185323200010
PM 12938220
OA Bronze
DA 2020-12-17
ER

PT J
AU Savino, W
   Martins, SA
   Neves-dos-Santos, S
   Smaniotto, S
   Ocampo, JSP
   Mendes-da-Cruz, DA
   Terra-Granado, E
   Kusmenok, O
   Villa-Verde, DMS
AF Savino, W
   Martins, SA
   Neves-dos-Santos, S
   Smaniotto, S
   Ocampo, JSP
   Mendes-da-Cruz, DA
   Terra-Granado, E
   Kusmenok, O
   Villa-Verde, DMS
TI Thymocyte migration: an affair of multiple cellular interactions?
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT International Symposium on Extracellular Matrix (SIMEC 2002)
CY OCT 07-10, 2002
CL ANGRA REIS, BRAZIL
DE thymocyte migration; extracellular matrix; integrins; chemokines; thymic
   epithelial cells; thymic nurse cells
ID THYMIC EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX COMPONENTS; CD34(+) CELLS;
   MOUSE THYMUS; T-CELLS; FIBRONECTIN; MICROENVIRONMENT; EXPRESSION;
   LAMININ; CHEMOKINES
AB Cell migration is a crucial event in the general process of thymocyte differentiation. The cellular interactions involved in the control of this migration are beginning to be defined. At least chemokines and extracellular matrix proteins appear to be part of the game. Cells of the thymic microenvironment produce these two groups of molecules, whereas developing thymocytes express the corresponding receptors. Moreover, although chemokines and extracellular matrix can drive thymocyte migration per se, a combined role for these molecules appears to contribute to the resulting migration patterns of thymocytes in their various stages of differentiation. The dynamics of chemokine and extracellular matrix production and degradation is not yet well understood. However, matrix metalloproteinases are likely to play a role in the breakdown of intrathymic extracellular matrix contents. Thus, the physiological migration of thymocytes should be envisioned as a resulting vector of multiple, simultaneous and/or sequential stimuli involving chemokines, adhesive and de-adhesive extracellular matrix proteins, as well as matrix metalloproteinases. Accordingly, it is conceivable that any pathological change in any of these loops may result in the alteration of normal thymocyte migration. This seems to be the case in murine infection by the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas' disease. A better knowledge of the physiological mechanisms governing thymocyte migration will provide new clues for designing therapeutic strategies targeting developing T cells.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Imunol, Lab Pesquisa Sobre Timo, Rio De Janeiro, RJ, Brazil.
   Univ Paris 05, CNRS, FRE 2444, Hop Necker, Paris, France.
   Univ Fed Alagoas, Dept Morfol, Lab Imunomorfol, Maceio, AL, Brazil.
   Univ Fed Juiz Fora, Fac Farm, Dept Analises Clin, Juiz De Fora, MG, Brazil.
   Fed Univ Rio De Janeiro, Inst Ciencias Biomed, Programa Pos Grad Ciencias Morfol, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Dept Patol, Rio De Janeiro, RJ, Brazil.
RP Savino, W (corresponding author), IOC, Dept Imunol, Lab Pesquisa Timo, Av Brasil,4365, BR-21045900 Rio De Janeiro, Brazil.
RI Villa-Verde, Dea M.S./Q-1238-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; Smaniotto, Salete/AAT-4056-2020; Mendes-da-Cruz,
   Daniella A/E-7875-2016; Smaniotto, Salete/T-3796-2017
OI Villa-Verde, Dea M.S./0000-0002-2685-5512; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Smaniotto, Salete/0000-0003-1527-5894;
   Terra-Granado, Eugenia/0000-0002-3616-140X
CR Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Aoudjit F, 1999, INT J CANCER, V82, P743, DOI 10.1002/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6
   BERRIH S, 1985, J HISTOCHEM CYTOCHEM, V33, P655, DOI 10.1177/33.7.3891843
   Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2
   CHANG AC, 1993, J IMMUNOL, V151, P1789
   Coelho VDM, 2002, NEUROENDOCRINOLOGY, V75, P139, DOI 10.1159/000048230
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   DESOUZA LRM, 1993, DEV IMMUNOL, V3, P123, DOI 10.1155/1993/48056
   Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   Kim MG, 2000, J IMMUNOL, V165, P192, DOI 10.4049/jimmunol.165.1.192
   Kondo K, 2001, J SURG ONCOL, V76, P169, DOI 10.1002/jso.1030
   Kutlesa S, 2002, IMMUNOLOGY, V105, P407, DOI 10.1046/j.1365-2567.2002.01384.x
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LANNESVIEIRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P1539, DOI 10.1177/39.11.1918928
   LYRA JSPO, 1993, J PATHOL, V171, P231, DOI 10.1002/path.1711710312
   Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943
   NEVESDOSSANTOS S, 2002, 2 INT S EXTR MATR AN
   PATEL DD, 1995, INT IMMUNOL, V7, P277, DOI 10.1093/intimm/7.2.277
   Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851
   Ramarli D, 1998, BLOOD, V92, P3745, DOI 10.1182/blood.V92.10.3745.422a25_3745_3755
   Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   SAVINO W, 2000, DEV IMMUNOL, V7, P19
   Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4
   VANVLIET E, 1986, CELL IMMUNOL, V103, P229, DOI 10.1016/0008-8749(86)90086-9
   Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M
   VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907
   Virtanen I, 1996, HISTOCHEM J, V28, P643, DOI 10.1007/BF02331385
   Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563
   Voermans C, 1999, EXP HEMATOL, V27, P1806, DOI 10.1016/S0301-472X(99)00113-7
   Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429
   Werneck CC, 2000, J CELL PHYSIOL, V185, P68
   Werneck CC, 1999, J CELL PHYSIOL, V178, P51, DOI 10.1002/(SICI)1097-4652(199901)178:1<51::AID-JCP7>3.3.CO;2-K
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536
NR 41
TC 8
Z9 9
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2003
VL 36
IS 8
BP 1015
EP 1025
DI 10.1590/S0100-879X2003000800007
PG 11
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 716DE
UT WOS:000185012900008
PM 12886455
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Mendes-da-Cruz, DA
   de Meis, J
   Cotta-de-Almeida, V
   Savino, W
AF Mendes-da-Cruz, DA
   de Meis, J
   Cotta-de-Almeida, V
   Savino, W
TI Experimental Trypanosoma cruzi infection alters the shaping of the
   central and peripheral T-cell repertoire
SO MICROBES AND INFECTION
LA English
DT Article
DE Trypanosoma cruzi; T-cell repertoire; thymus; lymph nodes; autoimmunity
ID POST-THYMECTOMY AUTOIMMUNITY; HUMAN CHAGAS-DISEASE; V-BETA REPERTOIRE;
   NEGATIVE SELECTION; THYMUS; MICE; EXPRESSION; IDENTIFICATION;
   PATHOGENESIS; LYMPHOCYTES
AB We investigated the thymic and peripheral T-lymphocyte subsets in BALB/c mice undergoing acute or chronic Trypanosoma cruzi infection, in terms of expression of particular Vbeta rearrangements of the T-cell receptor. We first confirmed the severe depletion of CD4(+)CD8(+) thymocytes following acute T cruzi infection. By contrast, the numbers of CD4(+)CD8(+) cells in subcutaneous lymph nodes increased up to 16 times. In subcutaneous lymph nodes, we found CD4(+)CD8(+) cells that expressed prohibited segments TCRVbeta5 and TCRVbeta12 (which are physiologically deleted in the thymus of BALB/c mice), as did some mature single-positive cells (CD4(+)CD8(-) and CD4(-)CD8(+)). In the thymus of infected animals, although higher numbers of immature cells bearing such Vbeta segments were seen, they were no longer detected in the mature single-positive stage, suggesting that negative selection occurs normally. We also found increased numbers of cells bearing the potentially autoreactive phenotype TCRVbeta5(+) and TCRVbeta12(+) in T-lymphocyte subsets from subcutaneous lymph nodes of T cruzi chronically infected mice. In conclusion, our data indicate that immature T lymphocytes bearing prohibited TCRVbeta segments leave the thymus and gain the lymph nodes, where they further differentiate into mature CD4(+) or CD8(+) cells. Conjointly, these findings show changes in the shaping of the central and peripheral T-cell repertoire in both acute and chronic phases of murine T cruzi infection. The release of potentially autoreactive T cells in the periphery of the immune system may contribute to the autoimmune process found in both murine and human Chagas' disease, (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Inst Oswaldo Cruz, Oswaldo Cruz Fdn, Dept Immunol, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz, Oswaldo Cruz Fdn, Cell Biol Lab, Dept Ultrastruct & Cell Biol, BR-21045900 Rio De Janeiro, Brazil.
RP Savino, W (corresponding author), Univ Paris 05, Hop Necker, CNRS, FRE 2444, 161 Rue Sevres, F-75743 Paris 15, France.
EM savino@necker.fr
RI Mendes-da-Cruz, Daniella A/E-7875-2016; Mendes-da-Cruz,
   Daniella/AAN-6644-2020; De Meis, Juliana/B-2211-2013; Cotta-de-Almeida,
   Vinicius/G-3939-2012; Cotta-de-Almeida, Vinicius/AAC-3721-2019
OI Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Cotta-de-Almeida,
   Vinicius/0000-0002-6753-3480
CR ACHAORBEA H, 1993, IMMUNOL REV, V131, P5, DOI 10.1111/j.1600-065X.1993.tb01527.x
   Antica M, 1999, J IMMUNOL, V163, P206
   BISELLI R, 1992, SCAND J IMMUNOL, V35, P439, DOI 10.1111/j.1365-3083.1992.tb02879.x
   Boileau C, 2000, J IMMUNOL, V164, P5713, DOI 10.4049/jimmunol.164.11.5713
   BONOMO A, 1995, IMMUNOL TODAY, V16, P61, DOI 10.1016/0167-5699(95)80089-1
   BONOMO A, 1995, J IMMUNOL, V154, P6602
   Cardoni RL, 1996, CELL IMMUNOL, V169, P238, DOI 10.1006/cimm.1996.0114
   Costa RP, 2000, SCAND J IMMUNOL, V51, P511, DOI 10.1046/j.1365-3083.2000.00706.x
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29
   Engman DM, 2002, ACTA TROP, V81, P123, DOI 10.1016/S0001-706X(01)00202-9
   Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020
   Fernandez-Mestre MT, 2002, TISSUE ANTIGENS, V60, P10, DOI 10.1034/j.1399-0039.2002.600102.x
   GONCALVESDACOST.SC, 1991, PATHOL BIOL, V39, P91
   HODES RJ, 1996, CURR PROT IMMUNOL, V17
   KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X
   Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210
   Kishimoto H, 2000, IMMUNOL RES, V21, P315, DOI 10.1385/IR:21:2-3:315
   Leiby DA, 2002, TRANSFUSION, V42, P549, DOI 10.1046/j.1537-2995.2002.00077.x
   LEITEDEMORAES MC, 1992, IMMUNOLOGY, V77, P95
   LEITEDEMORAES MD, 1994, INT IMMUNOL, V6, P387, DOI 10.1093/intimm/6.3.387
   McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   Munro JM, 1996, J CLIN PATHOL, V49, P721, DOI 10.1136/jcp.49.9.721
   Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
   Reza J N, 1998, Dev Immunol, V5, P161, DOI 10.1155/1998/89415
   Rutella S, 1999, CYTOMETRY, V38, P95, DOI 10.1002/(SICI)1097-0320(19990615)38:3<95::AID-CYTO1>3.0.CO;2-L
   SAVINO W, 1992, MEM I OSWALDO CRUZ, V87, P73, DOI 10.1590/S0074-02761992000900010
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1989, EUR J IMMUNOL, V19, P1727, DOI 10.1002/eji.1830190930
   SIMPSON E, 1993, IMMUNOL REV, V131, P93, DOI 10.1111/j.1600-065X.1993.tb01532.x
   Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107
   Umekita LF, 2000, BRAZ J MED BIOL RES, V33, P253, DOI 10.1590/S0100-879X2000000300001
NR 37
TC 40
Z9 41
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD AUG
PY 2003
VL 5
IS 10
BP 825
EP 832
DI 10.1016/S1286-4579(03)00156-4
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 717JP
UT WOS:000185085600002
PM 12919850
DA 2020-12-17
ER

PT J
AU Savino, W
   Mendes-da-Cruz, DA
   Silva, JS
   Dardenne, M
   Cotta-de-Almeida, V
AF Savino, W
   Mendes-da-Cruz, DA
   Silva, JS
   Dardenne, M
   Cotta-de-Almeida, V
TI Intrathymic T-cell migration: a combinatorial interplay of extracellular
   matrix and chemokines?
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID RECENT THYMIC EMIGRANTS; EPITHELIAL-CELLS; CXC CHEMOKINE; CD34(+) CELLS;
   BONE-MARROW; KEY ROLE; THYMOCYTES; FIBRONECTIN; EXPRESSION; ADHESION
AB Cell migration is crucial for intrathymic T-cell differentiation. Chemokines and extracellular matrix proteins per se induce thymocyte migration, and recent data suggest a combinatorial role for these molecules in this event. For example, thymocyte migration induced by fibronectin plus CXCL12/SDF1-alpha (stromal cell-derived factor1-alpha) is higher than that elicited by the chemokine alone. If such interactions are relevant in the thymus, abnormal expression of any of these ligands and/or their corresponding receptors will lead to defects in thymocyte migration. At least in the murine model of Chagas disease, this seems to be the case. Therefore a better knowledge of this complex biological circuitry will provide new clues for understanding thymus physiology and designing therapeutic strategies targeting developing T cells.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Dept Immunol, BR-21045900 Rio De Janeiro, Brazil.
   Univ Paris 05, CNRS UMR 8603, Hop Necker, Paris, France.
   Univ Sao Paulo, Sch Med, Dept Immunol, BR-14049 Ribeirao Preto, Brazil.
   Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultrastruct & Cell Biol, BR-21045900 Rio De Janeiro, Brazil.
RP Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Dept Immunol, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM savino@gene.dbbm.fiocruz.br
RI Silva, Joao S/A-4484-2008; Mendes-da-Cruz, Daniella/AAN-6644-2020;
   Mendes-da-Cruz, Daniella A/E-7875-2016; Cotta-de-Almeida,
   Vinicius/AAC-3721-2019; Cotta-de-Almeida, Vinicius/G-3939-2012
OI Silva, Joao S/0000-0002-3410-3927; Mendes-da-Cruz,
   Daniella/0000-0003-3697-1506; Mendes-da-Cruz, Daniella
   A/0000-0003-3697-1506; Cotta-de-Almeida, Vinicius/0000-0002-6753-3480; 
CR Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221
   Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1
   Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522
   Anderson G, 2000, IMMUNOLOGY, V100, P405, DOI 10.1046/j.1365-2567.2000.00067.x
   Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238
   Annunziato F, 2001, TRENDS IMMUNOL, V22, P277, DOI 10.1016/S1471-4906(01)01889-0
   Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6
   Aoudjit F, 1999, INT J CANCER, V82, P743, DOI 10.1002/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6
   Benoist C., 1999, FUNDAMENTAL IMMUNOLO, P367
   Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L
   Campbell JJ, 1999, J IMMUNOL, V163, P2353
   Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850
   CHANG AC, 1995, J IMMUNOL, V154, P500
   Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755
   CottaDeAlmeida V, 1997, CLIN IMMUNOL IMMUNOP, V82, P125, DOI 10.1006/clin.1996.4283
   Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215
   Dalmau SR, 1999, BLOOD, V93, P974, DOI 10.1182/blood.V93.3.974.403k19_974_990
   Dalmau SR, 2001, CELL MOL BIOL, V47, P75
   DEMORAES MCL, 1991, SCAND J IMMUNOL, V33, P267, DOI 10.1111/j.1365-3083.1991.tb01772.x
   dos Santos PVA, 2001, MICROBES INFECT, V3, P971, DOI 10.1016/S1286-4579(01)01461-7
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   Geberhiwot T, 2001, J CELL SCI, V114, P423
   Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271
   Hernandez-Lopez C, 2002, BLOOD, V99, P546, DOI 10.1182/blood.V99.2.546
   KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419
   Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443
   Kim MG, 2000, J IMMUNOL, V165, P192, DOI 10.4049/jimmunol.165.1.192
   Kondo K, 2001, J SURG ONCOL, V76, P169, DOI 10.1002/jso.1030
   Kremer L, 2001, J IMMUNOL, V166, P218, DOI 10.4049/jimmunol.166.1.218
   Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.0.CO;2-Y
   Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1
   Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943
   Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738
   McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202
   McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200
   MELLOCOELHO V, 2002, NEUROENDOCRINOLOGY, V75, P139
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851
   Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296
   Pelletier AJ, 2000, BLOOD, V96, P2682
   Ramarli D, 1998, BLOOD, V92, P3745, DOI 10.1182/blood.V92.10.3745.422a25_3745_3755
   RELF K, 2002, NATURE, V416, P94
   Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601
   Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346
   SAVINO W, 1993, DIABETES, V42, P134, DOI 10.2337/diabetes.42.1.134
   Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412
   Savino W, 1996, BRAZ J MED BIOL RES, V29, P1209
   SAVINO W, 2000, DEV IMMUNOL, V7, P19
   Schmeissner PJ, 2001, J IMMUNOL, V167, P3715, DOI 10.4049/jimmunol.167.7.3715
   Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051
   Suzuki G, 1999, J IMMUNOL, V162, P5981
   Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134
   Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4
   UNIYAL S, 1998, IMMUNOLOGIST S, V1, P255
   Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M
   VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907
   Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563
   Voermans C, 1999, EXP HEMATOL, V27, P1806, DOI 10.1016/S0301-472X(99)00113-7
   Wilkinson B, 1999, J IMMUNOL, V162, P3873
   Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626
   Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x
   Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536
   Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342
NR 63
TC 108
Z9 110
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD JUN
PY 2002
VL 23
IS 6
BP 305
EP 313
AR PII S1471-4906(02)02224-X
DI 10.1016/S1471-4906(02)02224-X
PG 9
WC Immunology
SC Immunology
GA 559GY
UT WOS:000176019500010
PM 12072370
DA 2020-12-17
ER

EF